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Abstract
This work was stimulated by the search for more potent drug/prodrug combinations in the 
field of the aromatic nitrogen mustards, for potential used in antibody directed enzyme 
prodrug therapy.
4-Acyl prodrugs of N,N-bis(2-chloroethyl)-4-amino-aniline, possible substrates for 
the bacterial enzyme acylarylamidase E.C. 3.5.1.13, were synthesised. Attention was focus 
on 4-N -acetyl and 4-Ntrifluoroacety 1 compounds. The relative reactivity towards 
hydrolysis of the prodrug and drug was examined at pH 7.4 and 37®C by HPLC. The 
hydrolysis of the prodrugs at different pH (2, and 12/13) was also examined and the products 
identified and quantitated.
The leaving group effect on stability and reactivity was also investigated for a series 
of simple aniline mustards of the type C6H4-N(CH2CH2X)2 with X-groups other than 
chloro, by comparing their hydrolysis behaviour in aqueous DMSO at 37®C and pH 7 - 9.
To advance the search for new prodrug structures, the N'-acyl derivative of 
N-(4-nitrophenyl)-4 -aminobenzyl carbamate was synthesised and evaluated as a possible 
substrate for thé acylarylamidase enzyme. The hydrolysis of the 4-N -acyl compound to its 
4-amino parent was briefly examined at pH 2-12 and 25®C. The 4-N’-acyl compound proved 
to be relatively stable whereas the N-(4-nitrophenyl)-4-aminobenzyl carbamate proved to 
be very reactive spontaneously decomposing to 4-nitro aniline and other identified products. 
Synthesis of the 4-amino parent was difficult but it was obtained from the protected 4 -amino 
carbamate of general formula 4-(G-NH)-C^H4-CH2-0-C(0)-NH-C^H4-Z [Z=nitro instead 
of 4-(N,N-bis-2-chloroethylamino)phenyl] by chemical removal of the protecting group G. 
Several protection groups G were investigated and the best conditions to remove them 
established.
11
Abbreviations
ABq
Ac
ACN
ADEPT
aqu
anhyd
Ar
f-BOC
br
Bu
CBZ
cone
DCM
DMF
DMSO
El
Et
Ether
EtOAc
lEC
FAB
G
GC
GC-MS
h
HPLC
m
Me
AB quartet 
acetyl (CHgfCO)-) 
acetonitrile
antibody directed enzyme prodrug therapy
aqueous
anhydrous
aryl
f-butoxycarbonyi ((CH3)3 0 (CG)-)
broad
butyl
benzyloxycarbonyl (C6H5CH2 0 (C0 )-)
concentration
dichloromethane
N,N-dimethylformamide
dimethyl sulfoxide
electron impact
ethyl
diethyl ether 
ethyl acetate
ion exchange chromatography
fast atom bombardment
protective group
gas chromatography
gas chromatography-mass spectroscopy
hour
high performance liquid chromatography
minute
methyl
111
MS mass spectrometry
Nu nucleophile
Ph phenyl
Pr propyl
Py pyridine
sat saturated
THF tetrahydrofuran
Tr trityl ((C6H5)3C-)
Ts p-toluenesulfonyl (P-CH3C6H4SO2-)
TsOH p-toluenesulfonic acid
X wavelength
e .  molar absorptivity
I V
Structural Formulae
The Structural Formulae of mustards, carbamates and related compounds synthesised in this 
thesis are represented below:
v - O - x
Y
“ L x
X
Compound 
index n®
H Cl (5)
H OH (37)
H OS0 2 CH3 (38)
H 0(C0)CH3 (39)
H SCN (40)
H ONO2 (41)
H OTs (44)
NO OH (50)
NO OSO2CH3 (51)
NO Cl (52)
NO ONO2 (53)
NH2 Cl (10)
NH3 + Q - Cl (54)
NH2 OS0 2 CH3 (55)
NH3+ -OSO2CH3 OSO2CH3 (56)
NH2 OH (66)
CH3(C0)NH Cl (1 1 )
CH3(C0)NH OSO2CH3 (57)
CH3(C0)NH CH3(C0)0 (58)
CH3(C0)NH OH (59)
CF3(C0)NH Cl (12)
CF3(C0)NH OH (65)
V.
/ T \ N
Compound 
index n®
CH3(C0)NH (60)
NH2 (61)
H (45)
G-NH CH2-OR 
G R
Compound 
index n®
H H (80)*a
(CO)OCH2C6H5 H (85)
C(C6H5)3 H (91)
(C0)0C(CH3)3 H (93)
(C0)CH3 (C0)CH3. (95)
(C0)CH3 H (96)
G-NH CH2-O-C-NH— Z 
G Z
Compound 
index n®
H NO2 (74)
(C0 )0 CH2C6H5 NO2 (75)
(CO)OCH2C6H5 CF3 (76)
C(C6H5)3 NO2 (77)
(C0)0C(CH3)3 NO2 (78)
(C0)CH3 NO2 (26)
(C6H2(N02>30)(H2) NO2 (94)
M-CH2-oj-N H —
M
Z
Compound 
2  index n®
4-N02(C6H4)
C6H5
CH3
H
CH3
NO2
(104)
(112)
(113)
V I
Contents
1. IntiDduction 1
1.1 An overview of the cancer disease....................................................................1
1.2 Aromatic nitrogen mustards used in cancer chemotherapy............................. 2
1.3 Antibody directed enzyme therapy (ADEPT).................................................9
1.4 Alkylation reactions of aromatic nitrogen mustards..................................... 14
1.4.1 Alkylation mechanism.....:............................................................... 14
1.4.2 Kinetics of hydrolysis.......................................................................17
1.5 Quantitative structure-activity relationships for aromatic nitrogen
mustards....................................................................................... •.................19
2 . Results and Discussion 1: Synthesis and Hydrolysis of Aromatic Nitrogen
Mustards 23
2.1 Leaving group effects on the stability and reactivity of aniline
mustards........................................................................................................ 23
2.1.1 Synthesis of aniline mustards (5) and (37) - (41)............................ 23
2.1.2 Hydrolysis of aniline mustards (5) and (38) - (41)...........................27
2.1.2.1 Autotitration assay....................................................  27
2.1.2.2 HPLC assay for aniline mustards (40) and (41)................ 29
2.1.2.2.1 Aniline mustard (40)......................................30
2.1.2.2.2 Aniline mustard (41)......................................31
2.2 Synthesis of potential aniline mustard prodrug/drug combinations............33
2.2.1 Synthesis of 4-nitroso aniline mustards (50) - (53)...........................34
2.2.2 Synthesis of 4-amino aniline mustards (10), and (54) - (56).............36
2.2.3 Synthesis of potential aniline mustard prodrugs (11), (12),
(57) and (58)..................  37
2.3 Stabilities of aryl mustards (5), and (10) - (12) in aqueous phosphate
buffer 3% DMSO at pH 7.4 and 37°C.................   40
2.3.1 HPLC assay........................   40
Vll
2.3.2 [on Chromatographic assay............................................................. 42
2.4 Isolation and identification of products for the decomposition 
(hydrolysis) of aryl mustards (11) and (12) in aqueous DMSO at 37®C
and different pH ........................ :................................................   44
2.4.1 Aryl mustard (11) at pH 2 and 7 ...............................................   44
2.4.2 Aryl mustard (11) at pH 12...............................................................44
2.4.3 Aryl mustard (12) at pH 2 and 7 .......................................................45
2.4.4 Aryl mustard (12) at pH 12,13 and 14.............................................45
2.5 Decomposition (hydrolysis) of aryl mustards (10) - (12) in aqueous
DMSO at 37°C and different pH followed by HPLC....................................46
2.5.1 Aryl mustard (10)..........................................  47
2.5.2 Aryl mustard (11)..............................................................................49
2.5.2.1 pH 2....................................................................................49
2.5.2.2 pH 12 and pH 13..................................................................49
2 5.2.3 Summary............................................................................. 50
2.5.3 Aryl mustard (12)......................................................... i...................53
2.5.3.1 pH 2............................. ;..................................................... 53
2.5.3.2 pH 12................................................................................... 54
2.5.3.3 pH 13................................................................................... 54
2.5.3.4 Summary............................................................................. 55
2.6 Hydrolysis of aryl mustards (10) - (12) in aqueous DMSO at 37°C and
different pH followed by UV-visible spectrophotometry........................ 60
2.6.1 Aryl mustard (10)............................................................................. 61
2.6.2 Aryl mustard (11)............................................................................. 61
2.6.3 Aryl mustard (12)............................................................................. 61
2.7 Stability of aryl mustard (58) in aqueous DMSO at 50°C and pH 12
determined by HPLC.....................................................................................65
2.8 The common ion effect by added Cl".........................  67
2.9 Synthesis of authentic products (59), (60), (65) and (66).............................. 67
3. Results and Discussion 2: Carbamate Prodrugs 70
3.1 Utility of carbamate compounds as prodrugs........................  70
3.2 Synthesis of 4 -amino protected carbamates and removal of the
protection group.......................................................................................... 72
3.2.1 The N'-benzyloxycarbonyl derivatives (75) and (76)..................... 75
Vlll
3.2.1.1 Synthesis............................................................................. 75
3.2.1.2 Hydrogenolysis..............     76
3.2.2 The N'-triphenylmethyl derivative (77)...................................... 80
3.2.2.1 Synthesis..............................   80
3.2.2 2 Hydrolysis...........................................................................82
3.2.3 The N’-tert-butoxycarbonyl derivative (78)....................................82
3.2.3.1 Synthesis ....................  ;.......................... 82
3.2.3 2 Hydrolysis of (78) and synthesis of picrate (94).................84
3 2.3.3 Study of the stability of (78) in mUd basic conditions 85
3.2.4 The N'-acetyl derivative (26)......................................................... 85
3.2.4.1 Synthesis............................................................................ 85
3.2.4.2 Decomposition................................................................... 87
3.2.4.2.1 HPLC studies...................................................87
3.2.4.2 2 UV/visible spectrophotometric studies.......88
32.4.2.3 Conclusions.......................... ;......................... 91
3.3 The 4 -amino carbamate (74)...................................................................... 93
3.3.1 Synthesis........................................................................................... 93
3.3.2 Spontaneous decomposition............................................................... 94
3.3.3 Spontaneous decomposition in the presence of Lil............................ 96
3.3.4 Discussion.........................................................................................102
3.4 Evaluation of N'-acetyl carbamate (26) as a substrate for acylaryl­
amidase   104
3.4.1 UV-visible procedures..................................................................... 104
3.4.2 HPLC procedures..............................................................................107
3.4.3 Conclusions..................................................................................... 108
3.5 Synthesis and reactions of model carbamates............................................109
3.5.1 Synthesis and hydrogenolysis of carbamate (104)......................... 109
3.5.1.1 Synthesis...........................................................................109
3.5.1.2 Hydrogenolysis.................................................................110
3.5.2 Synthesis of carbamate (112) ........................................ I l l
3.5.3 Synthesis and hydrolysis of carbamate (113)...............................112
3.5.3.1 Synthesis ..................................  112
3.5 3.2 Hydrolysis............................................................   113
IX
4 . Summary and Discussion 115
4.1 N-Acylaminoaryl and related N-mustards...............   116
4.1.1 Synthesis........................................................................................ 116
4.1.2 Stability and decomposition......................................................... 116
4.2 Carbamate drug/ prodrug combinations........................................................120
5. Experimental 122
5.1 General Instrumentation...........................................................................122
5.2 Reagents and Reactants.............................................................................   123
5.3 Synthesis of substrates.............................................................................. 124
5.3.1 N,N-Bis(2-hydroxyethyl)aniline (37)..............  124
5.3.2 N,A/-Bis(2-methanesulphonyloxyethyl)aniline (38) and
N,N-Bis(2-methanesulphonyioxyethyl)aniline ' hydro­
chloride (43)................................................................................... 124
5.3.3 N,N-Bis(2-acetoxyethyl)aniline (39).......................................... 125
5.3.4 N,N-Bis(2-ethyltoluene-4-sulphonate)aniline (4 4 ) ................... 125
5.3.5 N,N-Bis(2-chloroethyl)aniline (5)...............................  126
5.3.6 N,N-Bis(2-thiocyanoethyl)aniline (40)..................... 126
5.3.7 A/,N-Bis(2-nitratoethyl)aniline (41)........................................... 127
5.3.8 N,N-Bis(2-hydroxyethyl)-4-nitroso-aniline (50).......................127
5.3.9 N,N-Bis(2-methanesulphonyloxyethyl)-4-nitroso-aniline
(51).............................. -................................................................... 128
5.3.10 N,N-Bis(2-chloroethyl)-4-nitroso-aniline (52)...........................128
5.3.11 N,A/-Bis(2-nitratoethyl)-4-nitroso-aniline (53)..........................128
5.3.12 N,N-Bis(2-chloroethyl)-4-amino-aniline (10) and 
N,]V-bis(2-chloroethyl)-4-amino-aniline hydrochloride (54).... 129
5.3.13 N,N-Bis(2-methanesulphonyloxyethyl)-4-aminoaniline (55)
and JV,N-bis(2-methanesulphonyloxyethyl)-4-amino-aniline 
methanesulphonate salt (56)......................................................... 129
5.3.14 N-[4[N',N'-Bis(2-chloroethyl)aminolphenyl]acetamide (11).... 130
5.3.15 N-[4-[N',N-Bis(2-chloroethyl)amino]phenylltrifluoro-
acetamide (12)....................................................................  130
5.3.16 N-[4-[N',W-Bis(2-methanesulphonyloxyethyl)amino]
phenyl]acetamide (57)...................................................................131
5.3.17 N-[4-[N',W-Bis(2-acetyloxy)ethyllaminolphefiyl]
acetamide (58).............................  131
5.3.18 N-[4-[N',N*-Bis(2-hydroxyethyl)amino]phenyllacetamide
(59).................................................................................................. 132
5.3.19 N-[4-(4-morpholmo)phenyllacetaniide (60).............................. 132
5.3.20 N-[4-[lV',N'-Bis(2-hydroxyethyl)amino]phenyl]trifluoro-
acetamide (65)................................   133
. 5 .3.21 N,N-Bis(2-hydroxyethyl)-4-ainino-aniline (66 )....................... 133
5.3.22 4-(N-Benzyloxycarbonylamino)benzyl alcohol (85)................   133
5.3.23 4'-(N'-Benzyloxycarbonylamino)benzyl N-(4-nitrophenyl)
carbamate (75)................................................................................134
5.3.24 4'-(]V’-BenzyloxycarbonyIamino)benzyl A/-(4-trifIuoro-
methylphenyl) carbamate (76).....................   134
5.3.25 4-(IV-Triphenylmethylamino)benzyl alcohol (91).....................135
5.3.26 4 -(N'-TriphenyImethylamino)benzy 1 /V-(4-nitrophenyl)
carbamate (77)...............  135
5.3.27 4-(N-t-Butoxycarbonylaimno)benzyl alcohol (93)......................136
5.3.28 4'-(N'-f-Butoxycarbonylamino)benzyl N-(4-nitro-phenyl)
carbamate (78)....................................................................  136
5.3.29 4-(N-Acetylamino)benzyl methyl ester (95).............................. 137
5.3.30 4-(N-Acetylamino)benzyl alcohol (96)....................................... 138
5.3.31 4'-(WAcetylamino)benzyl N-(4-nitrophenyl) carbamate (26)... 138
5.3.32 4'-Aminobenzyl N-(4-nitrophenyI) carbamate, picrate
salt (94)..................................................................    138
5.3.33 4-Aminobenzyl N-(4-nitrophenyl) carbamate (74)....................139
5.3.34 4-Nitrobenzyl N-phenyl carbamate (104)................................... 139
5.3.35 Benzyl N-(4-methylphenyl) carbamate (112).............................140
5.3.36 Ethyl N-(4-nitrophenyl) carbamate (113)................................... 140
5.4 Reaction methods.........................................................................................141
5.4.1 Kinetics of mustard (5) and (38) - (41) hydrolysis followed by
autotitration .................................................................................. 141
5.4.2 Kinetics of mustard (10) - (12) hydrolysis followed by
UV-visible spectrophotometry.............................   141
5.4.3 Kinetics of mustard (5), (10) - (12), (40), (41) and (58)
hydrolysis and analysis of products followed by HPLC..............143
XI
5.4.3.1 Analysis of hydrolysis products of mustard (40) and 
kinetics of mustard (41) hydrolysis in aqueous DMSO.... 144
5.4.3.2 HPLC conditions for analysis of hydrolysis products 
from mustards (5), (10) - (12) and (5 8 ) ..........  145
5.4.3.2.1 Calibration curves for standards.................149
5.4.3.3 Hydrolysis of mustards (5), (10) - (12) and (58) in 
aqueous phosphate buffer/DMSO (3%, v/v) at pH 7.4
and 37°C............................................................................150
5.4.3.4 Hydrolysis of mustards (10) - (12) and (58) in aqueous 
DMSO (7:3, v/ v) at pH 2,12 or 13 and 37°C or 50“C.........150
5.4.4 Kinetics of mustard (5), and (10) - (12) hydrolysis in aqueous 
phosphate buffer/DMSO (3%,v/v) at pH 7.4 and 37®C
followed by ion exchange chromatography.................................. 150
5.4.5 Isolation and identification of hydrolysis products for
mustards (11) and (12) by GC and GC-MS...................................... 151
5.4.6 Decomposition of N'-acetyl carbamate (26)................................... 152
5.4.6.1 By UV-visible spectrophotometry.................................152
5.4.6.2 By analytical HPLC......................................................... 153
5.4.6 3 Hydrolysis by the enzyme acylarylamidase............ ,. 155
5.4.6.3.1 UV-visible spectrophotometric studies of
(26) and (103) hydrolyses............................. 155
5.4.6.3 2 HPLC studies of (26) hydrolysis ........ 156
5.4.7 Decomposition of carbamate (74)....................................................156
5.4.7.1 General procedure....................................................  156
5.4.7.2 Decomposition in the presence of L il................................157
5.4.8 Hydrogenolysis of N’-CBZ carbamates (75) and (76) and
carbamate (104)............................................................................. 158
5.4.8.1 General procedure...........................................................158
5.4.8.1.1 Product identification for carbamate (76).... 158
5.4.8.1.2 Product identification for carbamate 104).... 159
5.4.9 Hydrolysis of alcohol (91)...............  160
5.4.10 Hydrolysis of carbamate (113)........  160
5.4.11 Hydrolysis of ester (95)............................................   160
References 161
X l l
List of Figures
2.1 Hydrolysis of aniline mustard (41) in aqueous DMSO at pH 9 and 37°C................. 32
2.2 Decomposition of aryl mustards (5), (10), (11) and (12) in phosphate buffer at
pH 7.4 and 37®C, followed by HPLC..................................................................   41
2.3 Comparison of hydrolysis of mustards (5), (10), (11) and (12) in phosphate
buffer at pH 7.4 and 37°C, followed by ion exchange chromatograpy....................43
2.4 HPLC assays of N,N-bis(2-chloroethyl)-4-amino-aniline (10) decomposition
in aqueous DMSO at pH 12 and 37°C..........................................................................48
2.5 HPLC assays of N-[4-(A/',N’-bis(2-chloroethyl)amino]phenyl]acetamide (11)
decomposition in aqueous DMSO at pH 2 and 37°C...................................................51
2.6 HPLC assays of N-[4-[N',A/’-bis(2-chloroethyl)amino]phenyl]acetamide (11)
decomposition in aqueous DMSO at pH 12 and 37°C.............................................52
2.7 HPLC assays of [N-[4-[N',N'-bis(2-chloroethyl)amino]phenyl]trifluoro
acetamide (12) decomposition in aqueous DMSO at pH 2 and 37®C..........................56
2.8 HPLC assay of (N-[4-[N',N’-bis(2-chloroethyl)amino]phenylltrifluoro
acetamide (12) decomposition in aqueous DMSO at pH 12 and 37°C........................57
2.9 HPLC assay of [N-[4-[N',W-bis(2-chloroethyl)amino]phenyl]trifluoro-
acetamide (12) decomposition in aqueous DMSO at pH 13 and 37®C........................58
2.10 UV/Vis spectra of hydrolysis of JV,/'/-bis(2-chloroethyl)-4-amino-aniline
(10) in aqueous DMSO at 37°C and pH 12.................................................................. 62
2.11 UV/Vis spectra of hydrolysis of /V,V-bis(2-chloroethyI)-4-amino-aniline
(10) in aqueous DMSO at 37°C and pH 2 ........  63
2.12 UV/Vis spectra of hydrolysis of A/-[4-[N',N'-bis(2-chloroethyl)amino]
phenyljacetamide (11) in aqueous DMSO at 37°C and pH 2 .....................................63
2.13 UV/Vis spectra of hydrolysis of N-[4-[N',N'-bis(2-chloroethyl)amino]
phenyl]trifluoroacetamide (12) in aqueous DMSO at 37°C and pH 12................... 64
2.14 UV/Vis spectra of hydrolysis of N-[4-[fs/',N'-bis(2-chloroethyl)amino]
phenyl] trifluoroacetamide (12) in aqueous DMSO at 37°C and pH 2 .......................64
2.15 Hydrolysis of N-[4-[N',N -bis(2-acetyloxy)ethyl]amino]phenyl]acetamide
(58) in aqueous DMSO at pH 12 and 50°C  ........................................................... 66
x iii
3.1 UV/Vis spectra for hydrolysis of (26) in aqueous DMSO at.25°C........   90
3.2 iH-NMR of (74).......................................................................................................... 98
3.3 ^H-NMR and MS(EI) of the decomposition products from (74) in
DMSO/CHCI3 in the presence of equimolar Lil at 65®C for 24h - Fraction 1.......... 99
3.4 ^H-NMR and MS(EI) of the decomposition products from (74) in
DMSO/ CHCI3 in the presence of equimolar Lil at 65°C for 24h - Fraction 2 ......... 100
3.5 ^H-NMR and MS(EI) of the decomposition products from (74) in
DMSO/CHCI3 in the presence of equimolar Lil at 65°C for 24h - Fraction 3 .........101
3.6 Decomposition of (103) in tris / HCl buffer at pH 8.6 and 37°C.................................105
3.7 Decomposition of (26) in tris/ HCl buffer at pH 8.6 and 37®C...................................106
3.8 Hydrolysis of (113) in aqueous / DMSO at 37®C........................................................114
4.1 Hammet plot for the hydrolysis of mustards (5), (10), (11) and (12) in
phosphate buffer pH 7.4 and 37°C.......................................................................... 119
5.1 Hydrolysis of mustard (5) in aqueous DMSO at pH 9 and 37®C followed by
autotitration............................................................................................................. 142
5.2 HPLC chromatograms of mustards (10), (11) and (12) hydrolysis in aqueous
phosphate buffer/DMSO at pH 7.4 and 37®C.......................................................... 148
5.3 HPLC calibration curve for authentic (60)................................................................149
5.2 HPLC chromatogram for the hydrolysis of N'-acetyl carbamate (26) in
aqueous DMSO at pH 12 and 37°C............................................................................155
X IV
List of Tables
2.1 Hydrolysis rates for mustards (5) and (38M41) in aqueous DMSO at 37°C
obtained by autotitration of the acid released..........................................................29
2.2 HPLC assay of hydrolysis products for aniline mustard (40) in aqueous DMSO
at pH 9 and 37®C.....................................................................................................30
2.3 HPLC assay of hydrolysis products for aniline mustard (41) in aqueous DMSO
at pH 9 and 37®C.................................................................................................... 31
2.4 Values of k\ for the decomposition of aryl mustards (5), and (10)-(12) in
phosphate buffer at pH 7.4 and 37°C, followed by HPLC........................................ 42
2.5 Values of k\ and k2 for decomposition of aryl mustards (5), and (10)-(12) in
phosphate buffer at pH 7.4 and 37®C, followed by ion exchange 
chromatography...................................................................   43
2.6 Dependence of k\ and products on pH for N-[4-[N',N'-bis(2-chloroethyl)-
aminophenylacetamide (11) decomposition in aqueous DMSO at 37®C................ ...50
2.7 Dependence of k\ and products on pH for [N-[4-[N ',N'-bis(2-chloroethy 1) 
amino]phenyl]trifluoroacetamide (12) decomposition in aqueous DMSO at
37®C............................................................................................................................. 60
2.8 Half-lives ( t i /2) for the hydrolysis of aryl mustards (10) (12) in aqueous
DMSO at pH 2 and 37®C in the presence of NaCl or NaClO^...................................67
3.1 Stability of the N'acetyl carbamate (26) at 37°C over 24h....................................... 88
3.2 Capillary GC retention times for authentic compounds (80), (89) and (92)...............95
3.3 Approximate half-lives for the decomposition of (26) and (103) in tris/HCl
buffers at pH 8.6 and 37°C..........   107
4.1 Rate constants obtained by different assay methods for the hydrolysis of
mustards (5) and (10) - (12) in aqueous DMSO at 37®C under different 
conditions................................................................................................................. 118
5.1 Xmax of mustards and hydrolysis products in aqueous DMSO at different pH........ 143
5.2 HPLC conditions, retention times, and X^ax for authentic materials used in
the product analysis of mustards (40) and (41)........................................................144
XV
5.3 HPLC conditions and retention times for authentic materials used in product
analysis of the mustards (5), (10)-(12) and (58).......................................................145
5.4 Coefficients for HPLC calibration curves for authentic (11), (12), (59), (60),
and (65).....................................  149
5.5 Conditions for analysis by ion exchange chromatography and retention times
obtained for authentic phosphate buffer and Cl'................................................. 151
5.6 Conditions for GC and GC-MS analyses and retention times for authentic 
compounds involved in identification of hydrolysis products for mustards (11)
and (1 2 )............................................................................   152
5.7 HPLC conditions and retention times for authentic compounds involved in
decomposition of (26)...............................................  153
5.8 Coefficients for HPLCcalibration curves for authentic compounds involved in
decomposition of carbamate (26)..............................................................................154
5.9 Conditions and retention times for GC and GC-MS assay of carbamate (74)........... 156
5.10 GC and GC-MS conditions and retention times for compounds involved in .
hydrogenolysis of (76)...................................................................................... 158
5.11 GC and GC-MS conditions and retention times for the hydrogenolysis of (104).......159
5.12 HPLC conditions involved in hydrolysis of (95)................................  160
XVI
List of Schemes
1.1 Some nitrogen mustard drug/ prodrug combinations used in chemotherapy.................8
1.2 The first mustards used in ADEPT.........................................................................   11
1.3 Cephalosporin mustard carbamate prodrug used in ADEPT...................................... 12
1.4 Melphalan prodrug used in ADEPT.!.........................................................................   12
1.5 Proposed mechanism for quinone-methide prodrug reactivity............................... 13
1.6 The formation of cyclic aziridinium ion intermediate from aliphatic
2-halogenoethylamines............................................................................................. 14
1.7 Unimolecular hydrolysis of aryl nitrogen mustards involving a carbonium ion
intermediate..................................................................  14
1.8 Internal bimolecular mechanism..................   15
1.9 Dual mechanism of nucleophilic displacement for aryl nitrogen mustard
involving the same transition state........................................................................... 15
1.10 Scrambling of the deuterium label for both hydrolysis and acetolysis of aryl
mustards...............................................................................................  16
1.11 Proposed mechanism for the nucleophilic displacement of the aryl nitrogen
mustard.......................................................................................................................16
1.12 The two stage process involved in the hydrolysis of mustards.......................... 17
1.13 Reaction of alkylating agent with 4*-(4-nitrobenzyI)pyridine.................................18
2.1 Syntheses of aniline mustards (5) and (37) - (41)................................................... 24
2.2 Hydrolysis pathways for aniline mustard (40) in aqueous. DMSO at pH 9........ .....31
2.3 Hydrolysis pathways for aniline mustard (41) in aqueous DMSO at pH 9......  33
2.4 Common pathway for the synthesis of 4-(A/'-acylamino) aniline mustards.............34
2.5 Synthesis of 4-nitroso mustards (50) - (53).............................................................. 35
2.6 Synthesis of the N-acyl potential prodrugs (11), (12) and (57)...............................38
2.7 Synthesis of the N-acyl potential prodrug (58).......................................... .'..........39
2.8 Two steps involved in the hydrolysis of the aryl mustards................................... 42
2.9 Decomposition pathway for N,N-bis(2-chloroethyl)-4-amino-aniIine (10) in
aqueous DMSO at pH 12 and 37°C................................................ 47
x v i i
2.10 Decomposition pathways for N-[4-[N',N'-bis(2-chloroethyl)amino]phenyi]
acetamide (11) in aqueous DMSO at 37®C and different p H .....................................53
2.11 Decomposition pathways for [N-[4-[N',N’-bis(2-chioroethyl)aminolphenyl]
trifluoroacetamide (12) in aqueous DMSO at 37®C and different pH .......................59
2.12 Decomposition pathway for N-[4-[N',N'-bis(2-acetyloxyethyl) amino]
phenylacetamide (58) in aqueous DMSO at pH 12 and 50®C................................. 65
2.13 Synthesis of (65).........................................................................................................68
3.1 Mechanism for conversion of the carbamate prodrug into the active drug................ 71
3.2 Synthesis of the protected carbamates (26) and (75) - (78)........................................ 74
3.3 Synthesis of compounds (75) and (76)........................................  75
3.4 Hydrogenolysis of the N’-benzyloxycarbonyl derivative (75) for 14h.................... 77
3.5 Hydrogenolysis mechanism of N-benzyloxycarbonyl derivative (75).....................78
3.6 Hydrogenolysis of the N-benzyloxycarbonyl derivative (76) for 14h..................... 79
3.7 Hydrogenolysis mechanism of ccarbamate (76)................................  80
3.8 Synthesis of compound (77)..................    81
3.9 Synthesis of compound (78)......................................................................................... 83
3.10 Hydrolysis of compound (78)........................................  84
3.11 Synthesis of the N'-acetyl derivative (26).................................................  86
3.12 Hydrolysis of (26) in aqu. DMSO (pH 2, 7 or 12) and in DCM or THF at 37®C........... 92
3.13 Synthesis of 4'-amino carbamate (74)......................................................................... 94
3.14 The intermediate species being trapped by the nucleophile I".................................96
3.15 Spontaneous decomposition of (74) in chloroform/ DMSO at 65®C............................102
3.16 Thermal decomposition of (74).................................................................................. 103
3.17 The model reaction of aminobenzylquinolinium salts.............................................. 103
3.18 Model reaction of (103) as an acylarylamidase substrate......................................104
3.19 Decomposition mechanism of N'-acetyl carbamate (26) with acylaryl­
amidase..................................................................................................................... 1Ô8
3.20 Synthesis of (104)......................................................................................   109
3.21 Hydrogenolysis of (104) in H2 /Pd at 25°C............................................................ I l l
3.22 Synthesis of carbamate (112).................................................................................... 112
3.23 Synthesis of carbamate (113).................................................................................... 112
3.24 Equilibrium involving compound (113) in aqueous / DMSO and different pH 113
4.1 Two step decomposition pathway for mustard hydrolysis...................................... 119
4.2 Spontaneous decomposition of 4 -aminobenzylcarbamate structure................  120
X V l l l
Chapter 1
Introduction
1.1 An overview of the cancer disease
Cancer is a collective term for over a hundred types of malignant tumours. Malignant tumours 
are defined as a group of abnormally proliferating cells that can arise in any part of the body 
and become invasive; that is, they can spread from their sites of origin. If these proliferating 
cells remain strictly local and non-invasive, they are called benign tumours.^
Cancer cells arise from a single cell that has undergone permanent DNA changes. The 
result of this is that the daughter cells become relatively undifferentiated and lose their 
cell-cell contact inhibition. Repeated mitosis of these daughter cells then occurs at a much 
faster rate than those of the surrounding normal cells. There are two main changes in a cancer 
cell. The first change is of a regulatory nature. The multiplication of the cancer cell does not 
obey the normal regulatory mechanisms of the organism and it is in a continuous 
multiplication process. The second change of the cancer cell deals with its relation with the 
neighbouring cells. Thus, normal cells are limited to specific organs whereas cancer cells can 
invade other tissues. In addition, they can migrate through the blood or the lymphatic 
system to establish new colonies of cells in other, distant organs. This process is called 
metastasis and is responsible for the highly lethal nature of cancer.
Many factors are believed to be involved in the formation of most tumours. A wide 
variety of agents can act on the normal cells and transform them into malignant cells. The 
agents which contribute to carcinogenesis include: chemicals,^ physical agents  ^ (eg. ionizing 
and non-ionizing radiation), and biological agents (viruses,^ hormones )^.
Certain differences have been observed between normal and malignant cells. For 
example, malignant cells often have greater free radical character,^ lower pH,^ tumour 
associated antigens,® tumour-produced hormone peptides,® higher biowater content,^ higher 
potassium ion and lower calcium ion concentrations,^® different potassium isotope ratios,^®
and larger amounts of methylated nucleosides.^^ Further, some types of tumour cells 
{e.g. leukemia cells) require an external source of L-asparagine whereas normal cells do not.^^
Until recently, the treatment of non-disseminated solid tumours was performed by 
surgery and irradiation. Both methods can be considered to be relatively tumour selective, 
without significantly harming the rest of the body. If, however, the tumour was 
disseminated to various organ sites, the métastasés could be treated by chemotherapy and 
immunotherapy only. Chemotherapy is most effective when the number of malignant cells is 
small. It has considerable side effects due to the lack of specificity of action and the 
induction of resistance. Immunotherapy alone has a limited tumour spectrum. By using a 
combination of two or more of these methods, cure rates of certain cancers have been greatly 
improved. It is often necessary to employ surgical treatment followed by radiotherapy to 
reduce the tumour size to a level that can be effectively coped with by chemotherapy, which, 
in turn, would reduce the remaining tumour cells to a small enough number to be completely 
destroyed by the host immunologic defences.
Recently, some authors refer to the use of chemotherapy alone, performed in a more 
selective way, in the treatment of some solid tumours.^® The purpose of the present work is to 
give some contribution to this goal.
1.2 Aromatic nitrogen mustards used in cancer chemotherapy
Certain drugs inhibit cell division or selectively destroy reproducing cells without permanent 
injury to non-reproducing cells. The treatment of cancers with drugs of this type is a branch of 
chemotherapy.
Most drugs in current use inhibit cell division by interfering with either the synthesis 
or the metabolism of nucleic acids, or with cell m i t o s i s . N o n e  of the anti-cancer drugs 
discovered so far is capable of absolute discrimination between malignant cells and healthy 
normal cells. . The interference with the replication of normal cells, particularly those 
undergoing fast division as in the case of bone marrow and intestinal mucosa, leads to poor 
selectivity i.e. there is toxicity towards normal as well as cancerous tissue. A similar 
problem occurs in the radiation treatment of cancer. Thus, such anti-tumour agents produce 
side effects ranging from nausea and hair loss to suppression of the immune system.
Other problems associated with conventional drug treatment arise because the cancer 
may initially respond well to the treatment, but then develop a resistant subset of cancerous 
cells. Furthermore, some drugs fail to penetrate a tumour because of an inadequate blood 
supply or changes by mutation rendering the cell membrane impermeable to the drug.
The cancers which have responded best to chemotherapy are those where cell 
division is rapid as in choriocarcinoma (a rare form of cancer originating in the foetal 
membranes) and acute childhood leukaemia. In contrast, most human cancers such as lung, 
intestinal and breast cancer, do not respond well to this treatment because of their slower 
division.^^
Drugs used for cancer therapy can be categorised by their chemical class, mode of 
action or origin, i.e. whether derived from synthetic or natural sources. Such classes include 
alkylating agents, platinum derivatives, antimetabolites and antihormonal agents as well as 
numerous others such as plant products (vincristine, vinblastine and the podophyllotoxins), 
and antibiotics (Bleomycin and Adriamycin).^®'^^
Alkylating agents were the earliest and most successful anticancer drugs and have 
been the most systematically investigated. They include the nitrogen mustards (the largest 
category), aziridines, methanesulphonates and epoxides. All react with various cellular 
nucleophiles such as hydroxy, amino, mercapto, or imidazole groups of proteins and nucleic 
acids. However, it is cross-linking of opposite DNA strands by bifunctional alkylation 
(preventing separation of the two strands essential for cell division) which relates to their 
chemotherapeutic p r o p e r t i e s . T h e  DNA sites involved in alkylation reactions are 
preferentially the N7 guanine residue in a reaction dominated by the molecular electrostatic 
potential of the DNA site (thus, reaction occurs preferentially in the central runs of contiguous 
guanines where this potential is most negative ^®). It is also possible that alkylation of 
heterocyclic bases in nucleotides takes place by initial phosphate estérification followed by 
alkyl group transfer from oxygen to nitrogen.^^'24
The alkylating agents can have three main biological effects on cells. First, a 
cytostatic effect (low dosage) whereby cell mitosis is delayed or prevented. Secondly, a 
mutagenic effect (medium dosage) whereby cell division takes place, but the daughter cells 
are altered with possible development of carcinogenic properties. Thirdly, a cytotoxic effect 
(high dosage) whereby cells are irreparably damaged and killed.^ ^
In 1946, Goodman and Gilman^® studied the pharmacology of simple aliphatic 
nitrogen mustard derivatives and noted their effect on dividing cells. The two compounds 
tested were tris(2-choroethyl)amine (1) and bis(2-choroethyl)methylamine (2), better known 
as mustine. Compound (2), discovered in the course of work on potential war gases, was found 
to depress the white blood cell count. This suggested use for treating certain leukaemias and 
(2 ) was the first mustard used clinically to induce remission in malignant lymphomas.^® The 
term nitrogen mustard indicates its isosteric relationship to mustard gas (3).
The chemical reactivity of the nitrogen mustards depends on cleavage of the halogen 
atom X from the molecule. This reaction is facilitated by the electron releasing capability of 
the N-atom. Thus, by attaching the nitrogen mustard function to an aromatic ring, it is 
possible to obtain compounds less reactive than the aliphatic analogues. In order to obtain 
mild-acting agents, in 1948, Haddow and Ross began the study of the aromatic nitrogen 
mustards with the general formula Y-C6H4-N(CH2CH2X)2 (4) (where X was normaly Cl, Br 
or I). The first compound to be prepared and tested clinically was the simple aniline 
mustard (5). Subsequently, a large number of related compounds have been prepared and still 
remain in clinical use in many multi-drug regimens, for example Chlorambucil (6) (one of the 
slowest acting and least toxic of the nitrogen mustards) and Melphalan (7) (a phenylalanine 
mustard, whose L isomer is at least five times more reactive than the D isomer, showing the 
importance of chirality in biological activity^®). The aromatic nitrogen mustards (in 
contrast to their aliphatic counterparts which are highly reactive and vesicant) can be taken 
orally to reach target sites before extensive dissipation by side reactions.
N(CH2CH2C1)3
( 1)
Z(CHzCH2Cl)2
Z=CH3N (2) 
Z=S (3)
(CH2CH2%)2
o,m.p
(4)
Y N  (C H 2C H 2CD2
Y= H (5)
Y= (CH2)3C00H (6)
Y= CH2CH(NH2)C00H (7)
O2N
NO,
C O N H ?
(8)
Chart 1 Structures (5) - (8)
Early workers tried several modifications of the mustard structure in order to improve 
the selective toxicity towards cancer cells. In 1952, Dane Hi pointed out that drugs could be 
made more selective by increasing the number of variables affecting drug activity. 
Variations could be achieved by exploiting differences in chemical reactivity and physical 
properties (solubility, polarity) of drugs, and differences between normal and malignant cells 
(pH,^® enzyme levels, etc). Furthermore, moieties such as amino acids,28/31 
carbohydrates/^^ polypeptides, nucleosides and steroids could be used either to convey or to
inactivate the toxic constituent.33/34 Examples of drugs where attachment of the alkylating 
residue to a naturally occuring molecule (e.g. sugar, amino-acid) facilitate selective transport 
into tumour cells include Degranol^^ (a D-manital derivative), Melphalan^® 
(a L-phenylalanine derivative) (7), and Phenesterin (a cholesterol ester derivative).
The use of biological moieties to inactivate the toxic constituent of the anti-cancer 
drug is the principle of latent chemotherapeutic activity. This implies the design of a 
compound (prodrug) which is inactive but convertible in vivo (hydrolysis, reduction, 
oxidation) into an active form (drug) at the tumour site.
The important observation of Connors et al.^^  that the relatively inert mono 
functional alkylating agent, 2,4-dinitro-5-ethyIeneiminobenzamide (CB1954) (8 ), had a 
profound therapeutic effect on the Walker rat carcinoma but showed little or no effect on 
other cancers, suggested that the Walker carcinoma cells converted (8 ) to a potent cytotoxic 
agent. This reinforced the principle and potential benefits of drug activation at the site of 
the cancer. Recently, Roberts et al. proposed that (8 ) is converted enzymatically to a 
difunctional agent which caused DNA-DNA interstrand links.
Both the establishment of the principle of activation of a compound at a specific site 
and the observation of high levels of the azo reductase enzyme in primary liver tumours, led 
to the introduction of azomustard prodrugs (9) (Scheme 1.1). These compounds are 
deactivated by the conjugated ring system, and therefore show very low t o x i c i t y O n  
reaching the cancer cells, the protected mustards are reduced by azo reductase and converted 
to the highly toxic parent M,M-bis(2-chloroethyl)-4-amino-aniline (phenylenediamine 
mustard) (10), as outlined in Scheme 1.1. The reactivity of (10), the most common alkylating 
moiety employed, relates to electron donation by the 4-amino group, which increases the 
basicity of the tertiary nitrogen atom and facilitates the the formation of the aziridinium ion 
intermediate. Coupling of this 4-amino group to an electron withdrawing group reduces the 
electron donation power, thus the adduct formed should be less reactive than the free 
phenylenediamine mustard. Examples of other prodrugs that could be converted by 
enzymatic action into the effective drug (10) include the A/’-acylated derivatives (for which 
the acetyl (11) and the trifluoroacetyl (12) derivatives, first synthesised by Ross,40,41 were 
expected to be hydrolysed by an amidase 40) and the carbamate (urethane) derivatives
(13).^ '^42 On hydrolysis of the urethane group and consequent loss of CO2 (Scheme 1.1), the 
full reactivity of the parent mustard (10) becomes available. Incorporation of the electron 
attracting N-acyl or N -urethane group in the aromatic ring should, lower the reactivity of 
the mustard moiety because it reduces N-electron donation. The elaboration of aromatic
nitrogen mustards in these ways was extensively studied by Ross,^^'^'^^ Owen,^^'^^"^^ 
Warwick and their collègues.
It was suggested by Danielli,^^ and confirmed later by Benn,^^ that tumours develop 
adaptive enzymes after continuous administration of carbamates. These enzymes decompose 
the carbamate by fission of an ester or peptide linkage, and this condition is favourable for 
selective activation, at the tumour site, of carbamate derivatives of both N,N-bis(2- 
chloroethyl)-4-amino-aniline (10) and N,N-bis(2-chloroethyl)-4-hydroxy-aniline mustards. 
In particular, compounds like (16), its methyl ester (17), or the reversed' carbamate (18), 
proved to be of therapeutic interest because they possessed a high degree of selectivity 
against the Walker 256 tumour with particularly high chemotherapeutic indices 
(LD50/ED90) of 46,137 and 17, respectively [the larger the therapeutic index, calculated 
by dividing the dose which kills 50% of the animals in a group (LD5 0 ) by the dose which 
produces 90% inhibition of tumour growth (ED9 0 ), the greater the relative safety]. In 
comparison. Chlorambucil (6 ) has a chemotherapeutic index of 12 when measured under the 
same conditions. For compounds (16) and (18), the carboxylic acid group increased the 
solubility in aqueous media, overcoming the problem of insolubility conferred both by the 
mustard and the carbamate functions.
9  _ _  9
Z O .C -^ ^ X .C .Y  (CH2CH2C1)2
(16) Z = H, X = 0 , Y = NH
(17) Z = Me. X = O, Y = NH
(18) Z = H, X = NH, Y = 0
Chart 2 Structures (16) ~ (18)
In parallel, many phosphamide mustard prodrugs were produced as contenders for 
hydrolysis by phosphbramidases, reputed to be concentrated in tumour tissues. The most 
successful of these was Cyclophosphamide (14) in which the electron-withdrawing P=0 
group prevents cyclization of the nitrogen mustard by decreasing the availability of the 
nitrogen lone pair. Later, it was shown that activation of (14) was not due to hydrolysis 
within the tumour, but to liver microsomal oxidation by the cytochrome P-450 system which 
catalyzed C4-hydroxylation. The resulting 4-hydroxycyclophosphamide undergoes ring
opening to aldophosphamide, followed by p elimination to generate cytotoxic 
phosphoramide mustard (15) and acrolein (CH2=CH-COH) {Scheme 1.1).
The principal problem with the prodrug approach was the unfavourable distribution 
of activating enzymes in human tumours. However, whereas enzymes do not appear to be 
disposed in a consistent and exploitable fashion in human tumours, some macromolecules 
viewed as antigenic determinants have shown a more favourable distribution. Consequently, 
there have been many attempts to increase selectivity by coupling cytotoxic substances to 
antibodies directed at tumour associated antigens. These have been shown to localise 
selectively though not exclusively, at cancer sites in mvo. 50-55 Monoclonal antibodies 
armed with drugs, toxins or radioactive isotopes as cytotoxic warheads have been studied, 
and these constitute the antibody directed t h e r a p y ,5 /^57 first general strategy was to
conjugate the toxic component to the antibody in a single bifunctional molecule.^^ One 
problem with this approach is heterogeneity in the distribution of the antigens within 
tumour cells, so that even if an antibody-drug conjugate is internalised by cells expressing the 
antigen, a substantial proportion of cells fail to express it and so, escape. Also, the slow 
clearance of antibodies from blood, which may take several days,^® contributes to cytotoxic 
effects in normal tissues. Moreover, the direct conjugation of toxin to antibody limits the 
number of toxic molecules delivered to that of antibodies reaching the tumour. Thus, when 
cytotoxic substances are coupled to antibodies, time-concentration ratios for tumour and normal 
tissues tend to be less favourable than is necessary for major therapeutic effect. Yet a further 
problem is that of host antibody response to foreign protein, which can prevent treatments 
being repeated.
An improvement to antibody directed therapy (which had demonstrated favourable 
tumour localisation of the anti-cancer agent, but only limited therapeutic success) was 
achieved by separating the tumour targeting conjugated enzymes (antibody-enzyme complexes 
able to.activate prodrugs) from the toxic prodrug component, in two different molecules to be 
administered separately. Such targeting localised the enzyme to either the tumour cell 
membrane or to extracellular sites around tumour cells. The amplification inherent in the 
enzyme component of the antibody-enzyme conjugate may compensate for the small amount of 
conjugate retained in the tumour. This new approach constitutes the principle of Antibody 
Directed Enzyme Prodrug Therapy (ADEPT).^^
N (CH2CH2C1)2 N (CH2CH2C1)2 N (CH2CH2C1)2
azo redutase [ Hydrolysis
N
II -CO2
N
Ù
(9 ) y amidase
(13)
Y (CH2CH2C1)2
Y=NH(C0)CH3 (11) 
Y= NH(C0)CF3 (12)
cNH/N(CH2CH2C1)2 H2H^ ^N(CH2CH2C1)2f  Several steps ^O ....................... .......... - o
Cytochrome P-450 + CH2=CH-CH0
(14) (liver) (IS )
Scheme 1.1 Some nitrogen mustard drug/prodrug combinations used in chemotherapy
In parallel with the development of the prodrug concept and the antibody directed 
therapy, another technique known as combination chemotherapy has been used in the 
treatment of leukemias and lymphomas. This involves the administration of several drugs, 
simultaneously or sequentially, to preventing the development of resistance and to obtain a 
synergistic effect.
Other recent work improve the efficacy of aromatic mustards exploits
compounds with greater specificity for DNA. This approach should reduce the chance of 
losing active drug by side reactions with other cell components. Thus, with DNA-affinic 
carrier molecules (e.g. DNA-intercalating ligands like 9-aminoacridine) attached to the 
mustard, drug potency is increased, and the pattern of DNA lesions (and their repair) altered 
to reduce the monoadduct (genotoxic lesions) to cross-link (cytotoxic lesions) ratio.^^
Work is also proceeding to overcome problems with conventional enzymatic 
activation of prodrugs. The development of new prodrugs capable of bioactivation only in the 
absence of oxygen, as happens in large solid tumours where the blood supply is disorganized 
and inefficient, to give hypoxic regions, is being explored. Both hypoxia-selective 
antitumour agents based on nitrophenyl mustards ^3,64 j||^  which activation relates to the 
cellular reduction of the nitro group to the amino group, and quinone mustards,^^ are under 
investigation.
1.3 Antibody directed enzyme therapy (ADEPT)
The concept of ADEPT (Antibody Directed Enzyme Prodrug Therapy) is a more recent 
approach in the treatment of cancer. It was first demonstrated by Philpott et al.
1973 but Bagshawe and his colleagues 56,57,69,70 primarily responsible for its 
development and application in 1987, although Senter has made useful contributions. It 
consists of a two stage treatment where the delivery plus activation and the cytotoxic 
functions are carried on different molecules. First, the enzyme coupled to an antibody is 
directed to the corresponding antigen of the tumour cell. This first component combines the 
selective delivery of the antibody with a capability to generate a cytotoxic agent (drug) from 
a second subsequently administered component (prodrug). As with intact antibodies, the 
antibody-enzyme complex achieves the most favourable tumour to non-tumour distribution 
ratio several days after intravenous injection, by which time it has largely cleared from the 
blood and normal tissues. Administration of the prodrug at this time constitutes the second 
stage of the process and should result in the selective generation by enzyme catalysis of the 
active toxic drug at the tumour sites.
Enzymes chosen for such a role can be non-mammalian in origin and thus lack a human 
analogue. Ideally, there would be no comparable enzyme in the intestinal flora, although 
the importance or otherwise of this constraint would depend on the nature of the prodrug and 
whether it was secreted into the gastrointestinal tract. It is necessary to ensure that the 
enzyme can be conjugated to an antibody and remain stable and active in the extra-cellular 
compartment of tumours for relatively long periods.
One requirement for the prodrug is that it should be a compound of low toxicity that 
can be converted to a highly active cytotoxic substance only by the action of the chosen 
enzyme. The active product is likely to be a small molecule and therefore highly diffusible 
through the tumour. A short half life (a few seconds) would avoid toxic effects on normal cell 
renewal tissues.
The therapeutic success of ADEPT approach depends on several factors: (a) the 
stability of the prodrug in vivo; (b) the difference in toxicity between prodrug and drug; (c) 
the molar toxicity of the drug; (d) the pharmacokinetics of the prodrug; (e) the tumour 
selectivity of the antibody enzyme conjugate; (f) the turnover rate of the enzyme used in the 
conjugate; (g) the molecular weight and pharmacokinetics of the antibody enzyme conjugate; 
(h) the percolation and retention of the antibody enzyme conjugate at the tumour site and its 
elimination kinetics from normal tissues; (i) the concentration of the free unconjugated 
endogenous enzyme; and finally (j) the immunogenicity of the antibody enzyme conjugate/^
To overcome a common problem of rejection associated with the use of an antibody 
chemically linked to the enzyme of bacterial origin, Bosselet et al. recently developed a 
fusion gene consisting of a humanised tumour selective binding portion and a human lysosomal 
enzyme, which due to its fully human or humanised building blocks, should have a low 
immunogenicity in humans. This fusion protein might allow a site specific antibody directed 
enzyme prodrug therapy in triw.
The multiplicity of non-mammalian enzyme and prodrug combinations suggests that 
targeted enzyme chemotherapy is a large, new area to explore. Researchers are looking for 
new antibodies with specificity for human cancers as well as more suitable enzyme prodrug 
combinations. Monoclonal antibodies and improved techniques in immunohistochemistry 
allow detailed analysis of binding to tumours and normal tissues. Cell lines provide a viable 
cell test bed. Human tumour xenografts in nude mice ^5 or rats, allow in vivo testing of 
potential antibodies and conjugates for their ability to withstand in vivo conditions, and to 
localise at target sites. Also, antibodies can be tested in humans for their ability to localise 
in tumours. An antibody or other vector to improve the selectivity of cancer 
chemotherapeutic agents can only be considered for therapeutic use after its credentials in 
these preliminary situations have been thoroughly e x a m i n e d . ^ 5
In 1986 Searle et al. reported the first enzyme-antibody conjugate as an anti­
tumour agent against choriocarcinoma cells in vitro. The enzyme carboxypeptidase G2 
(CPG2), a zinc metaloenzyme isolated by Sherwood from the bacteria Pseudomonas sp. , 
was linked to a monoclonal antibody and directed at a subunit of human chorionic 
gonadotrophin. This enzyme catalysed the hydrolytic cleavage of reduced and non-reduced 
folates to pteroates and L-glutamate, thereby diminishing the continued external supply of 
folate, an essential metabolite in DNA synthesis and consequently, in cell replication. 
Subsequently (1988), carboxy peptidase G2 was used in the first matching antibody-enzyme- 
prodrug combination, by Bagshawe and co-workers to activate an alkylating agent 
(mustard (19)) (Scheme 1.2) and to eradicate an established human cancer xenograft of
10
choriocarcinoma. This tumour is resistant to conventional chemotherapy. Carboxy pepti­
dase G2 activated the prodrug by hydrolysis of the amide bond (as in folates) with release of 
glutamic acid and the alkylating agent ( 2 2 ) .  The conjugate carboxypeptidase G2-monoclonal 
antibody, was also examined in nude mice with xenografts of colorectal carcinoma.^^ After 
time for the conjugate to localise at tumour sites and clear from blood, the prodrug 
4- [(N,N-bis(2-chloroethyl)amino]benzoyl-L-glutamic acid ( 1 9 )  was injected and converted 
into the active benzoic acid mustard derivative ( 2 2 )  (Scheme 1.2). Mustard ( 2 2 )  was about 
100-fold more cytotoxic than its glutamated prodrug ( 1 9 ) .  In the absence of carboxypeptidase 
G2, the prodrug hydrolysed to active drug very slowly, whereas enzyme and antibody- 
enzyme conjugate effected rapid hydrolysis. Later, other related compounds [e.g. 
4-[N-(2-chloroethyl)-N-(2-methanesulphonyloxyethyl]amino]benzoyl-L-glutamic acid ( 2 0 ) ,  
and 4-[bis-N,N-(2-methanesulphonyl6xyethyl)amino]benzoyl-L-glutamic acid (21)] were 
shown to be suitable prodrugs for carboxypeptidase G2 with efficacy in two different human 
tumour cell lines and human choriocarcinoma xenografts implanted in nude mice.®® The 
first clinical success for ADEPT was achieved in 1991 by the Bagshawe team I® in the 
treatment of solid colorectal carcinoma using prodrug ( 2 0 )  with carboxypeptidase G2 linked to 
a fragment of a murine antibody. These alkylating agents were found to be good candidates 
for ADEPT in that their cytotoxicity is dose-related and they can be given repeatedly with 
less induced resistance than other classes of anticancer agents.®  ^®^
boOH ^CHzCHzXh
carboxypeptidase G, X a = X b = C l  ( 1 9 )
Xa=Cl.Xb=CH3S020 (20) 
Xa=Xb=CH3S0 2 0  (21)
^CHzCHzXb
(22 )
Scheme 1J2 The first mttëtards used in ADEPT
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R e c e n t l y t w o  other teams have reported that a series of cephalosporin mustard. 
prodrugs (23) activated by a monoclonal antibody-p-lactamase (extracted from Bacilus cents 
and Escherichia coU) can also be used with success in ADEPT. p-Lactamase catalyzed the 
release of the active N,N-bis(2-chloroethyl)-4-amino-aniline (10) (or related compounds - 
HN(CH2CH2C1)2, HN(CH2CHMeCl)2, HN(CH2CH2Br)2, HN(CH2CHMeBr)2] through a 
fragmentation reaction which occurs after the p-lactam ring is hydrolysed {Scheme 1.3).
(23) CO2H
&
P-lactamase catalysed 
hydrolysis
HO '“»^l
C02H °
1
R= X "  + CO2 + H z N - ^ - N
Ph
HO2C
CO2H
^ \ x C l
Cl
(10)
Scheme 1.3 Cephalosporin mustard carbamate prodrug used in ADEPT
A similar success has been reported foj the activation of a N-phenylacetamido 
derivative of Melphalan (24) into active Melphalan (7) by a monoclonal antibody- 
Penicillin-G amidase conjugate {Scheme 1.4). This establishes that (24) is a prodrug that can 
be enzymatically activated to form an active anticancer agent.
9
C6H5CH2CNH
HOOC
Penicillin-C 
amidase ^ 2
^  '^N (C H 2CH2a )2  *"hoCC'
(24) (7)
Scheme 1.4 Melphalan prodrug used in ADEPT
N(CH2CH2C1)2
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The work reported by Raison 06 on the reactivity of the quinone methide structure 
implies that compounds of general structure (25) (containing a carbamate group) should easily 
decompose with liberation of CO2 and the active drug (10) (Scheme 1.5). With this in mind, 
our aim was to synthesize a model compound [N-acetyl carbamate (26), where the mustard 
moiety was substituted by the nitro group] and to evaluate its suitability as a substrate for an 
acyl amidase enzyme and its ability to generate 4-nitro aniline, as suggested by Scheme 1.5 . 
Evidence was sought that (26) could be considered [after substitution of the nitro group by a 
mustard moiety like (10)], a prodrug for ADEPT,
R
H
1
R-N = <  > = C H 3 +
H
CO2 + H2N— N ^ 2 ^
Cl
^C1
( 10)
Scheme 1.5 Proposed mechanism for quinone-methide prodrug reactivity
CH3 C- NH— N — NO2
(26) 
Chart 3
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1.4 Alkylation reactions of aromatic nitrogen mustards
1.4.1 Alkylation mechanisms
Nitrogen mustards are powerful alkylating agents which reflects their use as antitumour 
drugs. The mechanism(s) for these reactions have been the subject of considerable debate, but 
detailed kinetic studies of their reaction with DNA are not available. Claims of S]sjl 
mechanisms (some involving primary carbocations in solution), S[sj2 mechanisms, and internal 
S]si2 processes wherein nucleophilic nitrogen participation affords an aziridinium ion 
intermediate have been made. There is some concensus for reaction via an Sisjl mechanism,®^ 
and that their biological effectiveness relates to the formation of an aziridinium ion 
intermediate (27),^ '^^ '^®® the formation of which is the rate-determining step. The 
formation and stability of the aziridinium ion is highly dependent on the basicity of the 
nitrogen (i.e. the availability of the nitrogen lone-pair electrons). The existence of this 
aziridinium ion intermediate, first proposed by Everett and Ross, has been demonstrated for 
aliphatic mustards®^'^^ (Scheme 1.6), but disputed for the less basic, aromatic 
mustards.^^'^^'^^^^ For these Everett and Ross proposed an Sisjl pathway with rate
CH2 — CH2
ki \  /  / C H 2CH2NU
RN (CH2CH2X)2 + X ^  RN (
'  ' \ H 2CH2X •'2 ^
(27)
Scheme 1.6 The formation of cyclic aziridinium ion intermediate from
aliphatic 2-halogenoethylamines
limiting formation of a carbocation intermediate (28) (Scheme 1.7).
.CH2CH2X k i /  CH2CH2 _ N u ' /C H 2C H 2N U
A rN . ^  ** A rN y  +  X  ^  ArN .
^ C H 2CH2X ^-1 ^  CH2CH2X ^ 2  CH2CH2X
(28)
Scheme 1.7 Unimolecular hydrolysis of aryl nitrogen mustards involving 
a carbonium ion intermediate
14
Chapman and James criticised this mechanism and suggested an internal 
bimolecular mechanism in which the unshared electron pair on the p-nitrogen atom 
cooperates in the decomposition (Scheme 1.8). This internal 5^2 mechanism still leads to 
first order kinetics provided that the first step is rate-determining.
0 / mslow KiX- I
RR'-N-CHzCHzX RR'-N^ \ -
‘ CH2 — X ° ‘ CHo
RR'-N, I + X
Scheme 1.8 Internal bimolecular mechanism
Bardos et al. modified this proposal after comparative studies of the hydrolysis 
and alkylation of 4’-(4-nitrobenzyl)pyridine (NBP) (Scheme 1.13) and suggested that SnI 
hydrolysis and Sn2 alkylation of NBP proceeds as shown in Scheme 1.9. According to this 
mechanism, the high-energy transition state of hydrolysis is a solvated carbocation-nitrogen 
dipole (29), whose collapse gives the observed product of hydrolysis. The transition state for 
alkylation is an 'S^2 complex' (31), consisting of an incipient aziridinium ion partly opened 
by the nucleophilic NBP reagent. Both hydrolysis and alkylation pass through transition 
state (30).
HoO
Ar-y-CH2CH20H
R'
Ar-y-CH2CH2X
R'
Ar-y-CH2CH2[NBP]
R'
(29)
(S) + X (S)
X®-,
Ô ,-Ç H 2
A r-N \ I 
J.^CH2R'
Ar-lvi\
R'
(30)
{NBP]
.C H ,- [ N B P ]
CHo
(31)'
Scheme 1.9 Dual mechanism of nucleophilic displacement for aryl nitrogen mustard
involving the same transition state
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Reaction via an aziridinium ion intermediate was also supported by Price et al 
and by Williamson and Witten on kinetic arguments, and by Benn et al who studied 
substitution reactions of aryl mustards (32) to (34) labelled with deuterium in the 
2 -position (Scheme 1.10), Scrambling of the deuterium label for both hydrolysis and 
acetolysis, proved intermediate formation of an aziridinium ion. Treatment with powerful 
nucleophiles, however, produced no scrambling of the deuterium label, which required direct 
displacement of Cl" without intermediacy of the aziridinium ion. The high reactivity of the 
aziridinium ion (29) compared to an alkyl analogue seems reasonable, and appreciable 
concentrations are therefore not expected. So, in 1970, Benn et al summarised the 
available data and concluded that nucleophilic displacement of the side chain halogen of 
aromatic nitrogen mustards may proceed by one of two competitive pathways (Scheme 1.11). 
The first involving direct S^j2 displacement, the second via the reactive aziridinium ion 
intermediate. The second pathway is preferred, except for reactions with powerful 
nucleophiles.
  £ ) -
(CH2CD2CD2 --------------►
H2O or AcOH Y
N (CH2CD20Z)2
(32) Y = H  (CD2CH7OZ)')
(33) Y = 4-MeO
(34) Y = 2,4-(N02>2
Z = H or Ac
Scheme 1.10 Scrambling of the deuterium label for both hydrolysis and acetolysis
of aryl mustards
A r f t ^  4- Cl
CH2CH2CI
]sju‘ yC H 2CH2Nu
Ar N (CH2CH2CI)2   ^  ArN
'^CHoCH^Ci
Scheme 1.11 Proposed mechanism for the nucleophilic displacement of the aryl nitrogen
mustard (Benn et al, 1970)
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1.4.2 Kinetics of hydrolysis
It is accepted that bis-2-chloroethyl aromatic nitrogen mustards (A) undergo stepwise 
hydrolysis with release of chloride ion and the formation of an aziridinium ion, which is 
attacked by water (or other nucleophiles) to yield (B). The same sequence is then repeated 
for the second 2-chloroethyl group in (B) to give the final diol product (C) (Schetne 1.12).
The hydrolysis of aromatic nitrogen mustards (even the more reactive) in aqueous 
acetone follows first order kinetics, with the formation of the aziridinium ion being rate- 
limiting. Factors that slow this step, such as the addition of chloride ion or a non polar 
organic solvent, prevent accumulation of the aziridinium ion.
y  CH2CH2CI
At—N
\C H 9CH9Cl
(A)
ki
k.i
CHi 
+ / \
Ar—N ' CH2
^CH2CH2C1
H2O
+ Cl
.CH2CH2 0H 
A r - N ^  + H
\C H 2CH2Cl
(B) 
k-2 I k2
yCH 2CH20H H2O 
At— N ^
\C H 2CH2OH
(C)
^ yCH 2CH2 0H
cfC
+ a
Schetne 1.12 The two stage process involved in the hydrolysis of mustards
The integrated rate equations for sequential first-order reactions (equation 1.1) are 
given by equations 1.2 to 1.5,^ where Aq is the initial concentration of A, [A]*, [B]*, [C]i and 
[ClJt are the concentrations of A, B, C and chloride ion, respectively, at time t, and k\ and ki 
are the pseudo first-order rate constants for the first and second steps:
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. . h
A — ► B + Cl — ► C + C f (1.1)
[Alt = Ao e" 1^*
[Bit = A oki/ik2-ki).(e' - e ' 2^*) (13)
[Clt = Ao/(t2-A:i).[A:2(l- e" ^1*) - fel(l-e' ^2 )^] = Ao-[Alt-[B]t (1.4)
[d ît = [Bit + 2[C]t = Ao(l-e- ^i‘) + Ao/(k2-ki).[k2(l-e-^t) _ kjH-e -^ 2^ )1 (1.5)
There has been much controversy over the evaluation of k\ and ki values from
experimental measurements. Most early kinetic work was based on indirect determination of 
unreacted A by estimation of released hydrogen^^'^®'®8,91,100,101 qj. chloride-ion 
assays^^'^^'102 (using potentiometric,l®^'104 conductim etricl^^ or ion selective 
electrodes^^^307) reaction with 4'-(4-nitrobenzyI)pyridine (NBP) (35),®®'^®®309 to
produce a coloured pyridinium salt (36) at alkaline pH (Schetne 1.13). This last method had 
a drawback since NBP reacts with all alkylating agents, measuring both intact mustard and 
the intermediate aziridinium ion. All of these indirect methods give incorrect estimates of 
mustard stab ilities.H ^ 'lll Recent investigations using high-performance liquid 
chromatography (HPLC) for the hydrolysis of Melphalan 112-114 ^^d Chlorambucil, and 
the hydrolysis and alkylating reactivity towards NBP and thiourea for 
4-anilinoquinolinium aniline mustards,^^^»^^^ gave more useful information on both the 
kinetics of mustard hydrolyses and the effect of chloride ion. HPLC allows simultaneous 
quantitation of the substrate-A and both the major hydrolysis products, half-mustard-B and 
diol-C. Thus, pseudo first-order rate constants for the first (k\) and second ( 2^) hydrolysis 
steps can be calculated from peak areas (i.e. concentrations) of the three species.
' OH
(36)
Schetne 1.13 Reaction of alkylating agent with 4'-(4-nitrobenzyl)pyridine
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1.5 Quantitative structure-activity relationships for aromatic 
nitrogen mustards
Quantitative structure-activity relationships (QSAR) have been formulated by several 
authors (Lien and Tong,^^® Panthananickal et Bardos et aL,®®'^ 22 Niculescu-
-Duvaz et and Denny et al. 126,127 ^ variety of aniline mustards of general
formula Y-C6H4N(CH2CH2X)2 (4) where X=C1, Br or I. Substituent constants for these 
structure-activity correlations were in large proposed by Hanch and Leo 128-130 g^d also by 
Mager and Exner.^® '^^^^ These relationships correlate chemical reactivity [i.e. rates of 
either hydrolysis or alkylation of 4'-(4-nitrobenzyl)pyridine (NBP)] with biological 
activity [expressed in multiple ways including toxicity [eg. LD50 - molar dose 
(mol kg"^) required to produce death in 50% of the population], antitumour activity [eg. ED90 
- molar dose (mol kg"^) to produce 90% reduction of tumour cell population], Hammett 
substituent parameters (a), lipophilicity constants (jt), steric parameters (/) and mutagenic 
and carcinogenic a c t i v i t i e s .  ^^1
From the work of Bardos and co-workers 88,122 vvith 4-substituted derivatives of (4) 
(X=C1, Br or 1), equations 1.7 and 1.8, respectively, were formulated for the antitumour 
activity (ED90) against the solid rat Walker 256 carcinoma and toxicity (LDso).^^^ In these 
equations (and equations 1.9 to 1.13), n = number of compounds analysed; r = correlation 
coefficient; a  (or cT depending on the best fit) = Hammett electronic parameter; Jsr (and Iq in 
equations 1.9 and 1.10 and 7 in eqn. 1.12) = indicator variables to define the steric parameters 
(/Br=0 for X=C1 or I but /gr^l for X=Br); n ~ Hansch lipophilic parameter defined by equation
1.6 where P% is the octanol/water partition coefficient of the derivative and Ph of the 
parent compound:
3iX = log Px - log Ph (L6)
N,N-bis(2-chloroethyl) mustard group is a very lipophylic moiety (re value of
1.0 the resulting simple phenyl derivatives' are very insoluble in water: the
octanol/water partition coefficient (log P) for N,N-bis(2-chloroethyl) aniline (5) is 2.9.^ ®^
The work of Bardos et al. 88,122 showed that the maximum efficacy and toxicity for 
the 4-substituted aniline mustards towards the solid tumour is found with rather lipophylic 
compounds whose log P is ca. 2.0 (equation 1.7 and 1.8).
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log (l/c ED90) = -1.19 o' + 0.75/Br - 1.00 n -  0.53 re^  + 3.84 (1.7)
n = 14, r = 0.94 *
log (1/C  LD50) = -1.31 o- + 0.51 /Br - 0.69 re - 0.35 re^  + 3.87 (1.8 )
n = 18, r = 0.93
Similar QSAR (equations 1.9 and 1.10) have been formulated by Hansch and his co­
workers using antileukemia activity data from the National Cancer Institute for other 
aniline mustards [type (4) with X=C1].^^^320 these equations, C125 = molar dose 
(mol kg-1) producing a 25% life-span increase (T/C=125) against the L1210 leukemia in mice 
whereas C%go = molar dose to elicit (T/C =180) against the P338 leukemia in mice. The 
indicator variable /p=l when ortho substituents are present on the aromatic ring (other 
factors being equal, ortho substitution produces more active congeners). The addition of a 
term in equations 1.9 and 1.10 did not improve the correlation. The negative coefficient for re 
in these equations implies that hydrophilic derivatives with P < 0 are more active against 
non-solid leukemia tumours. This is a contrast to the results obtained by Bardos and his 
collègues against the solid Walker tumour.
log(l/Ci25)= - 0.%cT - 0.31 re+ 0.8 6 /o +4.07 (1.9)
n = 19, r = 0.93
log(I/C180) = -1.39a  - 0.34 re + 0.30/q + 4.13 (1.10)
n = 16, r = 0.91
Ross 41,135 was the first to examine the reactivity of congeners of (4) (where X=C1 or 
Br) towards nucleophilic replacement by measuring their "percent hydrolysis" under 
standard conditions [30 min reaction in aqueous acetone 50%, v/v  at 66^Cj. Subsequently, 
Panthananickal et showed that Ross’ data correlated with equation 1,11. Further,
log % hyd = -1.42 a  + 0.45 Iq + 0.70 /gr + 121 (1.11)
n = 42, r = 0.95
the data obtained by Bardos et al. ®® for the rate of alkylation by NBP of 
4-substituted congeners of (4) (where X=C1, Br or I) is correlated by equation 1.12, where 1=1 
for X=Br or I and 1=0 for X=C1 (i.e. the Cl derivatives are about ten times less reactive).
log k = -1.92 o- +1.12 / -1.77 (1.12)
n = 14,r = 0.97
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Equations 1.11 and 1.12 show that two indexes of chemical reactivity (% hydrolysis 
and the rate of NPB alkylation) show good parallelism. The large negative value of p for 
the o term is consistent with an aziridinium ion intermediate (Scheme 1.12), highly 
dependent on the electron density on n i t r o g e n . T h e  positive value (+ 0,45) in equation 1.11 
for the indicator variable I a (To = 1 for the ortho substitution) shows that ortho substituents 
increase the rate of hydrolysis by a factor of ca. 3, no doubt by twisting nitrogen out of 
conjugation with the re electrons of the aromatic ring, thus making it more nucleophilic. The 
coefficient of variable /bc in equation. 1.11 shows that 2-bromoethyl substituents hydrolyse 
ca. 5-fold more rapidly than Cl substituents. Other data show that branching at the p carbon 
of the mustard "arm" produces a drastic increase in r e a c t i v i t y
The coefficients of both the indicator variables (7o, Ibf) and the a parameter in 
equations 1.11 and 1.12 are in reasonable agreement with those of equations 1.7 to 1.10. This 
suggests that aziridinium ion intermediate formation is a common, critical factor for both the 
hydrolysis and the anticancer action of aniline mustards which justifies the use of Ross' 
hydrolysis model for predicting the effect of substituents on in vivo cytotoxic activity. 
However, although the toxicity of aryl mustards also relates to their ability to alkylate 
cellular DNA, additional factors such as drug transport and metabolism as well as DNA 
repair have also to be considered in vivo.
The reactivity of aromatic mustards is dependent on both the electronic properties of 
the aromatic substituent and the nucleofugacity (leaving ability) of the X substituent. This 
latter property can be measured by the leaving-group constant L, defined as the S^j2 rate 
ratio for nucleophilic displacement of X relative to Br (for which 1=0) and b (a constant 
characteristic of the nucleophile)^®^' ®^® as expressed by equation 1.13,
loz(kJkBr) = bL (1.13)
Palmer et al. ^4 studied nucleofugacity effects for a series of aniline mustard congeners 
of (4) [where X were the four most commonly used leaving groups: Cl, Br, I and  
OSO2CH3 (OMs), and Y=H or NO2] in relation to biological data [ED50 values - the 
concentration of drug necessary to reduce cell numbers to 50% of controls] for two cell lines 
(UV4 and AA8 ). The biological activity data, however, did not parallel chemical 
reactivity. For unsubstituted aniline mustards (Y=H), the OMs compound (with the best 
leaving group, L= -2.05) was the least toxic and the Cl compound (L= -1.61) was the least toxic 
of the halogen derivatives. This agreed with earlier data for in vivo potency where bromo 
mustards were found to be on average 3 fold more potent than the corresponding chloro 
m u s t a r d s . T h e  4-nitroaniline mustards (Y=N0 2 ) were generally much less toxic
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(20-200 fold) than unsubstituted aniline mustards (Y=H), with the exception of the OMs 
compounds, where the difference was only 2-fold. Since aniline mustards have low water 
solubility, hydrophilic groups would be desirable for antileukemia drugs, with the OMs 
group (re= - 0.88) being the most favoured, followed by Cl (re= - 0.71) (see Table 2.1 for some 
re and L values). ADEPT requires aniline mustard substrates that are highly sensitive to 
electronic substituent effects (in order to get the largest differential toxicity between prodrug 
and drug) and therefore a leaving group X that is sensitive to electronic effects of the aryl 
Substituent. The OMs leaving group is insensitive to the electronic character of the aryl ring 
substituents. Further, although OMs is the most hydrophilic of the usual leaving groups 
available, it seemed to have little effect on the aqueous solubility of aiyl mustards with 
Y=H or Y=N0 2 - Thus, although the Cl leaving group gives a less potent aniline mustard, the 
superior solubility and sensivity to electronic effects of these compounds suggests their 
suitability for ADEPT testing.
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Chapter 2
Results and Discussion 1:
Synthesis and Hydrolysis of Aromatic 
Nitrogen Mustards
2.1 Leaving group effects on the stability and reactivity of 
aniline mustards
As noted in Chapter 1, little systematic information is available about the stability and 
reactivity of aniline mustards bearing different leaving groups in the N-ethyl substituents. 
To address these questions, a series of simple (unsubstituted) N,N-bis-X-ethyl aniline 
mustards (X=C1 (5), OH (37), OSO2CH3 (38), 0 C(0 )CH3 (39), SCN (40), ONO2 (41)) were 
synthesised and their rates of decomposition briefly determined in aqueous DMSO at pH 7 -9  
and 37°C. The ionic strength was not maintained at a constant value.
2.1.1 Synthesis of aniline mustards (5) and (37) - (41)
Synthesis of all these aniline mustards i.e., (bis-2-chloroethyl) (5), (bis-2-hydroxyethyl)
(37), (bis-2-methanesulphonyloxyethyl) (38), (bis-2-acetoxyethyl) (39), (bis-2-thiocyano- 
ethyl) (40) but not (bis-2-nitratoethyl) (41), are described in the literature. Their syntheses 
which have several common steps, are conveniently summarised by Scheme 2.1.
The preparation of nitrogen mustards usually proceeds via the corresponding 
bis(2-hydroxyethyl) amino derivative (37). This was prepared by the method of Ross,4L43 
which involves reaction of the amine (in our case aniline) with ethylene oxide in a Carius 
tube at ISC^C for 20h. At lower temperatures, large amounts of the monosubstituted product 
are produced.41 Only two equivalents of ethylene oxide were used to minimise unproductive 
formation of polymers of the type (42).
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RN[(CH2CH20)nCH2CH20Hl2 (42)
Ross' method was preferred over the reaction of aniline with halohydrins in the 
presence of a base (usually calcium carbonate) to neutralize acid coproducts, and over the 
route of Vingiello et al involving cleavage of a morpholine substituent to the mustard 
moeity using zinc chloride and conc. hydrochloric acid at 180°C.
Most of the hydroxyethyl and halogenoethyl compounds are light-sensitive and 
develop deep colours on exposure to air, especially in dilute solutions.
SCN
(40)
-SCN
N aSC N /
C2H5OCH2CH2OH
120“C
NH2 -
IH l)C l-O T s /P y  
OPC 2h, r.L Ih = \  „ _ r
150"C,20h ^ I— OH 2)H20
(37)
y
(44)
N
OTs
OTs
1) CH3S02C]/Py/-5®C
2)H20/H2S04
Caa2/
C2H5OCH2CH2OH
120“C
N
Cl
Cl
^  OSO2CH3
^  ” 1—OSO2CH3
(38)
9
POCCH3
(39)
(5)
AgNGs/CHaCN
40*C
|—ONO2 
N z :
I— ONO2
(41)
Scheme 2.1 Syntheses of aniline mustards (5) arid (37) - (41)
N,N-Bis(2-hydroxyethyl)aniline (37) was obtained as an impure solid. It was 
recrystallised five times from benzene to give pure white plates in 71% yield. The melting 
point 55.4-56®C agreed well with the literature m.p. 55®C.^  ^ The ^H-NMR spectrum in 
(CD3>2C0 showed two sets of triplets (8H) centred at 3.6 and 3.8 ppm, attributed to the 
hydroxyethyl CH2 groups, a multiplet (5H) centred at 7.0 ppm for the aromatic protons and
2 4
an exchangeable broad singlet (2H) due to the two OH groups. The IR spectrum showed a 
strong absorption at 3350 cm"  ^for the alcohol groups, and absorptions of medium intensity at 
1600,1500,1330 and 750 cm"  ^characteristic of a monosubstituted aromatic ring.
Synthesis of N,N-bis(2-methanesulphonyloxyethyl)aniline (38) and N,N-bis- 
(2-acetoxyethyJ)aniline (39) involved reaction of the bis(2-hydroxyethyl) intermediate (37) 
with methanesulphonyl chloride in pyridine at -5°C over 30 min for (38), and with acetyl 
chloride in pyridine at room temperature over 3h for (39). This route was previously used by 
Cohen et al. 1^0 ^nd Papanastassiou et al.  ^ for the synthesis of (38); the first synthesis of 
(39), reported by Ross 141,142 involved reaction of (37) with hot AC2O and AcONa. Both 
compounds were obtained as impure oils in 56 and 69% yield, respectively. They were 
purified by silica column chromatography using DCM for (38) and ether/DCM (l:l,v / v) for
(39). The yield of pure (38) after chromatography was low (ca. 36%). It was much easier to 
convert (38) into the crystalline hydrochloride salt (43) by passing dry gaseous HCl through a 
solution of crude (38) in chloroform until saturated. The solution was then refrigerated and 
the precipitated (43) was filtered, washed with cold chloroform (without exposure to air), 
and recrystallised from cold acetone to give colourless crystals in 75% yield showing m.p. 
77-82®C (lit.^40 m.p. 98-105°C). The ^H-NMR spectra of (38) and (43) in CDCI3 and 
(CÜ3)2SO, respectively, were similar. Namely, a singlet (6H) at 2.9 ppm for (38) and 3.2 
ppm for (43) due to the two SC>2CH3 methyl groups; two sets of triplets (4H) centred at 3.7 and 
4.3 ppm with a J=6.8 Hz for (38) and 3.75 and 4.35 ppm with a J=6Hz for (43), corresponding to 
the NCH2 and OCH2 groups, respectively; and a multiplet centred at 7.0 ppm for both 
compounds but integrating to 5H for (38) and to 6H for (43) for the aromatic protons, with an 
additional proton due to NH'*' for (43). The IR spectra of both (38) and (43) showed 
characteristically strong absorptions at 1350 and 1175 cm‘  ^ due to the OSO2CH3 group.^43 
The MS(EI) spectrum for (38) showed a peak at m/z=337 due to M"*", while the MS(FAB") 
spectrum for (43) showed a peak at m/z=372 corresponding to M-H"*".
The ^H-NMR spectrum in (CD3)2CO of N,N-bis(2-acetoxyethyl)aniline (39) showed 
a singlet (6H) at 2.0 ppm, due to the methyl ester groups; a double triplet (4H each) centred at
3.7 and 4.3 ppm with J=7.5 Hz for the NCH2 and OCH2 groups, respectively; and a multiplet 
(5H) centred at 7.05 ppm for the aromatic protons. Its IR spectrum showed a strong absorption 
at 1670 cm“l due to the ester carbonyl, as well as peaks at 1600,1500 (aromatic), and 1380 cm"  ^
(C-O, ester). The MS(FAB"*‘) spectrum of (39) had a strong peak at m/z=266 corresponding to 
MH+.
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The synthesis of N,N-bis(2-chloroethyl)aniline (5) previously described in the 
literature 41,43,140 involved direct replacement of the hydroxyl groups of (37) by halogen 
using either POCI3, PCI5, or occasionally SOCI2. A slightly different route was used here, 
involving activation of the diol by conversion of (37) into the 4-toluenesulphonyl chloride 
derivative (44),47/144 followed by displacement of the tosyl ester group using calcium 
chloride in 2-ethoxyethanol. ^  ^ 5 This reaction took place at 120°C for 1.5h. After extraction 
into benzene, N,N-bis(2-chloroethyl)aniline (5) was obtained impure in 60% yield. It was 
recrystaUised from toluene /n-hexane (1:1, v/v) giving a solid showing m.p. 43-45®C (lit.43 
m.p. 45°Q. The MS(EI) spectrum showed m/z=217 corresponding to and peaks at m/z=183 
and 168 for the liberation of a chloride atom (M+ - Cl) or for (M'*’ - CH2CI), respectively.
Synthesis of N,N-bis(2-ethyltoluene-4-sulphonate)aniline (44) followed a route 
similar to one described in the literature 140,146 involving reaction of (37) with toluene-4- 
sulphonylchloride in pyridine at 0°C for 2h and a further Ih at room temperature, followed 
by treatment with water to give impure (44) in 82% yield, and in 75% yield after 
recrystallisation from ethanol. The pure white needles showed m.p. 88-89°C (lit. 149 m.p. 
90-91®C) and its MS(EI) spectrum showed m/z=489 corresponding to M"*". The ^H-NMR 
spectrum in (CD3)2CO showed a singlet (6H) at 2.4 ppm for the methyl protons of the tosyl 
group; a double triplet (8H) centred at 3.6 and 4.1 ppm attributed to the CH2 groups; and two 
multiplets centred at 6.8 and 7.5 ppm integrating, respectively, to 5H and 8H (associated 
with the tosyl group) for the aromatic protons.
The synthesis of N,N-bis(2-thiocyanoethyl)aniline (40) involved reaction of the 
tosyl derivative (44) with sodium thiocyanate in 2-ethoxyethanol at 120®C for 3h, a 
different route from the one previously described in the literature. 147-150 product was 
purified by silica column chromatography using DCM as eluent, and further recrystallised 
twice from DCM/n-hexane (1:1, v/v) to give white crystals in 49% yield, showing m.p. 
68-70®C (lit. m.p. 73-74®C).147,148 jj |e  MS(FAB"*') spectrum showed m/z=264 due to MH^, 
and the ^H-NMR spectrum in (CD3)2CO showed two triplets at 3.3 and 3.8 ppm, both with 
1=8 Hz and integrating to 4H, attributed to the NCH2 and OCH2 groups, respectively; and a 
multiplet (5H) centred at 7.0 ppm for the aromatic protons: The IR spectrum confirms the 
-SCN rather than -NCS structure because of a sharp band of medium intensity at 2153 cm“  ^
due to the CsN moiety and a strong band at 722 cm‘  ^due to C-S moiety.
Finally, the synthesis of JV,N-bis(2-nitratoethyl)aniline (41) involved reaction of 
the chloro derivative (5) with silver nitrate in acetonitrile at 40°C for 15h. This gave (41) as
26
an impure compound in 66% yield. It .was purified by silica column chromatography using 
ether/n-hexane (1:2, v/v) as eluent, but the relatively low yield (41%) of recovered pure 
yellow oil reflected the difficulty of the purification. The MS(EI) spectrum showed m/z=271 
corresponding to M"^ . The ^H-NMR spectrum in (CDg)2CO showed two sets of triplets 
(4H each) centred at 3.8 and 4.75 ppm both with J=7Hz, attributed to the NCH2 and OCH2 
groups, respectively; and a multiplet (5H) centred at 7.0 ppm for the aromatic protons.
2.1.2 Hydrolysis of aniline mustards (5) and (38) - (41)
The reactions were complicated at the outset by the low aqueous solubilities of the aniline 
mustard substrates. Some indication of these difficulties is evident in Ross' early studies 43 
which were carried out in aqueous acetone (1:1, v/v) at 66®C. The aim of the present work 
was to obtain data in buffered, aqueous media at 37®C, to facilitate assessment of their 
behaviour in vivo.
The low aqueous solubility of the aniline mustards was partially circumvented by 
using aqueous-DMSO. The ionic strength was not maintained at a constant value.
2.1.2.1 Autotitration assay
It was anticipated that the reactions could be followed by autotitration of the 2 moles of acid 
HX released on hydrolysis:
2 H2O r—OH
0 - N = d  ------------ 0 - N = ;  + 2HX
n _ x  \ - f  n _ o H  (2.1)
In practice, this method proved difficult because relatively high (ca. lO’^^M) 
substrate concentrations were required to obtain accurate autotitration. In turn, this required 
relative high concentrations of DMSO (up to 30%, v/v) to maintain homogeneous reaction 
solutions, with a concomitant decline in electrode performance. With DMSO > 5% v/v, the 
sensitivity of the calomel and glass electrodes noticeably decreases after ca. 5h at 37®C. 
At pH 7 and 37®C, hydrolysis of some of the aniline mustard substrates was quite slow, which 
led to problems additional to the deterioration of electrode sensitivity. Autotitration of the 
released acid with dilute (5mM) aqueous NaOH requires sparging with N2 to avoid errors 
arising from CO2 absorption. At 37°C, this caused significant evaporation of water from the
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reaction solution and therefore further inaccuracies. For all of these reasons, examination of 
the hydrolysis of the aniline mustard substrates was limited to just a few experiments.
The reactions were carried out by injecting a stock solution of the aniline mustard in 
DMSO (lOOvil, 8xlO"^M) into a solution of aqueous DMSO (either 99:1, 9:1 or 7:3, v/v, 25cm^) 
at pH 7.0 or 9.0, contained in the thermostatted reaction vessel (37°C) of the autotitrator. 
The final concentration of substrate was ca. 3.2xl0”4 M. The solution was stirred vigorously 
under N2 and the pH was maintained at the preset value by the autotitrator by the addition 
of standard aqueous NaOH (5mM). The autotitrator recorded the volume of NaOH with 
time. The reactions were monitored until the addition of NaOH ceased, or for ca. 24h. 
Attempts to evaluate the pseudo first order rate coefficient ^  (Equation 2.2) either from the
Rate = fco [aniline mustard] (2.2)
initial rate of addition of NaOH or from plots of log (Voo - Vt) versus time, where Vt and 
Voo = volume of 5mM NaOH added by the autotitrator, at time t and infinity, respectively, 
were unsatisfactory: the plots were poorly linear probably because of electrode deterioration 
at long reaction times and infinity values were difficult to evaluate. Thus, kp values were 
calculated from reaction half-lives [ ti /2= time for addition of 50% of the theoretical amount 
of 5mM NaOH] estimated from the autotitrator plots, and they represent an average of the 
individual rate coefficient for expulsion of thé first and second N-ethy 1-2 -substituents. 
Pseudo first order rate coefficients (fco) and half-lives ( t i /2 ) for the hydrolyses of (5), (38),
(39), (40) and (41) under various conditions are summarised in Table 2.1. Also given are pKa 
values for HX which is relate to the nucleofugacity of X in protic solvents and Hansch 
lipophilicity constants for X'. From the data for (5), the hydrolysis rate is not strongly 
dependent on the % DMSO. From the data for (5) and (38), the hydrolysis rate is not 
strongly dependent on pH, and the reactions do not appear to be base-catalysed.
The low quality of the experimental data prevented analysis by the time ratio 
method to obtain individual values of and /c2. It is evident from the ion exchange 
chromatography (lEC) results, however, that k\ and ki are of similar magnitude 
(see Table 2.5). Thus, the average value (ko) reported in Table 2.1 is a good measure of the 
relative reactivity of the various mustards and the effect of nucleofugacity on reactivity.
28
Table 2.1
Hydrolysis rates for mustards (5) and (38) - (41) in aqueous DMSO at 37°C 
obtained by autotitration of the acid released
Mustard X pH H2O/DMSO
(v/v)
^0
(s-l)
*1 /2 pKa of 
HX«
3,^ LY
(5) Cl 7 99:1 2.1x10-4 56 min -6 .1 0.71 -1.61
9 99:1 2.1x10-4 56 min
9 9:1 1,2x10-4 96 min
9 7:3 1.0x10-4 114 min
(38) OSO2 CH3 7 99:1 3.3x10-3 3.5 min -1 .2 -0 .8 8 - 2.05
9 99:1 3.9x10-3 3.0 min
(39) 0C(0)CH3 7 99:1 no reaction - +4.76 0.64 - 4.68
over 24h
9 99:1 1.2x10-5 16h
(40) SCN 7 7:3 no reaction - -1.85 -0.48 ?
over 24h
9 7:3 no reaction -
over 24h
(41) ONO2 9 9:1 2 .2 x 1 0 -6 89h -1.44 -1.4 -1.90
9 7:3 1.9x10-6 1 0 2h
(a) in water, 25®C
0 ) 31 Hansch lipophilicity constant, according to eqn. 1.6 3^4 
(y) L Leaving group constant, according to eqn. 1.13 3^8
2.1.2.2 HPLC assay for aniline mustards (40) and (41)
According to the autotitration experiments, aniline mustard (40) appears to be stable to 
hydrolysis at pH 7.0 and 9.0 at 37®C: no measurable consumption of 5mM NaOH was apparent 
over 72h.
For aniline mustard (41), slow consumption of 5mM NaOH was apparent. It was of
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interest, however, to identify the products and to confirm that the slow consumption of base 
does not relate to reaction with atmospheric CO2
Accordingly, the reaction solutions for aniline mustards (40) and (41) were also 
analysed by HPLC against authentic N,N-bis(2-hydroxyethyl)aniline (37), 4-phenyl- 
morpholine (45), and the substrates, themselves.
2.1.2.2.1 Aniline mustard (40)
An aliquot of the reaction solution for the hydrolysis of JV,N-bis(2-thiocyanoethyl)aniline
(40) in aqueous DMSO (7:3, v/v) at pH 9.0 and 37°C, followed by autotitration of acid 
released (Section 2.1.2.1) for 72h, was analysed by HPLC. At this time there had been no 
significant consumption of 5mM NaOH and apparently no reaction.
The HPLC chromatogram showed 4 peaks whose relative peak areas and retention 
times (Rf) are summarised in Table 2.2. By comparison with authentic compounds, the peak 
at Rf=2.73 min is the solvent DMSO, the peak at Rf=3.63 min is N,N-bis(2-hydroxyethyl)- 
aniline (37), the peak at Rf=14.79 min is unreacted substrate, and the peak at Rf=22.89 min is 
probably 5-phenyl-tetrahydro-l,2,5-dithiazepine (46), the main product found by 
Dubinskaite et al. 147,148 decomposition of (40) in alkali, presumably formed by an
intramolecular reaction. Significantly, 4-phenylmorpholine (45) (Rf=6.76 min) was not 
formed as a reaction product.
Table 2.2
HPLC assay of hydrolysis products for aniline mustard (40) in aqueous DMSO (7:3,vlv) 
at pH 9 and 37°C after 72h reaction: k-263nm, [40]init ca. 3.2xl0r^M
Compound Retention time 
(Rf) (min)
Peak area
(%)
DMSO 2.73 10
N,N-Bis(2-hydroxyethyl)aniline (37) 3.63 10
N,N-Bis(2-thiocyanatoethyl)aniline (40) 14.79 65
5-Phenyl-tetrahydro-l,2,5-dithiazepine (46) 22.89 18
It is not possible from the data in Table 2.2 to determine the extent of reaction. Although 
substantial starting material (40) remains after 72h, the HPLC assay shows some 
decomposition in contrast to the autotitration results. The products formed are summarised
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in Scheme 2.2.
o - " = n !  —  o■SCN
(40) V (46)\
_ p O H
” ~L_oh
(37)
Scheme 2.2 Hydrolysis pathways for aniline mustard (40) in aqueous DMSO (7:3, v/v)
at pH 9 and 37°C
2.1.2.2.2 Aniline mustard (41)• f
The hydrolysis of A^,N-bis(2-nitratoethyl)aniline (41) in aqueous DMSO (7:3,vI v) at pH 9.0 
and 37®C was assayed at timed intervals by HPLC as described in the Experimental (Section 
5.4.2.1). The retention times (Rf) of peaks in the chromatogram, and their identification 
against authentic compounds, are summarised in Table 2.3, The variation of integrated peak 
areas with time are shown in Figure 2.1 and the slope of log (peak area) of (41) versus time 
gives ko = 1.9\ 10^ s"^ . The peak at Rf=2.45 min with a constant area at all reaction times
Table 2.3
HPLC assay of hydrolysis products for aniline mustard (41) in aqueous 
DMSO (7:3, v/v) at pH 9 and 37°C: [41Jinit ca. 3.2xlO'^M; à=263 nm
Compound Retention time 
(Rf) (min)
DMSO 2.45
N,N-Bis(2-hydroxyethyl)aniline (37) 3.78
N,N-Bis(2-nitratoethyl)aniline (41) 10.65
4-Phenylmorpholine (45) 7.21
Half-mustard (47) 7.65
corresponds to the solvent DMSO; the peak at Rf=3.78 inin showing a steady increase in area 
with time is the diol (37); the peak at Rf=7.65 min passing through a maximum area at 
ca. 40h was not identified against an authentic compound, but this behaviour is that expected
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b) Disappearance of of starting material (41), Rf=10.65 min and formation 
of products: (37), Rf=3.78 min; (45), Rf=7.21 min; (47), Rf=7.65 min
Figure 2.1 Hydrolysis of aniline mustard (41) in aqueous DMSO (7:3, viv) 
at pH 9 and 37"C over 97h: [41Ji„it ca. 3.2xlO~^M; A^263 nm
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for the half-hydrolysed mustard [N-(2-hydroxyethyl)-N-(2-nitratoethyl)aniline] (47) in 
Scheme 2.3; the small peak at Rf=7.21 min, which appears after 20h, corresponds to 
phenylmorpholine (45); and finally, the peak at Rf=10.65 min showing a steady decrease in 
area with time, is the starting substrate (41).
The HPLC assay shows that the hydrolysis of (41) in aqueous DMSO (7:3, v/v) at pH
9.0 and 37®C is slow (fco= 1.9x10"^ s"^ >, in good agreement with the autotitration results 
(1.9x10"  ^s’^  ). The decomposition pathways are outlined in Scheme 2.3.
N
ONQ2
(41)
0 N C > 2  H z O o t O K  / = = v
— -  v > ^
(47)
OH
OH
ONQ2
HjO or OH* r
—  0 - " = L
(37)
OH
OH
oG°
(45)
Scheme 2.3 Hydrolysis pathways for aniline mustard (41) in aqueous DMSO (7:3,vIv)
at pH 9 and 37*0
2.2 Synthesis of potential aniline mustard prodrug/drug 
combinations
The chemotherapeutic properties of aniline mustards are well documented as outlined in 
Chapter 1 . It is clear that the most potent compounds bear electron-donating substituents in 
the aromatic ring and good leaving groups (eg. halide, alkyl sulphonate) in the 
bis-N,N-dialkyl substituents. Other work at the PHLS Porton Down Laboratory and the 
Charing Cross Hospital, indicated that arylamidases might be suitable enzymes for ADEPT 
procedures. These considerations pointed to the potential utility of 4-(N-acylamino)aniline 
mustards (48) as prodrugs for ADEPT procedures.
O
(48)
X
X
H2N k - T -
(49)
Chart 4 Structures (48) and (49)
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This section reports the synthesis of the potential prodrug/drug combinations 
(48) /(49), with R=GH3 or CF3 and X=C1, OSO2CH3 or 0 C(0 )CH3, for subsequent chemical 
and biochemical evaluation. Most of these syntheses followed a common pathway 
(Scheme 2.4) involving introduction of a 4-amino substituent into the appropriate aniline 
mustard, via acid-catalysed nitrosation followed by catalytic reduction and finally 
acétylation of the free amino group.
NZzT  HX + ON—
X —  '- X
H i/P d
(48) (49)
Scheme 2.4 Common pathway for the synthesis of 4-(N'-acylamino) aniline mustards
2.2.1 Synthesis of 4-nitroso aniline mustards (50) - (53)
These compounds were obtained by a common, published^l method involving nitrosation of 
the parent aniline mustard in acidic aqueous sodium nitrite at 0  to -5*^ C according to 
Scheme 2.5. The aniline mustard was dissolved in aqueous HCl or HCIO4 (if XÆ1, to avoid 
displacement of X by Cl) plus some acetonitrile when necessary to solubilise the mustard. 
The solution was cooled to 0 to -5°C and aqueous NaNÛ2 (ca. 1.1 eq) was then added dropwise 
over 30 min, with vigorous stirring. The mixture was stirred for a further 30 min at 0 to -5®C. 
For compounds (50) and (51), the reaction solution was neutralized before extraction of the 
green, 4-nitroso product into an organic solvent. This method was first used by Ross et al. 41 
for the synthesis of (52) and subsequently for (50)^^  ^ and (51),^ but compound (53) doesn't seem 
to have been prepared previously.
N,N-Bis(2-hydroxyethyl)-4-nitroso-aniline (50) was obtained by nitrosation of 
N,N-bis(2-hydroxyethyl)aniline (37) in aqueous HCl, followed by neutralization with 
saturated NaHC0 3 , saturation of the solution with sodium perchlorate and extraction into
3 4
1)HCI,H2 0 /NaN02 
or HQ0 4  / NaNOj /ACN _ _  r “X
2) Ether or "  ^  ” L
^  ethylacetate A
(37). (SO) : X=OH
(38), (51) : X=0S02CH3 
(5), (52): X=C1
(41). (53) : X=0N02
Scheme 2.5 Synthesis of 4-nitroso mustards (50) - (53)
ethyl acetate. Pure (50) in 74% yield was obtained by silica column chromatography using 
ethyl acetate as eluent. This showed m.p. 134-136®C (lit. m.p. 137-138°C)1^2 g^d m/z=210 
corresponding to M'^ ' in the MS(EI) spectrum. The ^H-NMR spectrum in (CE>3)2CO showed 
two singlets (4H each) at 3.0 and 3.8 ppm for NCH2 and CH2OH groups, respectively; a broad 
overlapping singlet (2H) at 3.8 ppm for the two OH groups; and an AB quartet (4H) at 6.9-7.7 
ppm with J=10.1 Hz, for the aromatic protons. The most significant feature of the IR spectrum 
was a strong absorption at 3350 cm~^  due to the alcohol groups.
N,N-Bis(2-methanesulphonyloxyethyl)-4-nitroso-aniline (51) was obtained 
similarly by nitrosation of N,N-bis(methanesulphonyloxyethyl)aniline hydrochloride (43) 
in aqueous acetonitrile containing HCIO4 . After neutralization with NaOH to pH 7, 
extraction into DCM gave impure (51) which was purified by silica column chromatography 
using ethyl acetate as eluent. The pure product was obtained in 62% yield showing mp. 
116-118°C (lit.  ^mp. 117-118.5®C), and m/z=367 in the MS(FAB^) spectrum corresponding to 
MH^. The ^H-NMR spectrum in (CD3)2CO showed a singlet (6H) at 3.1 ppm for the methyl 
protons; two sets of triplets (4H each) centred at 4.1 and 4.6 ppm with a J=6 Hz, for the NCH2 
and CXZH2 groups, respectively; and an AB quartet (4H) at 7.1-7.8 ppm with J=10.3 Hz for the 
aromatic protons. The IR spectrum showed as most relevant feactures, bands at 1350 and 
1175 cm"  ^ characteristic of the (%0 2 CH3 group.
N,N-Bis(2-chIoroethyl)-4-nitroso-aniline (52) was obtained by nitrosation of 
N,N-bis(2-chloroethyl)aniline (5) in aqueous HCl followed by extraction into ether. After 
recrystallisation from ether, pure (52) was obtained in 79% yield with m.p. 79-80®C (lit. m.p.
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79-80°C) 41 and m/z=246 in the MS(EI) spectrum corresponding to M**". The ^H-NMR spectrum 
in (CD3)2C0  showed a double triplet centred at 4.0 ppm (integrating to 8H) for all the CH2 
protons; and an AB quartet (4H) at 6.9-7.9 ppm with J=9.0 Hz for the aromatic protons. The 
IR spectrum showed bands at 3268 (NH) 1600,1500 (Ar) and 1380 cm'l due to the nitroso group.
N,N-Bis(2-nitratoethyl)-4-nitroso-aniline (53) was obtained by nitrosation of 
N,N“bis(2-nitratoethyI)aniline (41) in aqueous acetonitrile (1:5, v/v) using HCIO4 and 
NaN02, followed by extraction into ether giving an impure product in 44% yield. After 
purification by silica column chromatography using DCM as eluent, pure (53) was obtained in 
30% yield with m.p. 85-87®C and a satisfactory elemental analysis. The MS(EI) spectrum 
showed m/z=300 corresponding to M**". The ^H-NMR spectrum in (CD3)2CO showed two sets 
of triplets (4H each) centred at 4.14 and 4.95 ppm with J=6.7 Hz, attributed to the NCH2 and 
OCH2 groups, respectively, and an AB quartet (4H) at 7.0-7.8 ppm with )=10.3 Hz for the 
aromatic protons. The IR spectrum shows a band at 1380 cm“l, due to the nitroso group.
The assignment of the -N-O stretching frequency for aromatic nitroso compounds has 
been a matter of some difficulty. The IR spectra of all the 4-nitroso aniline mustards show a 
band at 1340-1380 cm~^  due to the nitroso group, which agrees better with Nakamoto and 
Runde^^^ than the value of 1500 cm"  ^suggested by B e l l a m y . ^ ^ 4 , 1 5 5
2.2.2 Synthesis of 4-amino aniline mustards (10)/(54) and (55)/(56)
These compounds were obtained by catalytic hydrogenation of the appropriate 4-nitroso- 
aniline mustards in methanol using 15% palladium on charcoal as catalyst. This procedure 
was first reported by Ross 41 for the synthesis of (10).
The 4-nitroso-aniline mustard substrate was stirred under hydrogen at atmospheric 
temperature and pressure until the calculated volume of hydrogen had been consumed and the 
green colour had disappeared. The only difficulties related to the high reactivity of the 
neutral 4-amino products, which quickly decomposed (polymerised or oxidised). Thus, the 
products were converted immediately to either the more stable N-acyl prodrugs or the less 
reactive hydrochloride or sulphonate salts [by treatment of the reaction solution (after 
filtration of the catalyst) with either methanolic HCl or methanolic methane sulphonic 
acid]. Both N,N-bis(2-chloroethyl)-4-amino-aniIine (10) and N,N-bis(2-methane- 
sulphonyloxyethyl)-4-amino-aniline (55) were not isolated as neutral compounds but as their 
hydrochloride (54) or methanesulfonate (56) salts, respectively.
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Impure N,N-bis(2-chloroethyl)-4-amino-aniline hydrochloride salt (54) was 
obtained as a brown residue in 81% yield. A small amount was twice recrystallised from 
methanol/ether (1:1, v/v) to obtain a pure product as almost colourless plates with m.p. 
245-258“C [lit. m.p. 250-260°C (decomp.)], and a ^H-NMR spectrum in (CD3)2SO showing a 
singlet (8H) at 3.8 ppm for the CH2 groups; an AB quartet (4H) at 6.8-7.S ppm with a J=9.4 Hz 
for the aromatic protons; and a broad singlet at 10.3 ppm for the NH proton.
Impure N,N-bis(2-methanesulphonyloxyethyl)-4-amino-aniline methanesulfonate 
salt (56) was obtained in ca. 40% yield as oily residue. It was difficult to recrystallise and 
therefore used immediately in the next stage of the synthesis. Synthesis of (56) has not been 
reported.
2.2.3 Synthesis of potential aniline mustard prodrugs (11),(12), (57) and 
(58)
N-[4-[N ',N’“Bis(2-chloroethyl)amino]phenyl]acetamide (11 ), N-[4-[N',N'-bis(2-chloro 
ethyl)amino]phenyl]trifluoroacetamide (12) and N-[4-[N',N'-bis[2-methanesulphonyloxy 
ethyl]amino]phenyl]acetamide (57) were all obtained by acétylation of the appropriate 
4-amino substrate, immediately following the above reduction (Scheme 2.6). Following 
isolation, the crude 4-amino salt was treated with excess triethylamine plus acetic or 
trifluoroacetic anhydride. The yield of the reaction was usually low (ca. 20%) probably 
because the neutral 4-amino aniline mustard is very unstable. The literature suggests that for 
4-amino-N,N-dialkylanilines, loss of the N(CH2CH2X)2 moiety is very facile.^^ '^^^®
The synthesis of both (11) and (12) was first reported by Ross et al 40,41 Compound
(57) is new but the 3-N-acetylamino analogue was synthesised by Papanastassiou^ 43 yy a 
different approach involving estérification with methanesulfonyl-choride of 3-[N,N-bis- 
(2-hydroxyethyl)amino)acetanilide.
N-[4-[N',N'-bis(2-chloroethyl)amino]phenyl]acetamide (11) was obtained in 25% 
yield after recrystallisation from ether/n-hexane (1:1, v/v), further purification by silica 
column chromatography using ether/DCM (3:l,v/v) as eluent and two further 
recrystallisations from ether/n-hexane (1:1, v/v). It gave m.p. 120®C (lit. 41 m.p. 124-126®C), 
m/ z=274 corresponding to M"*" in the MS(EI) spectrum and a satisfactory elemental analysis. 
The ^H-NMR spectrum in (CDg)2CO showed two singlets, one at 2.1 ppm (3H) for the methyl 
protons, the other at 3.7 ppm (8H) for the protons in the CH2 groups, and an AB quartet (4H)
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at 6.7-7.S ppm with a J=10 Hz for the aromatic protons. The IR spectrum showed a strong 
absorption at 1650 cm‘  ^for the amide carbonyl group.
Hz]
Y'H
/ N X = C1 (10)X = OSOzCH3 (55)
HCl,MeOH (50%) or 
methane sulphonic acid /MeOH
N
X
X
(54)X = Cl, Y'= cr 
X = OSO2CH3, Y' = CH3SO3 (56)
1) EtsN, DCM
2) (CHaC0 )2 0  or {CF^C0)20
3)H20.DCM
N
X = C l , Y = NHC(0)CH3 (11)
X = C1, Y = NHC(0)CF3 (12)
X = OSO2CH3 , Y = NHC(0 )CH3 (57)
Scheme 2.6 Synthesis of the N-acyl potential prodrugs (11), (12) and (57)
Pure N,-(4-[N',N'-bis(2-chloroethyl)amino]phenyl]trifluoroacetamide (12) was 
obtained in 20% yield after a series of purification steps involving recrystallisation from 
ether/n-hexane (l:l,v/v), silica column chromatography using ether/n-hexane (1:1,v/v) and 
further recrystallisation from ether/n-hexane (l:l,v/v). The shiny silver crystals showed 
mp. 101-103®C (lit.40 m.p. 109-110®C), m/z=328 corresponding to in the MS(EI) spectrum 
and a satisfactory elemental analysis. The ^H-NMR spectrum in (CD3)2CO showed a singlet 
(8H) at 3.8 ppm for the CH2 groups; an AB quartet (4H) at 6.8 - 7.6 ppm with J=10.5 Hz for the 
aromatic protons; and a broad exchangeable singlet (IH) at 10.1 ppm for the NH proton. The 
IR spectrum showed a strong absorption at 1700 cm ^^ for the trifluoroacetamide carbonyl 
group.
N-[4-[N',N'-Bis[2-methanesulphonyloxyethyl]amino]phenyl]acetamide (57) was 
obtained as an impure syrup in 54% yield after silica column chromatography using ethyl 
acetate as eluent. It proved impossible to recrystallise. Normal phase HPLC using a silica 
column and several eluent mixtures (EtOAc/ACN/MeOH 98 :l:l,v /v /v  or EtOAc/DCM 
9:1,v/ v) also gave no purification. The MS(EI) spectrum showed m/z=394 corresponding to
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M"*", and the ^H-NMR spectrum in (CD3 )2CO showed two singlets at 2.0 (3H) and 3.0 ppm 
(6H) for the methyl amide and OSO2CH3 groups, respectively; two sets of triplets (4H) 
centred at 3.8 and 4.4 ppm with J=6.3 Hz, for the NCH2 and OCH2 groups, respectively; an 
AB quartet (4H) at 6.8-7.S ppm with a 1=10.4 Hz for the aromatic protons; and a broad 
exchangeable singlet (IH) at 9.0 ppm for the NH proton. The IR spectrum showed a strong 
absorption at 1670 cm"^ due to the amide carbonyl and absorptions at 1350 and 1175 cm"^ for 
the mesyl OSO2CH3 groups.
Finally, N-[4-[N',N’-bis(2-acetyloxy)ethyI)amino]phenyl]acetamide (58) was 
obtained by acétylation of commercially available N,N-bis(2-hydroxyethyl)-4-phenylene 
diamine sulphate with acetic anhydride in pyridine (Scheme 2.7), following prior conversion 
of the phenylene diamine salt into the free base by treatment with triethylamine for 10 min 
at room temperature. The acétylation was carried out at room temperature for 24h. After 
vacuum evaporation of the pyridine, the product was extracted into DCM. Compound (58) is 
not described in the literature and it was obtained in 31% yield after purification by silica 
column chromatography using ethyl acetate as eluent followed by two reciystallisations from 
DCM/n-hexane (l:l,v/ v). The shining white crystals of (58) showed m.p. 64-66®C and gave a 
satisfactory elemental analysis (see Experimental). The MS(EI) spectrum showed m/z=322 
corresponding to M"^  and the ^H-NMR spectrum (CD3 )2CO showed two singlets at 1.9 (6H) 
and 2.0 ppm (3H) for the ester and the amide methyl groups, respectively; two sets of triplets 
(4H each) centred at 3.6 and 4.2 ppm with J=6.7 Hz for the CH2 groups; an AB quartet (4H) at 
6.8-7.5 ppm with J=1Q.2 Hz, for the aromatic protons; and a broad exchangeable singlet (IH) 
at 8.9 ppm for the NH proton. The IR spectrum showed a strong absorption at 1745 and 1670 
cm"  ^characteristic for ester and amide carbonyl groups, respectively.
H SO 4 HgN—4 N
OH
OH
1) EI3N / Py
2) (CHgCOlsP
O
p  y — y  J  O CC H 3
C H 3 C N H -C  N O
O C C H 3
(58)
Scheme 2.7 Synthesis of the N-acyl potential prodrug (58)
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2.3 Stabilities of aryl mustards (5) and (10), (11) and (12) in
aqueous phosphate buffer 3% (v/v) DMSO at pH 7.4 and 
37°C
To progress the evaluation of aryl mustards N-[4-[N',N'-bis(2-chloroethyl)amino]phenyl] 
acetamide (11) and N-[4-[N',N’-bis(2-chloroethyl)amino]phenyl]trifluoroacetamide (12) as 
prodrugs for ADEPT procedures, the chemical stabilities of substrates N,N-bis(2-chloro- 
ethyi)aniline (5) and N,N-bis(2-chIoroethyl)-4-aminoaniline (10) as well as (11) and (12) 
were determined at pH 7.4 and 37®C. These reactions were carried out in 10"^M phosphate 
buffer containing 3% (v/v) DMSO to solubilise the mustard substrate. The reactions were 
followed by two procedures, HPLC assay and ion chromatography, and rates of decomposition 
were determined.
2.3.1 HPLC assay
These reactions were carried out in 1(T^M phosphate buffer containing 3% (v/ v) DMSO at 
pH 7.4 and 37®C using ca. 0.15 mM substrate (Experimental section 5.4.3 3). The reactions were 
followed by monitoring the decrease in substrate concentration by reverse phase HPLC 
according to the conditions described in Table 5.3 (Experimental, Section 5.4.3.2). This table 
also lists the HPLC retention times (Rf) for substrates and hydrolysis products for the assay 
conditions. In reverse phase column the most polar di-hydroxy compounds elute earlier, 
followed by the mono-hydroxy compound (half-mustard) and finally the intact mustard. In 
practice, aliquots (20 \i\) of the reaction solution were taken at timed intervals using an 
autosampler and on elution, the area of the substrate peak was determined by the computing 
integrator. The integrated peak areas decreased steadily with time to eventually reach a 
zero value.
The decomposition was assumed to follow pseudo first-order kinetics (Equation. 1.1 to 
1.5), and ki (the constant for the first step) was evaluated from plots of log (peak area) or 
(peak height) versus time. These were reasonably linear, validating equation 1.2. Values 
of/c2 were accurate to ± 10%.
The variation of both integrated peak areas (or peak heights) and their logarithmic 
values with time are shown in Figure 2.2. The values of k\ obtained are summarised in 
Table 2.4. It is evident that aryl mustard (10) bearing the 4-NH2 substituent (the potential 
drug) is ca. 15-fold and ca. 42-fold more unstable (ie. more reactive towards H2O) than the 
potential prodrugs (11) and (12), respectively.
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Figure 22 Decomposition of aryl mustards (5), (10), (11) and (12) in phosphate buffer at 
pH 7.4 and 3 7 ^ , followed by HPLC: [Buffer]=10~^M in 3% (v/v) aqueous 
DMSO; [substrate] init. ca. 0.15 mM
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Table 2.4
Values of ki for the decomposition of aryl mustards (5), (10), (11) and (12) in phosphate 
buffer at pH 7.4 and 37 followed by HPLC: [Buffer]-10'^M in 3% (v/v) aqueous
DMSO; [substratehnit ca. 0.15 mM
Compound 4-Substituent 104jti s-I k i ^ / k i ^ log ( k i^ /k i^ )
(5) H 1.10 1 -
(10) NH2 17.35 15.8 1.20
(11) NH(C0)CH3 1.13 1.03 0.01
(12) NH(C0)CF3 0.42 0.38 -0.42
2.3.2 Ion Chiomatographic assay
In the ion exchange chromatography method the release of Cl~ ion was measured and plotted 
as a function of time. Because Cl" is released in 2 steps (Scheme 2.8), its variation with time 
is complicated and the rate obtained is a complex function of and k2 which can be solved by 
time ratio methods.^^ Since ki is known from the HPLC assay (Section 2,3.1), it should be 
possible to deduce k2 from the ion chromatography ((H~) results as outlined in Scheme 2.8.
Cl «—OH __ I—OH
“ Lci ^   ^ ^  c, ^  “ Lou
Scheme 2.8 Two steps involved in the hydrolysis of the aryl mustards
The hydrolysis conditions were identical for both HPLC and ion exchange 
chromatography assay methods (i.e, phosphate buffer (lO'^M), 3% DMSO, pH 7.4 and 37®C) 
and both were performed using an automatic sample extraction and injection (Experimental 
Section 5:4 3). For the ion exchange method/ however, technical problems prevented stirring 
of the reaction solution as for the HPLC method. Figure 2.3 shows the behaviour of these 
mustards with time.
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Figure 2.3 Comparison of hydrolysis of mustards (5), (10), (11) and (12) in phosphate buffer 
at pH 7.4 and 37*C followed by ion exchange chromatograpy: [Buffer] lO'^M 
in aqueous DMSO (3%,v!v); [substrate] i„it ca. 0.15 mM
Table 2.5 shows the ki and k2 values calculated by the time ratio method 
(using initial k\ values obtained in Section 2.3.1).
Table 2.5
Values of kj and kz for decomposition of aryl mustards (5), (10), (11) and (12) in phosphate 
buffer at pH 7.4 and 37 “C followed by ion exchange chromatography:
[Buffer] 10'^M in aqueous DMSO (3% vfv); [substrate] init ca. 0.15 mM
Compound 4“Y Substituent lO^xiti (s-1) 104xjk2(s-^)
(5) H 2.56 1.79
(10) NH2 26.6 16
(11) NH(C0)CH3 2.9 1.6
(12) NH(C0)CF3 0.86 . 0.6
4 3
2.4 Isolation and identification of products for the
decomposition (hydrolysis) of aiyl mustards (11) and (12) in 
aqueous DMSO at 37°C and different pH
The products were obtained by dissolving the aryl mustard (either 20 mg (11) or 23 mg (12), 
0.072 mmol) in aqueous DMSO (7:3, v/v) (25 cm^) at pH 2, 7 or 12 (pH adjusted with either 
HCl or NaOH), and heating the solution at 37®C over 24h. The solution was then neutralized 
with NaOH or HCl and freeze-dried. The residue was extracted with ethyl acetate (20 cm^) 
and after vacuum evaporation of the solvent, analysed by MS, GC and GC-MS procedures. 
When a relatively pure product was obtained, it was also examined by 
^H-NMR spectroscopy.
2.4.1 Aryl mustard (11) at pH 2 and 7
These reactions gave a single, major product. The El mass spectrum showed m/z=238 and the 
^H-NMR spectrum in (CD3OD) showed 5=2.1 (3H, s, NHCOCH3), 3.4 (IH, br s, NH), 3.5 and 
3.6 (8H,dt, J=5.1 Hz, CH2), 4.8 (2H, br s, OH), 6.6-7.3 ppm (4H, ABqu, J=10.4 Hz, ArH). These 
data are consistent with structure (59) for this compound.
O  I—  OH
^ O H
(59)
Charts
The GC-MS spectra were inconclusive because (59) is hot ameniable to GC assay.
2.4.2 Aryl mustard (11) at pH 12
This reaction gave a mixture of two products. The El mass spectrum showed parent ions at 
m/z=238 [M'*' for (59)] and m/z=220 [M^ for (60)]. The GC-MS assay showed a large peak at 
Rf=15 min with m/z=220 corresponding to M"^  for (60).
NH—4  N
(60) 
Chart 6
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The above observations were confirmed by GC assays of the reaction mixture against 
authentic compounds 4-phenylmorpholine (45), 4-morpholinophenylacetamide (60), 
4-morpholinoaniline (61), 4-acetamidophenol (62), diethanolamine (63) and 4-aminophenol
(64). None of these compounds were evident at pH 2 and 7, but (60) was apparent after 24 min 
for decomposition at pH 12.
2.4.3 Acyl mustard (12) at pH 2 and 7
These reactions also gave a single, major product. The FAB mass spectrum (positive mode) 
gave m/z=293 (100%) which corresponds to the MH"*" ion for compound (65).
O ,-O H
OH
CF3 NH—^  N
(65)
Chart 7
2.4.4 Aryl mustard (12) at pH 12,13 and 14
At pH 12 this reaction gave a mixture of two products. The El mass spectrum showed two 
parent ions at m/z=292 [M"^  for (65)] and m/z=196 [M'*’ for (66)] at relative intensities of 21% 
and 12%, respectively.
OH
(66)
Chart 8
At pH 13, three products are formed. The El mass spectrum shows the above two 
parent ions at m/z=292 [M^ for (65)] and m/z=196 (M"*" for (66)], plus a third at m/z=178 (M+ for 
4-phenylmorpholine (61)],
At pH 14, there appears to be only one final product. Both ^H-NMR (CD3OD) 
examination showing 6=2.8 (4H, t, J=5.5 Hz, CH]), 3.7,(4H, t, J=5.5 Hz, CH%), 4.7 (2H, s, 
NH2) and 6.6 ppm (4H, 1=5.2 Hz, ArH) and the MS(El) spectrum showing m/ z=178 [20%, M'*' 
for (61)] and 12(0 (52, M+ - C3H6O) are consistent with the structure (61) for this product.
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NH%) and 6.6 ppm (4H, J=5.2 Hz, ArH) and the MS(EI) spectrum showing m/z=178 [20%, M"*" 
for (61)] and 120 (52, M'*' - C3H5O) are consistent with the structure (61) for this product.
(61) 
Chart 9
2 .5  Decomposition (hydrolysis) of aryl mustards (10), (11) and 
(12) in aqueous DMSO at 37^C and different pH followed 
by HPLC
In a standard procedure, the substrate mustard in neat DMSO (50 pi, 9xlO~^M) was injected 
into a thermostatted reaction vessel (37°C) containing aqueous DMSO (30 cm^, 7:3, v/v) 
adjusted to the required pH by the addition of either NaOH (IM) or HCl (IM). The 
concentration of substrate in the reaction solution was ca. 1.5xlO"^M. The reaction mixture 
was stirred and at timed intervals, an aliquot (20pi) was taken by an auto sampler and 
injected into the HPLC analyser. Details of the HPLC assay including retention times (Rf) 
for substrates and products are given in Table 5.3 (Experimental Section 5.4.3 2 and 5.4.3.4). 
Aliquots were collected at appropriate times, according to the kinetics of each substrate. 
Each aliquot was eluted to display all of the major products as well as the substrate. The 
area of each peak was recorded by a computing integrator and subsequently, either the peak 
heights or the integrated peak areas for the substrate and each product were plotted with 
respect to time. From these data for the substrate, the pseudo first-order rate coefficient k\ 
(equation 1.2) for the first hydrolysis step, was determined from plots of log peak area or log 
peak height versus time. These plots were invariably linear.
For hydrolysis of compounds (11) and (12) at pH 2, values of both k\ and kz were 
calculated by substitution of concentrations of the mustard (A), the half-hydrolysed mustard 
(B) and the final diol product (C) (Scheme 1.12) into the appropriate first-order equation 
reaction (1.2 to 1.5) and optimized using a mathematical method to determine the best fit 
(Enzeffiter method). Formation of several final products in basic conditions prevent the 
determination of values of and k2, simultaneously.
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2.5.1 Aryl mustard (10)
Because of a lack of time and purification difficulties, N,N-bis(2-chloroethyl)-4-amino- 
aniline (10) was examined at pH 12 only.
The HPLC data summarised in Figure 2.4 show that (10) (Rf=20.61 min) disappears 
rapidly in ca. 20 min. The HPLC trace after 40 min showed no evidence of (10). The reaction 
mixture rapidly darkened and the major product (Rf=4.20 min) was identified by HPLC 
comparison against authentic material, and by MS assay of the isolated reaction product, as 
N,N-bis(2-hydroxyethyl)-4-amino-aniline (66). Compound (66) was unstable, reaching a 
maximum concentration at ca. 40 min, then decomposed steadily. It was also possible to 
detect at Rf=14.64 min, the half-hydrolysed mustard (69) in the conversion of (10) to (66). 
Compound (69) showed a high turnover and was observable only in aliquots at 13 min and 20 
min reaction, which were frozen immediately on collection and subsequently analysed.
The plot of log (peak area) for (10) versus time gave an approximate value of 
k\= 4000 X 10"  ^s"  ^ ie ca. 120-fold faster than the decomposition of (12) (Section 2.5.3.2) and 
880-fold faster then the decomposition of (11) (Section 2.5 2.2), under similar conditions. 
The decomposition pathway for (10) at pH 12 is outlined in Scheme 2.9.
j r  
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r-fi,
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L ^ 'O H or
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Scheme 2.9 Decomposition pathway for N,N-bis(2-chloroethyl)-4-amino-aniline (10) 
in aqueous DMSO (7:3, v/v) at pH 12 and 37 X.
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Figure 2,4 HPLC assays of N,N-bis(2~chloroethyl)-4-amino-aniline (10) decomposition 
in aqueous DMSO (7:3, vjv) at pH 12 and 37"C; [lOJinit ca. 0.15 mM
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Hydrolysis is envisaged to proceed via two sequential S^i reactions producing 
aziridinium ion intermediates which react with water or HO", as for aryl mustards (11) 
(Section 2.5.2 3) and (12) (Section 2.5.3.4). Interestingly, concurrent formation of 
4-morpholinoaniline appears not to proceed with (10) at pH 12. It is possible that activation 
by 4-amino substituent promotes aziridinium ion formation by the intermediate (69) rather 
than reaction of the hydroxyl moiety to give 4-morpholinoaniline.
2.5.2 Aryl mustard (11)
2.5.2.1 pH 2
The HPLC data sununarised in Figure 2.5 show that: 1), the peak height of the substrate
M-l4-(N',N'-bis(2-chloroethyl)amino]phenyl]acetamide (11) at Rf=24.77 min, decreases to 
zero over 1000 min; 2), the peak area at Rf=17.87 min, corresponding to the half-hydrolysed 
mustard (67), increases to a maximum at ca. 300 min, then decreases to a small value at 
1500 min; 3), a major product corresponding to 75% reaction, at Rf=8.63 min, increases over 
1000 min after a clear induction period. This major product was identified as N-[4-[N\N'~ 
bis(2-hydroxyethyl)amino]phenyl]acetamide (59), by HPLC coelution with authentic 
material. The identity of this product after neutralization of the reaction mixture, freeze- 
drying of the solution and extraction of the residue with ethyl acetate, confirmed the product 
identity (see above).
The variation of log (peak height) for (11) with time is linear (see Figure 2.5 a) and 
gives ki= 2.65 x 10"^s" .^
2.5.2.2 pH 12 and pH 13
The HPLC data in Figure 2.6 for pH 12 show similar time-dependent behaviour for the peak 
height of the substrate (11) and the peak area of the half-hydrolysed mustard (67). The 
chromatograms also showed the formation of two main products. The major one, at 
Rf=8.63 min (corresponding to 74% reaction) is N-[4-[N',JV'-bis(2-hydroxyethyl)amino] 
phenyl] acetamide (59), as found at pH 2. The second product at Rf=15.16 min (corresponding 
to 20% reaction) was identified as 4-morpholinophenylacetamide (60), by HPLC coelution 
with authentic material. The identity of this product was also confirmed by GC-MS of 
isolated material (see above).
As for pH 2, the variation of log (peak height) for (11) with time, is linear (see 
Figure 2.6 a) and gives ki = 4.53 x 10"  ^s" .^
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The reaction at pH 13 was very similar to pH 12 except for a different ratio of the two 
hydrolysis products, and a different rate. |Thus, N-[4-[N',N'-bis(2-hydroxyethyl)amino] 
phenyl]acetamide (59) was the minor product in 20% yield, whereas 4-morpholino­
phenylacetamide (60) was obtained in 75% yield. The value of k\ is 8.0 x lO"  ^s" .^
2.5.2.3 Summary
The effect of pH on reaction rates (rate for the first step of hydrolysis) and products is 
summarised in Table 2.6. The products are consistent with the pathways outlined in 
Scheme 2.10. At pH 2, hydrolysis seems to proceed via two sequential Sni reactions producing 
aziridinium ion intermediates which react with water or HO". At pH 12 and 13, the reaction 
is complicated by ionization of the half-hydrolysed mustard, which promotes an alternative 
Sbji reaction leading to the formation of N-[4-(4-morpholinyl)phenylacetamide (60). The 
alternative reaction is pH dependent and the yield of (60) increases from 20% to 75% with 
increase of pH from 12 to 13. The rate of decomposition of (11) is virtually independent of 
pH. This supports an Sxi reaction for the first step of Scheme 2.10 rather than direct attack 
by H2O or HO".
Table 2.6
Dependence of kj and products on pH for N-[4-[N',N'~bis(2-chloroethyl)amino 
phenyljacetamide (11) decomposition in aqueous DMSO (7:3,vIv) at 37 °C
pH Product /  Yield (%) lO^xJti (s"l)
2 (59)/75 2.65
12 (59) /  74 4.53
(60) /  20
13 (59) /  20
(60) /  75
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Figure 2.5 HPLC assays of N-[4-[N\N'-bis(2~chloroethyl)aminoJphenyl]acetamide (11)
decomposition in aqueous DMSO (7:3, v/v) at pH 2 and 37‘C; [llJinit ca- 0-15 mM
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Figure 2.6 HPLC assays of N-[4-[N\N'-bis(2-chloroethyl)amino]phenyl]acetamide (11)
decomposition in aqueous DMSO (7:3,vlv) at pH 12 and 37®C; 111] init ca- 0.15 mM
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Scheme 2.10 Decomposition pathways for N-[4-[N\N'-bis(2-chloroethyî)amino]phenyl] 
acetamide (11) in aqueous DMSO (7:3,vjv) at 37 X. and different pH
2.5.3 Aryl mustard (12)
2 .5.3.1 pH 2
The HPLC data summarised by Figure 2.7 is very similar to that obtained for (11). Thus, the 
peak area of the substrate [N-[4-[N',N'-bis(2-chloroethyl)amino]phenyI)trifluoroacetami- 
de (12) at Rf=29.8 min decreases to zero over 3000 min, while the peak area at Rf=23.61 min 
corresponding to the half-hydrolysed mustard (68), increases to a maximun value at 
ca. 500 min, and then decreases to virtually zero at 3000 min. Also a single major product 
corresponding to 90% reaction with Rf=17.75 min increases steadily after an induction period. 
This product was identified as N-[4-[N',N'-bis(2-hydroxyethyl)amino]phenyl]trifluoro- 
acetamide (65), by HPLC coelution with authentic material. The identity of this product.
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after neutralization of the reaction mixture, freeze-drying of the solution and extraction of 
the residue with ethyl acetate, confirmed the product identity (see above).
The variation of log (peak area) for the disappearance of (12) with time is 
reasonably linear (see Figure 2.7 a) and gives k\ = 9.8 x 10"  ^s‘ .^
2.5.3.2 pH 12
The HPLC data in Figure 2.8 for pH 12 shows similar behaviour for the peak areas of 
substrate (12), although its decomposition is very much faster and virtually complete in 
100 min. Also, the half-hydrolysed substrate (68) is observable, but its peak area reaches a 
maximum at ca. 50 min and has disappeared at ca. 110 min. As for substrate (11), the 
chromatograms show formation of two main products at pH 12. One product at Rf=17.75 min, 
that forms faster and decomposes further, is identical to the N-[4-[bis(2-hydroxyethyl) 
amino]phenyl]trifluoroacetamide (65) formed at pH 2. The second product, at Rf=4.20 min 
corresponding to 69% reaction at ca. 110 min, was identified as N,N-bis(2-hydroxyethyl)-4- 
aminoaniline (66) by comparison of HPLC retention times against authentic material and by 
MS examination of isolated product on completion of the reaction (see above). The decrease 
of (66) with time probably relates to its oxidation to 4-benzoquinone di-imine and subsequent 
hydrolysis.^®®
The variation of log (peak height) for (12) with time (see Figure 2.8 a) gave 
k\ ca. 3.25 x 10”^  s" .^
2.5.3.3 pH 13
The HPLC data for decomposition under more alkaline conditions (Figure 2.9) shows faster 
reaction and an increased number of products. The substrate (12) peak virtually disappears 
after 36 min and is replaced by a series of peaks for products that fonn and decompose in the 
early stages of the reaction. A peak at Rf=23.61 min corresponding to the half-hydrolysed 
mustard (68) for the conversion of (12) into (65) is just detectable (< 3% peak area relative to 
initial peak area of substrate (12)) in one aliquot at 12 min, and a second peak at Rf=14.70 min 
probably due to the half-hydrolysed mustard (69) for the conversion of (10) into (66), is only 
seen over the initial 36 min. Two other peaks at Rf=17.75 min (identified as N~[4-[N',N'- 
bis(2-hydroxy ethyl) amino] phenyljtrifluoroacetamide (65)) and Rf=20.61 min (identified as 
Af,N-bis(2-chloroethyl)-4-amino-aniline (10)) are also evident in the HPLC chromatograms 
in small amounts (< 3%, relative to initial peak area of substrate (12)) for the early stages of 
the reaction only (< 200 min). Two peaks at Rf=4.20 and 12.18 min, corresponding to more 
stable products which increase at longer reaction times were identified as N,N-bis-
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(2-hydroxyethyl)-4-amino-aniline (66) and 4-morpholinoaniline (61), respectively. The 
identification of all these products apart from the half-hydrolysed mustards (68) and (69) 
was made by HPLC retention times against authentic compounds.
The variation of log (peak height) for (12) with time (see Figure 2.9 a) gave 
fcica. 505s‘l.
2.S.3.4 Summary
The effect of pH on reaction rates and products for the decomposition of [N-[4-[N ’,N'~bis- 
(2-chloroethyl)amino]phenyl]trifluoroacetamide (12) in aqueous DMSO (7:3,v/v) at 37°C is 
summarised in Table 2.7. For both compounds (11) and (12), decomposition is slower at pH 2 
than at pH 12 and 13. While at pH 2 the decomposition is ca. 3-fold faster for (11) than for 
(12), at pH 12 and 13 an inverse situation occurs: (12) hydrolyses ca. 7-fold faster then (11) 
and, in contrast to (11), cleavage of the N-trifluoroacetyl moiety of (12) is apparent at pH 12 
and 13. These findings suggest that different decomposition pathways operate in acidic and 
basic conditions. These pathways, outlined in Scheme 2.11, have the following 
characteristics:
1) At pH 2, the formation of N -[4-[N ',N '-bis(2-hydroxyethyl)am ino]phenyl] 
trifluoroacetamide (65) from (12) seems to involve similar, sequential Spi reactions producing 
aziridinium ion intermediates as for (11) (Scheme 2.10). The rate of this reaction is slightly 
slower, presumably because of increased electron-withdrawal by the N-trifluoro acetyl 
substituent (in (12)) compared with N-acetyl (in (11)). This reaction is described by Path 1 of 
Scheme 2.11.
2) At pH 12, formation of N-(4-[bis(2-hydroxyethyl)amino]phenyl]trifluoro- 
acetamide (65) proceeds via Path 1, identical to that for the decomposition of (11). 
Formation of N,N-bis(2-hydroxyethyl)-4-amino-aniline (66), however, must form by an 
alternative Path 2 involving initial cleavage of the N-trifluoroacetyl moiety to give (10), 
which rapidly decomposes to (66) via similar Spi reactions to those for (11) and (12). Because 
the overall decomposition of (12) at pH 12 is ca. 7-fold faster than (11), formation of (66) via 
Path 2 must predominate.
3) At pH 13, decomposition via Path 2 is complicated by ionization of the half- 
hydrolysed mustard (69) which promotes an alternative Spi reaction leading to the formation 
of 4-morpholinoaniline (61), in addition to (66). Here too, the ca. 7-fold faster decomposition 
of (12) relative to (11) implies (66) and (61) form predominantly by Path 2.
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Figure 2 .7  HPLC assays of [N-[4-[N',N'-bis(2-chloroethyl)atnino]phenyl]trifluoroacetamide
(12) decomposition in aqueous DMSO (7:3,vlv) at pH 2 and 37X1:
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Figure 2.8 HPLC assays of [N-[4-[N\N'-bis(2-chloroethyl)amino]phenyl]trifluoroacetamide
(12) decomposition in aqueous DMSO (7:3,vlv) at pH 12 and 379C;
fl27 init. ca. 0.15 mM
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Figure 2.9 HPLC assays of [N-[4-[N',N'-bis(2-chloroethyl)amino]phenyl]trifluoroacetamide
(12) decomposition in aqueous DMSO (7:3,vfv) at pH 13 and 37 °C:
[lliinit. ca. 0.15 mM
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Scheme 2.11 Decomposition pathways for [N-[4-[N',N'-bis(2-chloroethyl)amino]phenyl] 
trifluoroacetamide (12) in aqueous DMSO (7:3,v!v) at 37 *C and different pH
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Table 2.7
Dependence of kj and products on pH for IN44~IN',N'-bis(2-chloroethyl)amino]phenyl] 
trifluoroacetamide (12) decomposition in aqueous DMSO (7:3,vlv) at 37°C
pH Product / Yield (%) lO^ki (s'l)
2 (65) / 90 0.98
12 (65) /  10 32.5
(66) / 69
13 (66) / 64 50.5
(61) / 31
2.6 Hydrolysis of aryl mustards (10), (11) and (12) in aqueous 
DMSO at 37°C and different pH followed by UV-visible 
spectrophotometry
The hydrolysis of N,N-bis(2-chloroethyl)-4-aminoaniline (10), N-[4-[N',N'-bis(2-chloro- 
ethyt)amino]phenyl]acetamide (11) and N-[4-[N',N'-bis(2-chloroethyl)amino]phenyl] 
trifluoroacetamide (12) in aqueous DMSO (99:1, v/v, pH 12 and 2) and in phosphate 
buffer/DMSO (99:l,v/v, pH 7.4) at 37®C was also followed by UV-visible spectrophotometry, 
recording the spectra between 200 and 400 nm at timed intervals.
In general, the mustard in DMSO (30pl, 1.2xlO"^M) was injected into an aqueous 
solution (3 cm^) at pH 12 or 2 (adjusted with IM NaOH or IM HCl) or 0.05M aqueous 
phosphate buffer at pH 7.4, contained in a cuvette thermostatted at 37®C. This gave a 
substrate concentration of ca. IxlO'^M. The first spectrum was recorded immediately after 
addition of the substrate and then at timed intervals.
Some of the UV-Visible spectra were inconclusive; it was not possible to observe 
appreciable changes between the spectrum of the substrate and the spectrum of the final 
reaction mixture. The main reason is due to similar X^ax and extinction coefficients of the 
starting material, the intermediate half-hydrolysed mustards and the final products, as 
summarized in Table 5.1 (Experimental). Further, protonation of some compounds (NH2 
groups or mustard amine groups (pka ca. 5.8) complicated the interpretation of spectral 
changes.
Where substantial spectral changes were observed, an approximate value of the 
decomposition rate {rate = ko [substrate]} was calculated from reaction half-lives ( t i /2)
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where ti /2  = time for the absorbance of the reaction mixture to be reduced to half of its value 
(ti/2 = 0.693 ko). Attempts to calculate fco from plots of log (Aoo - At) versus time, where A» 
and At = absorbances at time t and oo, respectively, at a wavelength characteristic of the 
substrate, were unsatisfactory mainly because infinity values were difficult to evaluate.
2.6.1 Aryl mustard (10)
At pH 7, there is no observable change in the spectra over lOh, with a maximum at 260 mn of 
constant intensity.
At both pH 12 {Figure 2.10) and 2 {Figure 2.11), there is a decreased intensity of 
Xmax=255 and 260 nm, respectively (10) with time, faster at pH 12 (&o=2.3xl0"4 s" )^ than pH 2 
(A:o=2.6xlO"^  s" )^. The final products absorb at ca. 230 nm.
2.6.2 Aryl mustard (11)
At pH 7, there was no appreciable change in the UV-Visible spectra over 24h. The Xmax= 
270 nm of substrate (11) and Xmax=271 nm of the major final product N-[4-[N',Af’-bis- 
(2-hydroxy)ethyl]amino]phenyl]acetamide (59), are virtually identical at this pH.
At pH 12, a similar situation applies, although the spectra show a very small
decrease of intensity of X.max=270 nm and small increase at X.max-250 nm, with an isosbestic
point at 260 nm. These changes probably relate to the formation of the second product, 
4-morpholinophenylacetamide (60), with Xmax=258 nm. This product is formed only in 20% 
yield, compared to 77% for (59) (with ^ a x =  271 nm), so the spectral changes are attenuated.
At pH 2, it was possible to observe the decomposition of (11) {Figure 2.12) and the 
hydrolysis rate measured from these spectra give ^ =9.6x10"^ s" ,^ about the same as the rate 
obtained by HPLC analysis (fco=2.7xl0"^ s"^). The difference may relate to the higher 
concentration of DMSO (30%) used for the HPLC analysis. Figure 2.12 shows the decrease in
(11) (Xmax=265 nm) and the increase of (59) (Xmax=250 nm) with time, and a well-defined 
isosbestic point at ca, 260 nm.
2.6.3 Aryl mustard (12)
At pH 7, only a small variation of ^ax-286 nm for (12) was observed over 24h. This reflects 
the similarity of Xmax for the substrate and products ((59), Xmax=271 nm.
At both pH 2 and 12, however, it was possible to observe spectral changes that reflect 
the decomposition of (12) and to relate them to the HPLC results.
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Figure 2.13 refers to the decomposition of (12) at pH 12. It was a fast reaction with 
fco=5.8xl0"^ s"^  compared with fco=3.25xl0'^ s"^ , for HPLC. There was not a well-defined 
isosbestic point due to the formation of several products. It was possible however, to observe 
the rapid decrease of (12) (^max=279 nm) and the rapid formation of (10) (^max=254 nm). 
Product (10) decomposes rapidly and the absorbance above 240 nm virtually disappears. The 
final products absorb at lower wavelengths [(66), Xmax=253 nm; (61), )imax=220 nm].
At pH 2 {Figure 2.14) there is a well-defined isosbestic point at ca. 260 nm reflecting 
the conversion of (12) (?^max=285 nm) into N-[4-[N',N’-bis(2-hydroxyethyl)amino]phenyl] 
trifluoroacetamide (65) (Xmax=248 and 290 nm). A value ofAo=4.05 x 10“^  s‘  ^ is obtained from 
these data compared with Ico=0.98 x 10*^  s‘  ^by HPLC.
Spectrum t (h)
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Figure 2.10 UVlVis spectra of hydrolysis of N,N-bis(2-chloroethyl)-4-amirtO"aniline (10) 
in aqueous DMSO (9:1,viv) at 37°C and pH 12 : flOJ init ca- 1x1
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Figure 2.11 UVlVis spectra of hydrolysis of N,N~bis(2-chloroethyl)-4-amino-aniline (10) 
in aqueous DMSO (9:1,vIv) at 37°C and pH 2: [10] init. ca- IxlO'^M
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Figure 2.12 UVlVis spectra of hydrolysis of N -[4-[N ',N ‘-bis(2-chloroethyl)amino]phenyl]
acetamide (11) in aqueous DMSO (9:1,vjv) at 37°C and pH 2 :
111] init ca. IxlO^M
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Figure 2.13 UVlVis spectra of hydrolysis of N-[4-N'N'-bis(2~chloroethyl)aminoJphenyl} 
trifluoroacetamide (12) in aqueous DMSO (9:l,vjv) at 37°C and pH 12:
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Figure 2.14 UVjVis spectra of hydrolysis of N-[4-N',N'-bis(2-chloroethyl)amino]phenyl]
trifluoroacetamide (12) in aqueous DMSO (9:1,vjv) at 37°C and pH 2; 
[12] init, ca. IxlO-^M
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2.7 Stability of aryl mustard (58) in aqueous DMSO at 50°C 
and pH 12 determined by HPLC
N -[4-N ',N '-bis(2-acetyloxy)ethylam ino]phenyacetam ide (58) was synthesised to 
investigate the effect of nucleofugacity on the differential reactivity of aryl mustard 
prodrug/drug combinations. Unfortunately, lack of time prevented full examination of this 
factor.
The stability of (58) was briefly examined in aqueous DMSO (7:3, v /v) at 50®C and 
pH 12 using reversed-phase HPLC to follow both the loss of (58) (Rf=19.91 min) and the 
formation of both the half-hydrolysed mustard (70) (Rf=15.16 min) and the final hydrolysis 
product 4-[N,N-bis(2-hydroxyethyl)l-phenylacetamide (59) (Rf=8.63 min) (Scheme 2.12) 
(Experimental 5.4 3.2 and 5 4.3.3). The identity of (59) was established by comparison of 
HPLC retention time against authentic compound and by mass spectral examination of the 
reaction product.
The pseudo first order rate (t% ) for decomposition of (58) in aqueous DMSO (7:3, v/v) 
at pH 12 and 50®C, determined from the plot of log (peak area) of (58) versus time, was 
ca. 2.4 X10"^  s"^ , and the HPLC trace of the reaction mixture after 38 min showed no trace of 
(59). Further, the intermediate (70) increased, passed through a maximum concentration at 
ca. 40 min and then disappeared (Figure 2.15).
Other brief experiments (Experimental S.4.3.3) showed (58) was very stable in 
aqueous phosphate buffer (3% v /v  DMSO) at pH 7.4 and 37®C, showing only ca. 5% 
decomposition over 24h.
O
O I - O ' ^  O i-O H
- M 2 2 .
(58) 6  (70) S
H2O/HO'
O r-OH
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Scheme 2.12 Decomposition pathway for N-[4-N\N'-bis(2~acetyloxyethyl)amino]phenyl-
acetamide (58) in aqueous DMSO (7:3,vjv) at pH 12 and 50 *C
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Figure 2.15 Hydrolysis of N-[4-N',N'-bis(2-acetyloxy)ethyl]amino]phenyl]acetamide (58) 
in aqueous DMSO (7:3, v/v) pH 12 at 50®C: 158} inu, ca. lxlO~^M
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2.8 The common ion effect by added Cl"
Retardation by added Cl" of the hydrolysis of mustards (10), (11) and (12) was also briefly 
examined by UV-visible spectroscopy. The mustard in DMSO (10 jil, 1.5xlO"^M) was injected 
into a solution (3 cm^) of the salt (0.5M) (NaCl or NaClO^) at pH 2 (adjusted with IM HCl) 
in DMSO (9:1, v/v) contained in a cuvette thermostatted at 37°C. This gave, an initial 
substrate concentration of ca. 5 x 10"^M. The first spectrum was recorded immediately after 
addition of the substrate and then at timed intervals. Similar reactions were run in dilute 
HCl, and HCIO4. The results in Table 2.8 show clearly that addition of NaCl retards the 
acid hydrolysis of (10), (11) and (12). The retardation is larger for NaCl than NaClO^, 
which.suggests the operation of a common ion rather than a salt effect. These results agree 
with previous observations^^'^ on the common ion effect observed for Cl".
Table 2.8
Half-lives (ti/2) for the hydrolysis of aryl mustards (10), (11) and (12) in aqueous 
DMSO (9:1,vjv) at pH 2 and 37®C in the presence of NaCl or NaCl04
t l /2  (h)
Compound 0.01 M HCl 0.01 M HCl, 0.01 M HCl, 
0.5M NaCl 0.5 M NaC104
O.IM HCIO4
N,N-Bis(2-chloroethyl)-
-4-amino-aniline (10) 17 20 9 6.5
N-{4-[N W-Bis(2-chIoroethyl) 
amino-pheny]]acetamide (11) 2 5 2 ?
N-14-[N',N’-Bis(2-chloroethyl)- 
aminolphenyl]trifluoroacetamide (12) 5 9 3.5 4.5
2.9 Synthesis of authentic products (59),(60),(65) and (66)
These were synthesised to facilitate product analysis for the hydrolysis of mustards (11) and
(12). Both (60) and (65) are not described in the literature.
N-[4-[N',N'-Bis(2-hydroxy)ethyl]amino]phenyl]acetamide (59) was obtained by 
mild, base hydrolysis of N-[4-lN',N’-bis(2-acetyloxy)ethyl]amino]phenyl]acetamide (58) 
using aqueous NaOH (pH 12) at 37°C for 5h, (Scheme 2.12), a different route to the one
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followed by DeGraw et al. who react 4'-aminoacetanilide with ethylene oxide in aqueous 
acetic acid.
The reaction was followed by HPLC: the starting material (58) gave Rf=19.91 min 
and the final hydrolysis product (59) gave Rf=8.63 min; the formation of an intermediate 
compound (70) (Rf=15.16 min) (presumably from removal of only one of the two O-acetyl 
functions) was also apparent. The reaction solution was neutralised with gaseous CC>2 to pH 
7 before extraction with DCM. Compound (59) was obtained in 87% yield and was not 
subjected to further purification. It showed m.p. 142-150°C (decomp.), (lit.^^0 ^ .p . 
141-142.5®C) and the MS(EI) spectrum gave m/z=238 corresponding to M’*'. The ^H-NMR 
spectrum in CD3OD showed a singlet (3H) at 2.1 ppm for the acetyl group, two double 
doublets (8H in total) centred at 3.5 and 3.6 ppm with J=5 Hz for the hydroxyethyl CH2 
groups, an AB quartet (4H) at 6.7-7.4 ppm with J=10 Hz for the aromatic protons, and an 
exchangeable 3H singlet at 4.9 ppm for the OH and NH protons. The IR spectrum showed a 
strong absorption at 3500 and 1560 cm"  ^corresponding to the alcohol and the carbonyl group, 
respectively.
Synthesis of 4-morpholinophenylacetamide (60) involved a simple acétylation with 
acetyl chloride of 4-morpholinoaniline in THF at room temperature for Ih. Triethyl amine 
was added to neutralise released HCl. After purification by silica column chromatography 
using DCM as eluent, (60) was obtained as a white solid in 78% yield with m.p. 198-200°C. 
The MSfFAB"*") spectrum showed m/z=221 corresponding to MH^ and MS(FAB") m/z=219 
corresponding to M-H'*'. The ^H-NMR spectrum in CDCI3 contained a singlet (3H) at 2.14 
ppm for the methyl group; two sets of triplets (4H each) centred at 3.11 and 3.86 ppm 
(1=1.4 Hz) for the morpholine ring; an AB quartet (4H) at 6.88-7.38 ppm (J=3 Hz) for the 
aromatic protons and a broad exchangeable singlet (IH) at 7.41 ppm for the NH proton. The 
IR spectrum showed a strong absorption at 1660 cm~^  for the amide carbonyl group.
N-[4-N 'N '-Bis-(2-hydroxyethyl)amino]phenyl]trifluoroacetamide (65) w as 
obtained by acid hydrolysis (pH 2, HCl) of the mustard 4-[N',N'-bis(2-chloroethyl)amino] 
phenyl]trifluoroacetamide (12) in aqueous DMSO (7:3,v/v) for 12h at 37“C {Scheme 2.13).
?  y r -x  HCl/Hp/DMSO 9  y— V 1 " ° "
C fyC N H -^ } -N Z Z  ---------------------   CF^CNH-C
■Cl ' *-OH
(12) (^5)
Scheme 2.13 Synthesis of (65) 
68
The reaction was followed by HPLC and when all the starting material had been consumed, 
the mixture was neutralized (NaOH) and freeze dried. The residue was extracted into ethyl 
acetate. The product (89% yield) was not further purified as HPLC showed a single peak at 
Rf=17.75 min. The MS(FAB^) spectrum showed m/z=293 corresponding to MH^. The ^H- 
NMR spectrum in (CD3)2CO showed two sets of triplets (4H each) centred at 3.62 and 
3.75 ppm with J=1.3 Hz for the hydroxyethyl CH% groups, and an AB quartet (4H) at 6.98-7.59 
ppm with J=2 Hz for the aromatic protons. The IR spectrum contained strong absorptions at 
U= 3500 (for the alcohol group) and 1700 cm“^  for the amide carbonyl.
N,N-Bis(2-hydroxyethyl)-4-aminoaniline (66) was obtained impure in 34% yield by 
neutralization of an ethanolic solution of N ,N -b is(2 -h y d ro x y e th y l)-4 -am in o  
aniline sulphate salt (previously recrystallised from ethyl alcohol) with one equivalent of 
aqueous NaOH (IM). After 10 min, the solution was freeze-dried and the residue extracted 
into ethyl acetate. It proved impossible to purify and gave m.p. 85-95®C, (lit.^^^ m.p. 
87-88°C) The MSfFAB"**) spectrum showed m / z=197 corresponding to MH^ and the ^H-NMR 
spectrum in (CDglzSO {doublet (8H) at 3.2 ppm for the CH] groups, an AB quartet (4H) at 
6.8-7.5 ppm for the aromatic protons, and a broad exchangeable singlet (2H) at 4.9 ppm for the 
NH or OH groups} is consistent with isolation of the neutral compound (66).
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Chapter 3
Results and Discussion 2:
Carbamate Prodrugs
3.1 Utility of carbamate compounds as prodrugs
The most potent aryl mustards are those bearing electron donating substituents such as the 
4-amino group, and N,N-bis(2-chloroethyl)-4-amino-aniline (10) appears to be one of the 
most reactive mustards studied.^
The aim of the work reported in this chapter was to prepare and evaluate model aryl 
prodrugs containing a 4-amino group deactivated by the carbamate moiety. This carbamate 
moiety was expected to decompose spontaneously to generate the 4-amino-aryl-mustard drug 
following activation by an enzyme, possibly the acylarylamidase E.C3.5.1.13, used in 
previous experiments involving ADEPT (see Appendix). Scheme 3.1 briefly sununarises the 
sequence of steps involved. Action of the enzyme on the protected 4 -amino substituent 
terminal of carbamate (71) was envisaged to generate the reactive carbamate (72) bearing a 
free 4 -amino group. Electron donation by the 4 -amino group was anticipated to 
spontaneously cleave the carbamate function, with liberation of CO2, to release the active 
4-amino aryl compound (73). If the group Z was the N,N-bis(2-chloroethyl)amine structure, 
this would generate the active mustard drug, N,N-bis(2-chloroethyl)-4-amino-aniline (10).
The work reported in the following pages concerns the synthesis of 
4-aminobenzyl N-(4-nitrophenyl) carbamate (74) (where Z=N02), and examination of its 
stability in organic and aqueous media at 37°C. Identification of the decomposition products 
gave some insight into the mechanism of decomposition. The nitro group was chosen because 
it can be easily converted into a mustard moiety to progress development of the prodrugs.
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Synthesis of (74) was difficult due to the free 4'-amino group. It was generated from 
the corresponding protected 4‘-amino carbamate (71) by chemical removal of the protecting 
group G. The best conditions for the removal of the protection were investigated.
Four precursors of (74) with different protecting groups G were investigated - 
benzylo5Q^carbonyl (CBZ) (75) and (76) (exception for 2=CP3), triphenylmethyl (Trityl) (77), 
t-butoxycarbonyl (f-BOC) (78), and acetyl (Ac) (26) derivatives. Synthesis of these 
compounds, their stability, and the method of removal of the protection, are described and 
evaluated.
The N'-f-butoxycarbonyl protected carbamate (78) proved best for the synthesis of 
(74). Conditions were found for the removal of the N'-f-butoxycarbonyl group without 
damaging the central benzyloxycarbonyl bond in the molecule. Compound (74) was obtained 
in crystalline form as a picrate derivative.
The N’-acetyl protected carbamate (26) was synthesised, its stability evaluated and 
it was examined as a substrate for the acylarylamidase B.C. 3.5.1.13 enzyme. It was found to 
generate (74) and is therefore a potential prodrug.
G-NH ;-NH-
Enz
Step 1
(71) Protected carbamate
H2N- / o
Step 2 
- CO2
(72) Reactive carbamate 
(74) Z = NO2
HN CH2 + H2N (73) Drug
H2N
X
“Lx
(10) X = Cl
Scheme 3.1 Mechanism for conversion of the carbamate prodrug into the active drug
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3.2 Synthesis of 4 -amino protected carbamates and removal 
of the protection group
Many different groups have been used for the protection of the amino functions, dependent on 
the synthetic conditions.^^^”^ ^  ^ A prime requirement for the 4 -amino function of compound
(74) was removal of the protection under conditions that would not damage the central 
carbamate function. This function is base labile,^^^ so its removal must be effected by either 
mild acid or hydrogenolyses.
Four different protection groups were examined: benzyloxycarbonyl (CBZ) and the 
related f-butyloxycarbonyl (f-BOC), both giving carbamate derivatives; triphenylmethyl 
(trityl), giving an N-alkyl derivative; and finally acetyl (Ac) to form an amide derivative.
According to the literature,^^^'^^^'^^® the CBZ group can be introduced by reacting 
aqueous solutions of the amino derivative with benzyl chloroformate, at slightly alkaline 
pH (e.g. using MgO), at temperatures between 0 and 20®C. Its removal can be achieved with 
good selectivity by catalytic hydrogenolysis. ^  Other methods of removal include reaction
with trialkylsilanes,^^^ acid hydrolysis,^®^ photolytic c le a v a g e ^ o r  electrochemical 
reduction.^7^
The trityl group can be introduced by reaction with triphenylmethyl chloride in the 
presence of mild base^^^ and removed by very mild acid hydrolysis. It can also be 
removed by catalytic hyd rogenolysis, ^  but more slowly than the CBZ group.
The f-BOC group can be introduced by reaction with di-f-butyl dicarbonate^^^ or 
f-butyl azidoformate^^^ at room temperature, and easily removed by very mild acidic 
hydrolysis using either trifluoroacetic add or formic add.^^^ Removal of f-BOC by HCl 
(3M) in ethyl acetate is also r e p o r te d .R e c e n tly , the selective removal of f-BOC in the 
presence of benzyl ester and benzyloxycarbonyl groups was achieved with mercaptoethane- 
sulphonic add in glacial acetic acid.^^ '^^®® f-BOC shows resistance towards hydrogenolysis
and alkaline h y d r o l y s i s . ^ ® ^
The Ac group can be introduced with a variety of acylating agents. It is difficult to 
remove chemically, but enzymes are effective under mild conditions.^
The synthesis of the N'-protected carbamates N CBZ (75) and (76), N-trityl (77), 
N-f-BOC (78) and N'-Ac (26) was achieved in two sequential steps generalised in 
Scheme 3.2. The first step involves N-protection of 4-aminobenzyl alcohol (80).. The second
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step is the condensation of the protected alcohol with an arylisocyanate. The addition of 
arylisocyanate is normally at 0®C followed by temperature increase to 25- 40°C.
For the N'-trityl and N’-f-BOC derivatives, this condensation proved difficult. The 
4-nitrophenylisocyanate reacted with the protected alcohol slowly, or not at all, to give the 
trimer (81) and urea (82) as major products. Similarly, for reaction of protected alcohol with 
phenylisocyanate, there was a relatively large yield of trimer (83) and urea (84) 
derivatives. All the ureas were insoluble and they were identified by MS(EI) showing a 
strong peak corresponding to the M+ ion at m /z  = 492 for (81), m /z  = 357 for (83), m /z  = 256 for
(82), and m /z  = 212 for (84). To overcome this problem, both N-trityl and N-f-BOC protected 
alcohol was converted in situ into a more reactive anion, by reaction with n-butyllithium, just 
before the addition of arylisocyanate. Further, the arylisocyanate was added in four 
aliquots to avoid high concentrations favourable to self condensation.
O
(81) X = N02 (82) X = N02
(83) X = H (84) X = H
Chart 10 Structure (81) - (84)
The N'-protected carbamate products (26), (75), (76), (77) and (78) were purified by 
silica column chromatography, sometimes followed by recrystallisation . The low solubility 
of all the protected carbamates in most organic solvents complicated purification and 
contributed to the very low yields of recovered pure products.
The protected carbamates were characterized by their MS and ^H-NMR spectra. 
The IR spectra confirmed the presence of the most significant functional groups: the secondary 
carbonyl carbamate shows a strong absortion at 1722-1705 cm"  ^ that agrees well with Pinchas' 
observations.^®^ For some compounds, elemental analysis was realised to confirm the 
molecular formula.
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H 2 N - Y _ y — C H 2 -0 H  
(80)
A. C6HsCH2 0 (C0 )Cl/Mg0 .H2p,Ether
B. (C6H5)3CC1 / EtaN. DCM
c. o[co2C(CH3)3]2 / the
D. 1)0(C0CH3)2/Py^ ACNH-C6H4-CH2-OAC (95) 
2 .1) aqNaOH.EtOH 2 .2 )CC>2
G-NH / CH2-OH
G = (C0)0CH2C6H5 (CBZ) A (85)
G = C(C6H5)3 (trityl) B (91)
G =  (C 0 )0 C (C H 3 )3  (f-BOC) C (93)
G =  (C 0 )C H 3  (Ac) D (96)
Aj. NO2-C6H4-NCO/ACN.DCM 
A2. CF3-C6H4-NCO/ACN.DCM
B. l)n-BuLi/THF 
2)N02-C6H4-NC0
C. l)n-BuLi/THF 
2) NO2-C6H4-NCO
D. N0 2 -C6H4-NC0 /ACN,DCM
G-NH
O
C H 2 -O C -N H
G = (C 0 )0 C H 2 C 6 H 5 , Z = N 0 2 A i (75)
G = (C 0 )0 C H 2 C 6 H 5 , Z=CF3 A 2 (76)
G = C(CeH5)3, Z = N 0 2 B (77)
G =  (C0)0C(CH3)3, Z = N Ü 2 C (78)
G =  (C 0 )C H 3 . ’ Z = N 0 2 D (26)
Scheme 3.2 Synthesis of the protected carbamates (26) and (75) - (78)
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3.2.1 The N*-benzylôxycarbonyl derivatives (75) and (76)
3.2.1.1 Synthesis
The reactions for the synthesis of 4'-(N'-benzyloxycarbonylamino)benzyl N-(4-nitrophenyl) 
carbamate (75) and 4'-(N'-benzyloxycarbonylamino)benzyl N-(4-trifluoro-methylphenyl) 
carbamate (76) is shown in Scheme 3.3. Both involved a similar sequence: (1), protection of 
the amine substituent of the 4-aminobenzyl alcohol (80) by conversion into a 
N-benzyloxycarbonyl derivative (85); and (2), condensation of this protected compound with 
4-nitrophenylisocyanate to give (75) or with 4-trifluoromethyIphenyl isocyanate to give 
(76).
The carbamates (75), (76) and (85) are new compounds.
4-(N-Benzyloxycarbonylamino)benzyl alcohol (85) was best synthesised by reaction 
of the 4-aminobenzyl alcohol with benzyl chloroformate, at room temperature, using MgO as 
the base catalyst, in a biphasic aqueous ether solvent (85% crude yield). Other bases (EtgN,
>-CH2-0H 
(80)
C6H5CH2OCOCI/
M g 0 ,E ther,H 2 0 /r.t.
f?
C6H5CH2-O-C-NH—^ ^ ^ - C H 2-0 H
(85)
X-C6H4-N=C=0/ACN.DCM
P O
C6H5CH2-0-C-NH-/^-CH2-0-C-NH—/ ^ - x
(75) X = NO2
(76) X = CF3
Scheme 3.3 Synthesis of compounds (75) and (76)
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Na2C03) in acetonitrile or THF gave much lower amounts (10% crude yield). The reaction 
was monitored by silica tic and the product purified by silica column chromatography using 
ether eluent. It was further purified by recrystallisation from ether/n-hexane (5;l,v/v) to 
give the pure (85) in 64% yield, with a sharp m.p. 94-95°C. The compound was characterised 
spectroscopically and detailed results are given in the Experimental (Section 5.3.22). The 
most significant findings were a peak at m/ z=257 in the MS(EI) spectrum corresponding to 
, and a strong IR absorption at u=3300 cm"^ characteristic of the alcohol group and 
u=1710 cm'l corresponding to the carbamate carbonyl group.
4'-(N'-Benzyloxycarbonylamino)benzyl N-(4-nitrophenyl) carbamate (75) was 
obtained in a crude yield of 69% and after silica column chromatography using ether, 
followed by recrystallization from petroleum ether (40-60®C) in a pure yield of 20%, with 
m.p.l59-160°C and a satisfactory elemental analysis. It was characterized spectroscopically. 
Thus, MS(FAB‘) shows a peak at m/z=420 due to M-H^; ^H-NMR in CDCI3 shows a double 
singlet (4H) centred at 0=5.25 and 5.30 ppm assigned to the two CH% groups, a multiplet (9H) 
centred at 7.3 ppm due to the aromatic protons of the protecting group and the 4-amino benzyl 
moiety, and an AB quartet (4H) centred at 7.85 ppm (J=10.3 Hz) characteristic of the 4- 
nitroaniline moiety; the IR spectrum shows a strong absorption at 1730 cm"^ due to the 
carbamate functions, and no absorption around 3300 cm~ ,^ characteristic of the alcohol group.
The main impurities appeared to be the urea derivative 02N-C6 H 4 -NH)2 CO 
[MS(EI) m/z=302; ^H-NMR ((CD3>2SO) 0=8.1 ppm (8H, ABqu, J=10Hz)] and 4-nitroaniline 
[MS(ED m/z=138; ^H-NMR (CDCI3) 6=7.5 ppm (4H, ABqu, J=10 Hz)].
4'-(N’-Benzyloxycarbonylamino)benzylN-(4-trifluoromethylphenyl) carbamate (76) 
was obtained in a pure yield of 43%, after silica column chromatography (see Experimental) 
and gave m.p. 167-170.5°C. It was also characterised spectroscopically. Thus, MS(EI) shows 
m/z=444 due to M"*"; ^H-NMR (CDCI3 /(CD3)2CO) shows two singlets (2H each) at 6=5.1 and 
5.15 ppm, due to the CH2 groups of the benzyl and carbamate groups, plus a multiplet (13H) 
centred at 7.5 ppm due to the aromatic protons; the IR spectrum shows a strong absorption at 
1720 cm‘l due to the carbamate carbonyl group.
3.2.1.2 Hydrogenolysis
Removal of the benzyloxycarbonyl protection from compounds (75) and (76) was effected by 
hydrogenolysis over Pd/C (10%), following a literature method.
Both compounds gave unsatisfactory results insofar as the required deprotected 
carbamate was not obtained. Thus, (75) gave 1,4-phenylenediamine (86 ) rather than (74)
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{Scheme 3.4), and (76) gave 4-aminobenzotrifluoride (87) rather than (8 8 ) {Scheme 3.6). 
Nonetheless, these reactions were examined further to investigate the sequence of 
benzyloxycarbonyl group cleavage.
Hydrogenolysis of carbamate (75) (0.5 mmole) in ethyl acetate with Pd/C  catalyst at 
room temperature was monitored by silica tic against authentic of 4-toluidine (89) and 
4-aminobenzyl alcohol (80). After 2h and 5h, the tic showed the presence of 4-toluidine plus 
starting material (75). After 14h, neither 4-toluidine nor (75) were evident and a new diffuse 
spot had appeared on the tic plate. As the hydrogen up-take corresponded to 1.5 mmol 
(i.e. 3-fold more than expected), the reaction was worked up to reveal the formation of 
1,4-phenylenediamine (8 6 ) in 45% yield in the isolated reaction products [(MS(EI) 
m/z=108, M+); %-NMR (CDCI3) 0=3.15 (4H, s, exch) and 6.5 ppm (4H,m)].
These results do not exclude the initial formation of 4-toluidine as evidence of 
deprotection of (75) and decomposition of (74). The absence of 4-toluidine among the final 
products may relate to its high volatility, and resulting loss, during hydrogenolysis and 
work-up.
Formation of 1,4-phenylenediamine requires not only removal of the N -CBZ 
protection from (75), but also cleavage of the central urethane moiety and reduction of the 
4-nitroaniline to 1,4-phenylenediamine, as outlined in Scheme 3.5.
/ : - n h - ^ ^ -c h 2 -o - 6 n h  -NO2 
(75)
H2/Pd
Required
/  \c H 3  + H2N^^~~yCH2-0-^-NH-/~\-N02
(74)
Final product 
found
H2N-^~~^-NH2
(86)
Scheme 3.4 Hydrogenolysis of the N'-benzyloxycarbonyl derivative (75) for 14h
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Scheme 3.5 Hydrogenolysis mechanism of N'-benzyloxycarbonyl derivative (75)
Because the hydrogenolysis of compound (75) was complicated by concurrent reduction 
of the 4-nitro group, an analogous compound (76), bearing the 4-trifluoromethyl group, was 
synthesised and examined.
On hydrogenolysis after 14h, (76) gave as final products, a mixture of 
4-aminobenzotrifluoride (87) and benzylalcohol (90), rather than (88) (Scheme 3.6). 
Monitoring the reaction by GC using a BP20 colunrn against authentic 4-aminobenzotrifluoride 
(87), benzylalcohol (90) and 4-(N-benzyloxycarbonylamino)benzyl alcohol (85), gave 
additional information about the sequence of product formation.
Hydrogenolysis of carbamate (76) (0.5 mmol) in ethanol with Pd/C catalyst at room 
temperature gave after 15 min, two GC peaks with the same retention times as 
4-aminobenzotrifluoride (87) (Rf=13.91 min) and carbamate (85) (Rf=18.11 min). With time.
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the area of the first peak increased to a constant value but the second peak disappeared and 
was not detected in further chromatograms. After 30 min, a third peak with the same 
retention time as benzylalcohol <90) (Rf=12.30 min) appeared, which increased with time to 
reach a maximum, and then decreased. Spiking with authentic compounds confirmed the 
identification of these three peaks as 4-aminobenzotrifluoride, carbamate (85) and 
benzylalcohol, respectively.
(76)
H2/Pd
/
Required
(88)
^ " “^-CH20H + H2N-^"~^CF3
(90) (87)
Final products 
found
Scheme 3.6 Hydrogenolysis of the H-benzyloxycarbonyl derivative (76) for 14h
GC of samples taken after 2h showed the presence of new peaks which, along with 
some intermediates, were identified by GC-MS. These included 4-toluidine (89) (m/z=107), 
H(C0)NHC6H4CH3 (m/z=135), possibly H(C0)NHC6H4CH20(C0)H (m/z=151), an 
undontihcd compound with m/z-244, and the two previous observed 4 aminobenzotrifluoride 
(87) (m/z=161) and benzylalcohol (90) (m/z=108).
The results showing that compound (85) and 4-aminobenzotriflupride (87) are the first 
detectable products on hydrogenolysis suggest that cleavage of the central carbamate moiety 
proceeds more rapidly than removal of the terminal N'-carbamate protection, as summarised 
by Scheme 3.7. Thus, the N-benzyloxycarbonyl group is inappropriate for protection of the 
terminal N-atom because hydrogenolysis preferentially removes the central carbamate 
moiety and it is therefore impossible to obtain the required prodrug.
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Scheme 3.7 Hydrogenolysis mechanism of carbamate (76)
3.2.2 The N*-triphenylmethyl derivative (77)
3.2.2.1 Synthesis
The synthesis of 4’-(N '-triphenylm ethylam ino)benzyl N -(4-triflu orom eth ylp h en yl)
carbamate (77) was effected by the reactions outlined in Scheme 3.8. These involved:
»
(1) reaction of 4-aminobenzyl alcohol (80) with triphenylmethyl chloride in DCM with one 
equivalent of triethylamine at 35®C to give quantitatively the crude trityl protected alcohol
(91). Purification by silica column chromatography followed by recrystallisation from 
bCM/n-hexane gave (91) in 77% yield; (2) condensation of (91) with 4-nitrophenyl 
isocyanate in the presence of one equivalent of n-butyllithium in THF to give the protected 
carbamate (77) in 76% yield after purification by silica column chromatography.
(80)
(C6H5>3CCl/DCM,Et3N
(C6H5>3C-NH - ^ ^ C H 2 - 0 H
(91)
1)BuLi/THF
2)N02-C6H4-N=C=0
(77)
Scheme 3.8 Synthesis of compound (77)
4-(N-Triphenylmethylamino) benzyl alcohol (91) is a new compound. It gave 
m.p. 188-190°C and was identified spectroscopically. The MS(EI) spectrum showed the M+ at 
m/z=365 and a base peak at m/z=243 due to the Ph3C+ (trityl) fragment. The ^H-NMR 
spectrum in ((CD3 >2SO) showed two exchangeable (IH) peaks at 5-3.4 (s) and 4.75 (t) ppm, 
due to the NH and OH protons, a 2H doublet at 4.2 ppm due to the CH2 group and in the 
aromatic region, two sets of resonances at 6.55 ppm (4H, ABqu, J=8.7 Hz) and 7.25 ppm (15H, 
m). The IR spectrum confirms, the presence of an alcohol group with an absorption at 
3620 cm"^ and a secondary amine at 3440 cm"^. The strong intensity of this peak suggests 
intramolecular association between the OH and NH groups.
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4 '-(N'-Triphenylmethylamino)benzyl N-(4-nitrophenyl) carbamate (77) gives 
m.p. 79-88°C and is unlikely to be pure. Silica tic of (77) shows the presence of a trace 
impurity that proved impossible to remove by column chromatography. The elemental 
analysis shows that the carbon content is higher than expected (found: 76,7%, calculated: 
74.8) with the nitrogen content slightly less (found: 6.9%, calculated: 7.9). The high carbon 
content impurity may well be a trityl compound like PhgCOH. The MS(EI) spectrum shows 
no peak corresponding to M"**, instead it shows a peak at m/z=485 corresponding to - C(%, 
and a base peak at m/ z=243 due to the Ph3C"^  fragment. The ^H-NMR spectrum in CDCI3 is 
consistent with the structure and impurity conclusions. It shows a singlet (2H) centred at 
6=4.4 ppm due to the CH2 group, two sets of AB quartets (J=2.0 and 2.2 Hz) that integrate to 
4H each and are centred at 6.5 and 6.8 ppm, respectively, and a multiplet centred at 7.3 ppm 
for the trityl group that integrates to 17H instead of 15H. Finally, the IR spectrum shows a 
strong absorption at 1730 cm"  ^due to the carbamate carbonyl function.
3.2.2.2 Hydrolysis
The problem with the use of a triphenylmethyl group as protection lies in the extreme 
difficulty of obtaining a pure compound. Purification by silica column chromato graphy 
generates an impurity probably due to Ph3 COH, and recrystallisation from ether/ 
n-hexane did not remove it. This behaviour is due to the extreme lability of the 
triphenylmethyl group.
In order to evaluate the lability of the triphenylmethyl group, carbamate (77) was 
hydrolysed in aqueous acetone (l:l,v/v, pH 2) at 25°C over 2h, and the reaction was followed 
by silica tic against 4-nitroaniline (92), 4-aminobenzyl alcohol (80) and 4-(N-triphenyl- 
methylamino)benzyl alcohol (91). It was possible to observe after 2h, the complete 
disappearance of (77) and among several final products only 4-nitroaniline was identified.
Similarly, the N -triphenyImethyI alcohol (91) was hydrolysed under the same 
conditions. A tic after 2h showed complete disappearance of (91) and no evidence for the 
presence of 4-aminobenzyl alcohol.
3.2.3 The N-terf-butoxycarbonyl derivative (78)
3.2.3.1 Synthesis
The synthesis of 4’-(N'-ferf-butoxycarbonylamino)benzyl N-(4-nitrophenyl) carbamate (78) 
was effected by the sequence of steps in Scheme 3.9. The reactions are as follows: (1) 
formation of the N-BOC derivative of 4-aminobenzyl alcohol (93) by reaction with
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di-f-butyl dicarbonate in THF; (2) condensation of the protected alcohol (93) with 4-nitro­
phenyl isocyanate to give the N'-protected carbamate (78); this reaction was carried out in 
two steps, first adding f-butylithium in THF to generate the alcohol anion which was 
immediately reacted with the isocyanate.
Both (93) and (78) are new compounds.
(80)
O O
(C H 3 )3 C O fc o f to C (C H 3 ) 3  /T H F
(C H 3)3C -0-(Î-N H  - ^ ^ ^ C H 2 - 0 H
(93)
1) BuLi/THF
2)N02-C6ft|-N=C=0
O O
(C H 3)3C -af-N H -^^C H 2-aC -N H -^^^^N 02
(78)
Scheme 3.9 Synthesis of compound (78)
The synthesis of 4-(N-ferf-butoxycarbonylamino)benzyl alcohol (93) followed a 
literature p ro c e d u re .^ A fte r  purification by silica column chromatography, pure (93) was 
obtained in 75% yield and gave m.p. 79-81®C and a satisfactory elemental analysis. MS(£1) 
showed m/z=223 corresponding to M+ and a base peak at m/z=57 corresponding to the 
fragment +C(CH3 )g. The ^H-NMR (CDCI3 ) showed a singlet (9H) at 5=1.48 ppm due to 
C(CH3)3 group, a second singlet (2H) at 4.47 ppm attributed to the CH2 group and an AB 
quartet (4H, J=2.2 Hz) centred at 7.15 ppm for the aromatic protons. Two broad exchangeable 
^H singlets, at 5=3.77 and 7.29 ppm relate to the OH and NH groups. The IR spectrum 
showed strong absorptions at 3480, 3380 and 1700 cm"^ attributed to the OH, NH, and 
carbamate carbonyl groups, respectively.
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Pure 4'-(N’-ferf-butoxycarbonylamino)benzyl N-(4-nitrophenyl) carbamate (78) was 
obtained in 64% yield after silica column chromatography followed by recrystallisation from 
ether/n-hexane: it gave m.p. 158-161®C, and a satisfactory elemental analysis. The MS(EI) 
spectrum showed m/z=387 corresponding to M+ and a base peak at m/z=57 from the +C(CH3)3 
fragment. ^H-NMR (CDCI3 ) showed a singlet (9H) at 6=1.52 ppm for the C(CH3>3 group, a 
second singlet (2H) at 5.15 ppm, attributed to the CH2 group, two AB quartets (both 4H and 
J=2 Hz) centred at 7.35 and 7.76 ppm for the aromatic protons, plus two exchangeable singlets 
at 6.55 and 7.17 ppm attributed to the NH protore. The IR spectrum confirmed the presence of 
two carbamate carbonyl groups showing a strong absorption at 1760 and 1715 cm'^.
3.2.3.2 Hydrolysis of (78) and synthesis of picrate (94)
On treatment with HCi (3M) in ethyl acetate, followed by neutralization (5% aqueous 
* NaHC0 3 ) and extraction into DCM, (78) gave several products, as shown by silica tic. The 
MS(EI) m/z=287 confirmed the presence of (74), but the yield of less than 10% was 
unsatisfactory.
Hydrolysis of (78) with mercaptoethanesulfonic add in 20% (v/v) aqueous acetic acid 
at 25®C was more successful (Scheme 3.10). Silica tic of the reaction mixture prior to work-up 
showed the presence of (74) in high yields (> 50%). Neutralization of the mixture with 
aqueous sodium bicarbonate developed a deep yellow colour and a silica tic showed extensive 
formation of 4-nitroaniline (92). The hydrolysis product (74) was therefore isolated from the 
acidic reaction mixture by conversion to ttie picrate derivative (94), by adding aqueous picric 
add (1%, w/w), and cooling to 0®C, in a yield of 84% (Scheme 3.13). The MS(FAB+) spectrum 
of the picrate showed m/z=289 due to N0 2 C6 H4 NH(C 0 )0 CH2 C6 H 4N H 3 +, and the 
MS(FAB') spectrum showed m/z=228 due to the picrate anion.
O __  O
( C H s ) 3 C 0 C N H - ^ ^  CH2OCNH - ^ ^ ^ N 0 2  
(78)
HSC2H4SO3HICH3COOH
(CH3)3C0H +  CO2 +  H 2 N - ^ ^ ^ C H 2 C x Ü n H - ^ ^ N 0 2
( 7 4 )
Scheme 3.10 Hydrolysis of compound (78)
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S.2.3.3 Study of the stability of (78) in mild basic conditions
In view of the problems encountered in removing the N BOC protection from (78), especially 
rapid decomposition during the basic work-up, the stability of (78) in THF containing 
saturated aqueous sodium bicarbonate was examined at 25®C over 24h. Both MS and 
^H-NMR assays of extracts of the reaction mixture showed more than 90% of the starting 
material (78) remained. This implies that (78) is relatively stable in mild base, and the low 
product yields on neutralising acidic reaction solutions with 5% aqueous sodium bicarbonate 
relate to the instability of (74) rather than (78).
3.2,4 The N-acetyl derivative (26)
3.2.4.1 Synthesis
The synthesis of 4'-(N’-acetylamino)benzyl N-(4-Nitrophenyl) carbamate (26) involved the 
series of reactions outlined in Scheme 3.11. These are: (1) Reaction of 4-aminobenzyl alcohol 
with acetic anhydride in pyridine at 25®C for 12h and a further Ih at 40®C, to give 4-(N- 
acetylamino)benzyl methyl ester (95). (2) Mild, basic hydrolysis at 40®C to selectively 
remove the ester function to give 4-(N-acetylamino)benzyl alcohol (96). (3) Condensation of 
(96) with 4-nitrophenylisocyanate in acetonitrile and DCM at 25®C for 4h and a further 5h at 
40®C. Carbamates (26) and (96) are new compounds.
4-(N-Acetylamino)benzyl methyl ester (95) was obtained in a crude yield of 93% 
(m.p. 101-103®C) and it was used in the subsequent reaction without purification. The MS(EI) 
showed m/ z=207 corresponding to M"*"; ^H-NMR ((CD3)2CO) showed two singlets (3H) at 
0=2.02 and 2.07 ppm attributed to OCOCH3 and NHCOCH3, respectively, a third singlet 
(2H) at 5.01 ppm due to the CH2 group, an AB quartet (4H) centred at 7.51 ppm due to the 
aromatic protons and a broad, exchangeable singlet (IH) at 9.21 ppm, attributed to the NH 
proton; the IR spectrum showed strong absorptions at 1760 and 1680 cm"  ^corresponding to the 
ester and amide carbonyl functions.
4-(N-Acetylamino)benzyl alcohol (96) was obtained in 76% yield from hydrolysis of
(95) in aqueous-ethanolic NaOH at pH 12 and at 40®C for 6h, followed by neutralization with 
CO2 and extraction into ethyl acetate. It gave m.p. 115-117.5®C; MS(EI) gave m/z=165 
corresponding to M"'’; the ^H-NMR spectrum ((CDg)2CO) showed a singlet (3H) at 0=2.1 ppm 
due to the N-acetyl group, a doublet (2H, J=7 Hz) centred at 4.6 ppm attributed to the CH2 
group, an AB quartet (4H, J=ll Hz) centred at 7.45 ppm for the aromatic protons, and two
8 5
H 2N -^2^C H 2-O H
(80)
O
CH3-C-NH
O o
CRsàoàcn^ /Py, 25®C/12h,40®C/lh
O
CH2-0 -C-CH3
(95)
O
1) aqNaOH /ethanol, 40®C
2)C02 3) ethyl acetate
C H 3-tN H ^-^^C H 2-O H
(96)
N02C6H4-N=C=0 /ACN,DCM, 25®C/lh.40®C/5h
t
O _  O
CH3-0 NH- /^ -C H 2 -0 -C -N H —/ ^ - N Q z
(26)
Scheme 3.11 Synthesis of the N'-acetyî derivative (26)
exchangeable peaks (a tripIet,lH, J=7 Hz, centred at 4.2 ppm and a broad singlet (IH) at
9.1 ppm, due to OH and NH, respectively); the IR spectrum showed strong absorptions at 3450 
and 1680 cm"^ due to the alcohol and the amide carbonyl group, respectively.
4 -(N'-Acetylamino)benzyl N-(4-nitrophenyl) carbamate (26) was obtained in 69% 
yield after silica column purification and gave m.p. 200-201®C. The MS(FAB") spectrum 
showed m/z=328 corresponding to M-H+ and the ^H-NMR spectrum [EtOD/(CD3 )2SO] 
showed a singlet (3H) at 6=2.09 ppm for the N-acetyl group, a singlet (2H) at 5.16 ppm due to 
the CH2 group, two sets of AB quartets (4H each) centred at 7.78 and 7.93 ppm due to the 
aromatic protons, and a broad exchangeable singlet (2H) at 4.40 ppm due to the NH protons. 
The IR spectrum showed strong absorptions at 1722 and 1700 cm"^ due to the carbonyl groups of 
the carbamate and amide functions, respectively.
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3.2.4.2 Decomposition
The N -acetyl carbamate (26) is insoluble in water and either insoluble or poorly soluble in 
most organic solvents. DMSO is exceptional so most of the decomposition studies were carried 
out in aqueous DMSO (7:3, v/v) and a few in either DCM or THF.
Two sets of experiments were carried out. The first using HPLC detection to identify 
products, the second using UV-visible spectrophotometry for time dependent measurements.
3.2.4.2.1 HPLC studies
N'-Acetyl carbamate (26) (ca. 4xlO‘^ M) was decomposed at 37®C over 24h in aqueous solutions 
of DMSO (7:3, v/v) at pH 2, 7 and 12, as well as in two organic solvents: DCM and THF. The 
products were assayed by HPLC against authentic 4-nitroaniline (92) (Rf=19.20 min), 
4-aminobenzyl alcohol (80) (Rf=2.98 min), 4-(N-acetylamino)benzyl alcohol (96) (Rf=13.58 
min) and the substrate itself (26) (Rf=24.01 min). Details of these experiments are given in 
Experimental (Section S.4.6.2).
The HPLC detection was carried by UV at X=249 nm. This wavelength was chosen 
because it corresponds to the X^ax (or the decomposition products (80) and (96). The HPLC 
assays for the various reactions are summarised in Table 3.1. Both the products are 
identified and their relative concentrations reported.
In aqueous DMSO (7:3,v/v) at pH 2 and 7, (26) is relatively stable showing less than 
10% decomposition at 37®C over 24h. The decomposition products identified by HPLC were 
4-nitroaniline (92) (7-8%), 4-(N-acetylamino)benzyl alcohol (96) {ca. 1%) and 4-amino- 
benzylalcohol (80) (8-9%), all in small amounts. The solid residue formed was not identified.
In aqueous DMSO {7:3,v I v) at pH 12, decomposition is more extensive and the solution 
develops a deep yellow colour. After 24h at 37®C, only ca. 8% of the starting material 
remains, the major products being 4-nitroaniline (92) (90%) and 4-(N-acetyl-amino)benzyl 
alcohol (96) (58%), together with smaller amounts of 4-aminobenzyl alcohol (80) {ca. 11%). 
Formation of large amount of 4-nitroaniline explains the deep yellow coloration.
Spontaneous decomposition of (26) in THF and DCM is more extensive than in aqueous 
DMSO and after 24h at 37°C, the relative peak area of (26) was only 8% in DCM and 6% in 
THF. The same decomposition products were identified [(80), (96) and (92)] but in different 
relative amounts.
The effect of solvent on the stability of (26) may relate to solubility differences.
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Table 3.1
Stability of the N ’-acetyl carbamate (26) at 37®C over 24h
Conditions Condition of final 
reaction solution
Structure, Rf (min) and 
(% product relative to [26]initial)
H2O/DMSO (7:3,v/v) Solid residue (26) 24.01 (68)
pH 2 (80) 2.95 (9)
(92) 19.20 (8)
(96) 13.58 (1)
H2O/DMSO (7:3,v/v) Solid residue (26) 24.01 (67)
pH 7 (80) 2.95 (8)
(92) 19.20 (7)
(96) 13.58 (1)
H2O/DMSO (7:3,v/v) Deep yellow solution, (26) 24.01 (8)
pH 12 no solid residue (80) 2.95 (11)
(92) 19,20 (90)
(96) 13.58 (58)
DCM Yellow solution. (26) 24.01 (8)
no solid residue (80) 2.95 (19)
(92) 19.20 (86)
(96) 13.58 (49)
THF Yellow solution. (26) 24.01 (6)
no solid residue (80) 2.95 (39)
(92) 19.20 (87)
(96) 13.58 (31)
3.2.4.2.2 UV/visible spectrophotometric studies
The decomposition of carbamate (26) in aqueous DMSO (7:3, v/ v) at pH 2, 7 and 12 and 
temperatures from 25®C to 70®C was also followed by UV/visible spectrophotometry of the 
reaction solutions between X=240 and 500 nm at timed intervals. Usually, a stock solution
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(10 pi) of (26) in DMSO (1.2 xlO"^M), was injected into a cuvette containing aqueous DMSO 
(7:3,v/v) (3cm^) at pH 2, 7 or 12, adjusted with either NaOH (IM) or HCI (IM). The cuvette 
was placed in the temperature regulated compartment of the spectrophotometer, and the 
UV/visible spectrum recorded when required.
3.2.4.2.2.1 Reactions at 25®C
A plot of absorbance of the reaction solution against time is represented in Fig. 3.1 for the 
three different conditions studied: a) neutral conditions; b) acid conditions; c) basic conditions, 
all at 25®C for 15h.
Both in neutral (pH 7) and in acidic (pH 2) conditions, the initial maximum 
absorbance is centred at X=325 nm [Fig 3.1 a) (pH 7) and b) (pH 2)]. As the reaction proceeds, 
the absorbance slightly decreases, but there is no shift in the position of X^ax The decrease 
in the intensity of Xmax occurs with simultaneous formation of a white precipitate (this 
precipitate was not analysed).
In basic (pH 12) conditions, a different behaviour occurs. The initial X^ nax at 395 nm 
shifts to 360 nm as the reaction proceeds (Fig 3.1 c). The initial absorbance in basic conditions 
is similar to that observed initially in neutral and acidic conditions, but it does not decrease 
with time. Other major differences are the development of a deep yellow colour in the basic 
solution, in contrast to the colourless neutral and acid reaction solutions, and no evidence of a 
white precipitate.
3.2.4.2.2.2 Reactions at 70°C
The above procedure was also carried out keeping the reaction solutions at 25®C for Ih and 
then at 70®C for 48h.
As for 25®C, a similar behaviour was apparent for neutral and acidic conditions and a 
different behaviour in base. However, at 70®C decomposition is faster and more extensive.
For acidic and neutral conditions during the first hour at 25®C, the intensity of the initial 
^max=325 nm decreased, then increased as the temperature rose from 25 to 70®C, probably due 
to an increased solubility of (26). Further, in neutral conditions after 49h, the Xmax shifts 
from 325 to 330 nm with a shoulder at X i^ax > 360 nm. In acidic conditions after 49h, the Xmax 
shifts from 325 to 368 nm.
In basic conditions, the reaction proceeds faster than in neutral or acidic conditions. 
During the first 20 min at 25®C, the Xmax shifts from 395 to 360 nm, and after 48h at 70®C 
shifts from 360 to 384 nm.
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a
500 240
Figure 3.1 UV/visible spectra for hydrolysis of (26) ih aqueous DMSO (7:3,vjv) at 25®C 
for 15h: a) pH 7 b)pH 2 and c) pH 12 ; [79}init. ca- 4xlO~^ M; 
scans 1-6 (15 min interval), scans 7-21 (60 min interval)
The UV spectra of 4-nitroaniline in aqueous DMSO (7:3,v/ v) at 25°C and pH 2, 7 and
12 all show an absorbance maximum at X=381 nm; the UV spectra of 4-nitroisocyanate under
similar conditions show Xmax =342 nm at pH 2 and 7, and Xmax=348 nm at pH 12.
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The UV-visible results suggest that even at 70®C over 48h, 4-nitroaniline is not 
formed in observable amounts in either neutral or acidic conditions. In basic conditions after 
heating the solution at 70®C over 48h, the final Xmax =384 suggests complete 
decomposition of carbamate (26) into 4-nitroaniline; however, at 25°C over 24h, this 
decomposition is not observable.
These results suggest that carbamate (26) is relatively stable in aqueous solutions at 
pH7,pH2and25®C.
3.2.4.2.2.3 Effect of adding excess acid to the basic solution and excess base to the acidic 
solution
The effect of pH change for the reaction solutions was also examined. The procedure was the 
same as that described previously (Section 3.2.4.2.2.1) and after adding substrate, the 
solutions were kept at 25°C for no longer than 10 min (i.e. before significant decomposition had 
occurred) before adding acid or base.
On adding excess HCI to the basic solution, the Xmax immediately shifted from 395 to 
325 nm and the colour of the solution changed from deep yellow to colourless.
On adding excess of NaOH to the acidic solution, an immediate shift of Xmax from 
325 to 400 nm occurred with simultaneous development of a deep yellow colour.
These results suggest an acid-base equilibrium at pH 12, involving (26) and (97) 
(Scheme 3.12).
3.2A.2.3 Conclusions
Both the HPLC identification of the final reaction products and the UV-visible studies 
(pointing to a possible acid-base equilibrium at pH 12) suggest that hydrolysis of (26) is fast 
and base-catalysed, leading to 4-(N-acetylamino)benzylalcohol (96) and 4^nitroaniline (92) 
as major products (Path 1 in Scheme 3.12). 4-(N-Acetylamino)benzylalcohol (96) hydrolyses 
further to 4-aminobenzylalcohol (80).
In neutral and acidic conditions, decomposition is very slow and the main hydrolysis 
products are 4-aminobenzylalcohôl (80) and 4-nitroaniline (92). A possible explanation for 
their formation may be hydrolysis of (26) to (96) and a further hydrolysis of (96) to (80). The 
initial hydrolysis of the amide function in (26) leads to compound (74) which gives a polymer 
of general structure -(-NH-C6H4-CH2-)n- (98) and compound (99) rather than 4-amino- 
benzylalcohol (80) (Path 2 in Schetne 3.12) as discussed in Section 3.3.4.
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Scheme 3,12 Hydrolysis of (26) in aqueous DMSO (7:3, v/v) at pH 2, 7 or 12
and in DCM or THF at 37
92
3.3 The 4 -aminô carbamate (74)
3.3.1 Synthesis
The 4-aminobenzyl N-(4-nitrophenyl) carbamate (74) was obtained via the N’tBOC 
derivative (78) as previously outlined by the following sequence of steps: (1) Mild.hydrolysis 
of (78) in THF using 20% (w/v) 2-mercaptoethanesulphonic acid in glacial acetic acid at 25°Q 
followed by immediate reaction with aqueous picric acid to form the picrate salt (94), in 84% 
yield. (2) Conversion of the isolated picric salt to the neutral carbamate by treatment with 
10% (w/v) aqueous ethanolamine, which removes the picrate moiety by formation of the
more stable picric salt of ethanolamine (100). Compound (74) was then extracted into ether.
This sequence is described by Scheme 3.13.
Silica tic of the ether extract containing (74) showed that the product was impure and 
that the impurities increased quickly on standing. This suggests that (74) is very labile. It 
was therefore purified by silica column chromatography using ether immediately after 
extraction. Three separate columns, however, were required to obtain a reasonably pure 
sample of compound (74). The major impurities showed Rf=0.2 (4-nitroaniline (92)) and 
Rf=0.35 (unidentified); the required compound (74) gave Rf=0.15. After isolation, compound 
(74) was identified by MS and NMR, as described below.
4'-Aminobenzyl N-(4-nitrophenyl) carbamate, picrate salt (94) was obtained in 84% 
yield and gave m.p. 120-122°C. The MSfFAB"*") spectrum shows m/z=289 corresponding to 
N0 2 C6H4NHC(0 )0 CH2C6H4NH3 ‘^  and MS(FAB”) spectrum shows m/ z=228 corresponding 
to the picrate anion (Q2N)3C6H2 0 ‘. The ^H-NMR ((CD3)2SO) shows a singlet (2H) at 
0=5.26 ppm consistent with the benzylic CH2 group, two sets of AB quartets (4H each and both 
with J=2 Hz) at 6.62-7.45 ppm and 7.71-8.22 ppm, corresponding to the 4-nitroaryl and 
4-phenylene moieties, respectively, and a singlet (2H) at 8.63 ppm corresponding to the 
aromatic protons of the picrate anion; the broad, exchangeable singlet at 10.08 ppm and 
multiplet at 7.43 ppm are attributed to the NH protons. The IR spectrum shows a strong 
absorption at 1760 cm~^  due to the carbamate carbonyl group.
4-Aminobenzyl N-(4-nitrophenyl) carbamate (74) was obtained reasonably pure in 
55% yield and gave m.p. 110-140®C (decomp). The MS(FAB") spectrum shows m/z=286 due to 
M-H*  ^and the ^H-NMR spectrum [CDCI3+ (CD3)2SO] shows a singlet (2H) at 0=5.04 ppm 
corresponding to the benzylic CH2 group, two sets of AB quartets (4H each) at 6.65-7.17 ppm
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Scheme 3.13 Synthesis of 4 ‘-amino carbamate (74)
with J=2.1 Hz, and 7.70-8.11 ppm with j=2.3 Hz, as expected for the aromatic protons; 3 
broad, exchangeable singlets at 3.26,4.47 and 10.10 ppm are attributed to NH protons. The IR 
spectrum diows absorptions at 1760 cm*  ^and 3400 cm~ ,^ of strong and medium intensity, due to 
the carbamate carbonyl and the NH2 groups, respectively.
3.3.2 Spontaneous decomposition of (74)
From the difficulties encountered in purification, 4 -aminobenzyI N-(4-nitrophenyl) 
carbamate (74) appeared to be a labile compound. It was therefore decided to study its 
spontaneous decomposition first. Accordingly, compound (74) dissolved in DMSO/chloroform 
(3:7, v /v) was kept at 65®C, and the reaction mixture monitored by silica tic, GC, GC-MS and 
^H-NMR over 48h.
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Silica tic, using ether as eluent, of the reaction mixture showed complete 
disappearance of (74) after 2h at 65°C, to form three major products with Rf=0,7 (same Rf as 
4-nitroaniline (92)), Rf=0.5 and Rf=0.3. Silica tic of the reaction mixture at later times 
(5h, lOh, 48h) did not show any major changes.
Capillary GC analysis of the reaction mixture was also carried out using on-column 
injection (to minimise decomposition) on BP5 and BP20 columns, the former with a N-specific 
detector. Under the temperature programme employed, authentic compounds showed 
retention times listed on Table 3,2 (carbamate (74) is not eluted on either BPS or BP20 
columns).
After 2h at 65®C, the reaction mixture showed two peaks only on the BPS column, at 
Rf=11.91 min (4-nitroaniline) and at Rf=24.50 min (unidentified). After lOh and 48h at 65°C, 
the reaction mixture gave similar chromatograms on the BPS column with a small increase in 
the peak at Rf=24.50 min.
Similarly, assays with the BP20 column showed one signal with Rf=13.0 min 
(4-nitroaniline) after 2h at 65°C, with no further changes for longer reaction times.
Significantly, the GC assays gave no evidence for the formation of 4-aminobenzyl 
alcohol (80) or 4-toluidine (89) products.
Table 3.2
Capillary GC retention times (Rf) for authentic compounds (80), (89) and (92)
(jonyound
Column: BPS
Rf/min
BP20
4-Aminobenzyl alcohol (80) 8.26 Not eluted
4-Toluidine (89) 3.85 4.12
4-Nitroaniline (92) 11.91 13.0
Samples of the reaction mixture after 2h and 48h at 65°C were also analysed by 
GC-MS using a BPS column, on-column injection, and a similar temperature programme to the 
one for the regular GC assays. These gave 2 major signals at Rf=13.8 min (larger), and 
Rf=25.6 min, which correspond to the two peaks in the regular GC traces at Rf=11.91 min and 
Rf=24.50 min. The first showed m/z=138 corresponding to M"** for 4-nitroaniline (92) and the 
second showed m/ z=243 corresponding to M"*" for N-(4-aminobenzyl)-4-nitroaniline (99).
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Significantly, no evidence was found for the formation of either 4-aminobenzylalcohol (80) or 
4-toluidine (89).
An MS(EI) assay of the solid residue formed by the reaction in DMSO/ CHCI3 (7:3, 
v/v) at 65°C after 5h showed the presence of several strong peaks with m /z at multiple 
values of 105. This is consistent with the formation of a polymeric product, with a 
-(-NH-C6H4-CH2-)n- structure, by self condensation of the methide fragment from the 
substrate (74).
In a separate experiment, carbamate (74) in (CD3)2SO/CDCI3 (3:7,v/y) was heated 
at 65°C in a sealed NMR tube. The ^H-NMR spectra recorded after 2h showed that the 
signals for (74) had entirely disappeared (Figure 3.2). New signals then apparent were a 
broad singlet (2H) at 6=4.41 ppm (probably due to a benzylic CH2 group), a second broad 
singlet (2H) at 6.12 ppm, a third broad singlet (2H) at 6.61 ppm, an AB quartet (4H) at 6.63- 
7.95 ppm (J=2.0 Hz), and two broad singlets (IH each) at 6.94 and 7.07 ppm. Spectra of the 
reaction mixture recorded after 5h,10h, 24h and 48h at 65®C were similar to that after 2h, 
despite formation of a precipitate in the NMR tube after 5-6h. These ^H-NMR spectra 
therefore confirm the chromatography experiments ie. compound (74) decomposes over 2h at 
65®C to give products that are not transformed by further heating.
3.3.3 Spontaneous decomposition in the presence of Lil
In view of the above results and especially the formation of polymeric material, attempts 
were made to trap the 4-amino methide fragment (101) by carrying out the decomposition of 
(74) in DMSO/ chloroform (3:7, v/v) at 65°C and in the presence of equimolar Lil.
The choice of Lil as a trapping agent relates to its thermal stability and the strong 
nucleophilicity of I". Formation of 4-a-iodomethylaniline (102) was anticipated 
(Schetne 3.14). This compound is not described in the literature, but the related compounds 
4-a-cloromethylaniline,^®3 4-a-fluoromethylaniline and 4-a-bromomethylaniline 
have been reported.
( 1®1) ( 102)
Scheme 3.14 The intermediate species being trapped by the nucleophile T
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The reaction products were examined by silica tic (using ether as eluent), GC/MS and 
^H-NMR in similar ways to those described in Section 3.3.2. Briefly, identical findings 
apply to those obtained without Lil, and no new products were formed:
After 2h at 65°C, the substrate (74) completely disappeared. At this point, silica tic 
of the reaction solution (ether eluent) gave 2 spots as before, with Rf=0.5 and 0.7, and the 
GC-MS was also identical with and without added Lil: the same two major peaks were 
observed at Rf=13.2 min and Rf=24.5 min showing m/z=138 and m/z=244, respectively.
After 3h at 65°C, the reaction was worked-up to isolate products by vacuum 
evaporating the solvent and extracting the solid residue with DCM. The DCM was then 
vacuum evaporated, the residue suspended in ethyl acetate and applied to a silica 
preparative plate. Three major fractions were obtained with Rf=0.6, 0.4 and 0.2. Each 
fraction was removed from the plate, extracted into DCM, the solvent vacuum evaporated 
and the residues analysed by ^H-NMR and MS:
Fraction 1 with Rf=0.6 gave both MS(EI) spectrum (ie. m/z=138) and ^H-NMR 
spectrum identical to that of 4-nitroaniline (92) (Figure 3.3). It also had a GC retention time 
identical with 4-nitroaniline.
Fraction 2 with Rf=0.4 gave both MS(FAB" )^ spectrum (ie. m/ z=244) and ^H-NMR 
spectrum consistent with N-(4'-aminobenzyl)-4-nitroaniline (99) (Figure 3.4) (see Section 
3.3.2).
Fraction 3 with Rf=0.2 gave MS(FAB‘*‘) spectrum with strong peaks at 
m/z= multiple values of 105 and a ^H-NMR spectrum in CDCI3 / (0 0 3 )2 8 0 , showing a doublet 
at 6=2.6 ppm and an AB quartet at 7.6-7.8 ppm (Figure 3.5). The ^^C-NMR spectrum shows 
only two signals at 78.36 (triplet) and 39.92 ppm (septet). The MS findings suggest a 
polymeric -(-NH-C6H4-CH2-)n- structure for this fraction.
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Figure 3.2 ^H-NMR of (74) : a) immediatly after dissolving in CDCI^/(CD3)2SO
Tvithout heating; b) after heating at 65°C over 2h
98
j U
J E Î i It Ityy , î i ÏÏH . Ip g m  99
IBL
l l i l
im
lis I3B
Figure 3.3 ^H-NMR and MS(EI) of the decomposition products from (74) in DMSO/CHCI3
(3:7, viv) in the presence of equimolar Lil, at 65°C for 24h - Fraction 1
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Figure 3.5 ^H-NMR and MS(E1) of the decomposition products from (7 4 ) in DMSOICHCÎ3
(3:7, v/v) in the presence of equimolar HI, at 65°C for 24h - Fraction 3
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3.3.4 Discussion
The above results suggest that after 2h at 65®C, carbamate (74) completely transforms into 
3 products, identified as N-(4’-aminobenzyl)-4-nitroaniline (99), 4-nitroaniline (92), and a 
polymer having the general structure -(-NH-C6H4-CH2-)n- (98) {Scheme 3.15).
O
- ( ] ) -N 0 2  -----   H 2N -Ç ^C H 2-N H -^]^N 02 + CO2 +
(74) (99)
—e H N - ^ - C H 2 ) ü -  + H 2 N -^ -N Q 2
(98) (92)
Scheme 3.15 Spontaneous decomposition of (74) in chloroform/DMSO (7:3,vlv) at 65
Insufficient information was obtained to deduce the mechanisms by which these 
products form. It is conceivable, however, that carbamate (74) thermally extrudes CO2 in 
DMSO/CHCI3 mixtures, to give a caged pair of ions which can either recombine {Path 1 in 
Scheme 3.16 ) to give the N-(4'-aminobenzyl)-4-nitroaniline (99), or by H+-transfer {Path 2 in 
Scheme 3.16 ) to generate 4-nitroaniline (92) and the aryliminomethide (101 ). Subsequent 
reactions outside the solvent cage by (101) could generate the polymeric material (98) 
{Scheme 3.16).
The formation of 4-nitroaniline (92) could relate to simple hydrolysis of the 
carbamate (74). However, the reaction medium contains no water and there is no evidence of 
4-aminobenzyl alcohol (80), the expected co-product of an hydrolysis reaction.
The formation of polymeric substances from self-condensation of an arylimino­
methide intermediate has precedence in the decomposition of 4-aminoben2ylquinolinium 
salts {Scheme 3.17).^^ The failure to trap the aryliminomethide by added T, however, is 
difficult to rationalise on the limited information available.
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Scheme 3.16 Thermal decomposition of (74)
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Scheme 3.17 The model reaction of aminobenzylquinolinium salts
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3.4 Evaluation of N'-acetyl carbamate (26) as a substrate for
acylarylamidase
Because the 4’-(N'-acetylamino)benzyl N-(4-nitrophenyl) carbamate (26) is reasonably 
stable in aqueous DMSO (7:3, v/v) (< 10% decomposition at pH 7 and 37®C over 24h), it was 
briefly investigated as a potential substrate for the enzyme acylarylamidase E C. 3.5.1.13.
3.4.1 UV-visible procedures
Initially, the acylarylamidase enzyme was tested in tris/HCI buffers (100 mM, pH 8 .6) at 
37°C against 10‘^ M 4-nitroacetanilide (103) as a model substrate. The reactions were carried 
out by UV-vis spectrophotometry (X=25(M50 nm), monitoring the release of 4-nitroaniline 
(92) (Schetne 3.18) from solutions in the thermostatted cuvette at 37°C, both in the presence 
and absence of acylarylamidase (2.7x10"  ^units), as described in the Experimental.
P  EC 3.5.1.13 P
C H 3-C -N H -T ^N 02 ---------------------------   CH3-C-OH + H zN -T ^ N O z
lOOihM Tris/HCl pH 8.6 
(103) (92)
Scheme 3.18 Model reaction of (103) as an acylarylamidase substrate
The variation of the UV-visible absorbances with time are shown as Figure 3.6, 
where the intervals between successive scans is 4 min (scan 12 after 1.5h).
The spectra in Figure 3.6 a shows that 4-nitroacetanilide (A,max=315 nm) hydrolyses 
rapidly in the presence of acylarylamidase E C. 3.5.1.13 to release 4-nitroaniline (Xmax= 
380 nm). A well-defined isosbestic point at X=342 nm is apparent, indicating a clean 
conversion of 4-nitroacetanilide into 4-nitroaniline.
The spectra in Figure 3.6 b show that release of 4-nitroaniline in the absence of the 
enzyme, is ca. 2 x 1(P fold slower. An isosbestic point at X=340 nm is also apparent.
The results confirm the procedure for testing substrate and that the sample of 
acylarylamidase is active.
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overFigure 3.6 Decomposition of (103) [IxlO^^M] in tris/HCl buffer at pH 8.6 and 37 C
1.5 h: a) with acylarylamidase (lSxl(r^wiitslctT^); b) without enzyme 
scans 1-11 (4 min interval), scan 12 after 1.5h
Carbamate (26) was tested as a substrate for acylarylamidase E.G. 3.5.1,13 in the 
same way as 4-nitroacetanilide. Thus, (26) (10‘^M) was reacted with acylarylamidase (2.7 x 
10-4  units) in tris/HCl buffers at pH 8.6 and 37°C in the thermostatted cuvette of the 
spectrophotometer, and the spectrum scanned at intervals of 4 min (scan 11 after 1.5h). The
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spectra, both with and without acylarylamidase, are shown in Figure 3.7. It is clear that 
carbamate (26) decomposes much faster in the presence of acylarylamidase, but the UV 
spectra over 1.5h show only a poorly defined isosbestic point (Figure 3.7 a). This suggests 
that decomposition of (26) proceeds by more than one pathway. There is a slow change in the 
spectra of (26) in the absence of acylarylamidase (Figure 3.7 b), which mainly reflects slow 
precipitation of the substrate from the reaction solution.
Absorbance
0.15
250 450 250 450
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Figure 3.7 Decomposition of (26) [IxW^M] in trislHCl buffer at pH 8.6 and 37°C over 1.5h :
a) with acylarylamidase (IBxW^ uniisfat^), b) without enzyme; 
scans 1-10 (4 min interval), scan 11 after 1.5h
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Approximate half-lives from the spectrophotometric data for the hydrolysis of 
4-mtroacetanilide (103) and the N -acety Icarba ma te (26) in the presence and absence of 
acylarylamidase enzyme E C. 3.5.1.13 are listed in Table 3.2. Insufficient time was 
available to carry out further quantitative experiments to determine Vmax Km values for 
the substrate-enzyme combinations. Nonetheless, the data in Table 3.3 show that 
N-arylcarbamate (26) is a substrate for the acylarylamidase E.G. 3.5.1.13, almost as good as 
4-nitroacetanilide (103).
Table 3.3
Approximate half-lives for the decomposition of (26) and (103) [lxlO~^M] 
in trislHCl buffers at pH 8.6 and 37°C
Compound En^me Half-life
Carbamate (26) none > 450 h
Carbamate (26) 18xl0"^units/ cm^ 12 min
4-Nitroacetanilide (103) none >400 h
4-Nitroacetanilide (103) 18xl0"^units/ cm^ 11 min
3.4.2 HPLC procedures
The decomposition of carbamate (26) by acylarylamidase E.G. 3.5.1.13 in tris/HGl buffer at 
pH 8.6 and 37®G was also followed by analytical HPLC. Products were identified by 
retention time against authentic 4-nitroahiline (92) (Rf=19.20 min), 4-aminobenzyl alcohol 
(80) (Rf=2.98 min) and 4-acetamidebenzylalcohol (96) (Rf=13.58 min). Reactions were 
carried out in a volumetric flask immersed in a thermostatted bath at 37°C, and aliquots of 
the reaction solution were withdrawn and injected at timed intervals (see Experimental).
The HPLC assay of the reaction solution just before the addition of the enzyme, 
showed only one peak (Rf= 24.01min) corresponding to N'-acylcarbamate (26). One minute 
after addition of the enzyme, the HPLC assay showed a peak of reduced area at Rf=24.01min, 
plus a new peak at Rf= 19.20min corresponding to 4-nitroaniline. After 3 min, a second new 
peak at Rf=11.9 min (not identified) appeared in the HPLC chromatogram, along with the 
peaks due to 4-nitroaniline and (26). An HPLC assay after 15 min, showed complete 
disappearance of the starting material (26), a large peak at Rf= 19.20 min due to 
4-nitroaniline and a small peak at Rf=11.90 min [not identified, but probably due to N-(4- 
aminobenzyl)-4-nitroaniline (99)].
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Neither 4-aminoben^l alcohol (80) nor 4-(N-acetyIamino)benzyI alcohol (96) were 
detected as reaction products at any stage of the reaction.
3.4.3 Conclusions
Both the HPLC assays and the absence of a good isosbestic point in the UV-visible spectra of 
the reaction solutions suggest that decomposition of N'-acylcarbamatc (26) may proceed via 2 
concurrent pathways as represented in Scheme 3.19. The enzyme facilitates hydrolysis of the 
N'-acyl moiety to give compound (74), which then decomposes via 2 concurrent pathways to 
4-nitroaniline (92) (Path 1, Scheme 3.19) or N-(4-aminobenzyl)-4-nitroaniline (99) (Path 2, 
Scheme 3.19).
O O
CHa-tf-NH -^ C H 2 -0 -C f'N H -(^ N 0 2
Posinon 1 Position 2
(79)
(74)
CO2
H2N = ^ )= C H 2 + H N -(2 )-N Q 2
(ti/2 > 490h)
Path 2
H2N - \_ ^ C H 2-NH 
(99)
Path 1
—(-HN-^^^^CH2 >-n— + H2N -^ |^ -N 02
(98) (92)
Scheme 3.19 Decomposition mechanism of N'-acetyl carbamate (26) with
acylarylamidase
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3.5 Synthesis and reactions of model carbamates
3.5.1 Synthesis and hydrogenolysis of 4-nitrobenzyl N-phenyl carbama­
te (104)
In order to clarify the behaviour of compounds possessing both an aromatic 4-nitro group and a 
carbamate function under catalytic hydrogenolysis, a model compound 4-nitrobenzyl 
N-phenyl carbamate (104) similar to (75) but lacking a protected 4-amino group was 
synthesised and examined.
3.5.1.1 Synthesis
The synthesis of (104) followed the procedure previously described for condensation of a 
benzyl alcohol with an aryl isocyanate. The 4-nitrobenzyl alcohol (105) in ACN was reacted 
with phenylisocyanate for 48h at room temperature (Scheme 3.20). After vacuum 
evaporation of the solvent and extraction into DCM, the compound was purified by silica 
flash chromatography followed by silica column chromatography using ether/n-hexane 
(l:l,v /v) as eluent. The impurities removed by the purification included the trimer of 
phenylisocyanate (83) and N,N-diphenyl urea (84).
The pure compound obtained in 71% yield gave m.p. 146-148°C and a satisfactory 
elemental analysis. It was identified by MS(EI) which gave m/z=272 (M+), and by ^H-NMR 
which showed a singlet (2H) at 8=5.2 ppm, attributed to the benzylic CH2 group, a multiplet 
plus an AB quartet (1=8.8 Hz) centred at 7.3 and 7.7 ppm (aromatic protons) and integrating to 
5H and 4H, respectively, and an exchangeable, broad singlet (IH) at 6.8 ppm, corresponding 
to the NH proton. The IR spectrum shows a strong absorption at 1740 cm"^ confirming the 
presence of a carbonyl carbamate function.
/ = \  o =c =n - 0 / a c n  _  p  _
----------------------- - NO2 —/  V C H 2-0 -C-NH-/ \
(105) (104)
Scheme 3.20 Synthesis of (104)
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3.5.1.2 Hydrogenolysis
Compound (104) was dissolved in ethyl acetate and stirred under hydrogen with Pd / C 
catalyst at room temperature as for the hydrogenolysis of compound (75). The reaction was 
monitored by GC using a BP20 column against authentic 4-toluidine (89), aniline (106), 
4-riitrotoluene (107) and 4-nitrobenzyl alcohol (105) (Experimental 5.4.8.1.2). Aliquots of the 
reaction mixture were assayed at regular intervals:
a) At t=0 min, only the substrate (104) (Rf=66.12 min), and a small peak at 
Rf=45.38 min [same Rf as 4-nitrobenzyl alcohol (105)] were detectable.
b) After 15 min, two new compounds with Rf=11.79 min (same Rf as aniline (106)) and 
Rf=12.66 min [same Rf as 4-toluidine (89)] plus an increased amount of 4-nitrobenzyl alcohol 
(105) were evident. The substrate (104) (Rf=66.12 min) had decreased to less than 10% of its 
original concentration.
c) After 90 min, the chromatogram showed no differences from that at t=15 min except 
for the complete disappearance of the substrate (104).
Further aliquots injected after 5h and 48h of reaction showed the presence of 
4-nitrobenzyl alcohol (105), aniline (106) and 4rtoluidine (89) plus a few new, unidentified 
small peaks.
An aliquot of the reaction solution after 48h, was also analysed by GC-M5 using a 
BP20 column to confirm the major products. The compounds identified included 
phenylisocyanate (108) (Rf=2.4 min, m/z=119), aniline (106) (Rf=4.3 min, m/z=93), N-ethyl- 
4-methylaniline (109) (Rf=4.6 min, m/z=135), 4-toluidine (89) (Rf=4.8 min, m/z=107), 
4-methylacetanilide (110) (Rf=7.7 min, m/z=149), 4-nitrobenzyl alcohol (105) (Rf=9.6 min, 
m/z=153), together with 3 other compounds at Rf=5.1, 5.6 and 6.2 min, which were not 
identified.
The major products of hydrogenolysis were 4-toluidine (89) and aniline (106). It was 
not possible to detect at any stage of the reaction aryl carbamate (111) resulting from simple 
reduction of the 4-nitro group or 4-nitrotoluene (107). These results, summarized in 
Scheme 3.21, suggest a simultaneous hydrogenolysis of the carbamate and the nitro groups.
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Q2N - ^ ^ ^ C H 2-0 H + H2N - ^ ^
(1 0 5 )^ ^ 1 5 3  (10«)m/z=93
+
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Scheme 3.21 Hydrogenolysis of (104) in H2lPd at 25 *C
3.5.2 Synthesis of Benzyl N-(4-methylphenyl) carbamate (112)
The aryl carbamate (112) was synthezised to assist in identifying the hydrogenolysis and 
hydrolysis products of arylcarbamates (75) and (76). It was never found, however, among the 
hydrogenolysis and hydrolysis products of carbamates (75) and (76).
Synthesis of (1 1 2 ) involved condensation of 4-toluidine (89) with benzyl 
chloroformate at 0®C in the presence of MgO (Scheme 3.22), following the procedure 
previously described for the synthesis of (85).
I l l
9
■ CHz-O-C-Cl y = \  9  / “ >
H 2 N - ^  i - C H ,    ( J - C H 2 0 C . N H - (  j - C H ,
(89) (112)
Scheme 3.22 Synthesis of carbamate (1X2)
The reaction was followed by silica tic (ether/n-hexane (2:1, v/v). Compound (112) 
was obtained in 89% yield after silica column chromatography using DCM as eluent, and gave 
m.p. 78“79®C. ' It was characterised spectroscopically by MS(FAB+) m/z=242 (MH+) and by 
MS(FAB“) which showed m/z=240 (M-H+). The ^H-NMR (CDCI3 ) spectrum showed two 
singlets at 6=2.2 (3H) and 5.1 ppm (2H) attributed to the 4-CH3 and benzylic CH2 groups, 
respectively; an AB quartet (4H, f=9.2 Hz), centred at 7.1 ppm and a multiplet <5H) centred at
7.3 ppm, both attributed to the aromatic protons. The IR spectrum showed a strong absorption 
at 1725 cm~l due to the carbamate carbonyl group.
3.5.3 Synthesis and hydrolysis of ethyl N-(4-nitrophenyI) carbamate
(113)
3.5.3.1 Synthesis
Synthesis of ethyl N-(4-nitrophenyl) carbamate (113) involved reaction of 4-nitrophenyl 
isocyanate with ethanol at 40®C for Ih  (Scheme 3.23). It was obtained impure in 98% yield, 
and puritied by silica flash chromatography using DCM as eluent. The pure compound gave 
m.p. 134-135®G. It was characterized by MS(EI) giving m/z=210 (M+) and iH-NMR (CDCI3) 
showing a triplet (3H) at 5=1.3 ppm and a quartet (2H) centred at 4.2 ppm for the ethyl ester 
group; an AB quartet (4H, J=9.0 Hz) centred at 7.9 ppm for the aromatic protons; and an 
exchangeable, broad, singlet (IH) at 7.3 ppm due to NH. The IR spectrum showed a strong 
absorption at 1743 cm"l due to the carbamate carbonyl group.
(32N - / ^ - N = C = 0 + CH3CH2OH -------------0 2 N - /^ - N H - t 0 - C H 2 C H 3
(113)
Scheme 3.23 Synthesis of carbamate (113)
112
3.5.3 2 Hydrolysis in aqueous/DMSQ (9:l,v/v) at 37®C and different pH
Compound (113) in DMSO (10 pi, 14.5 mM) was injected into a thermostatted cuvette at 37®C 
containing aqueous DMSO (9:1, v/v) at either pH 2, 7 or 12 (adjusted with either HCl or 
NaOH). The concentration of (113) in the cuvette was 4.8x10"® M. UV spectra were recorded 
between 250-500 nm immediately, and at timed 20 min intervals.
The reactions at pH 2 and 7 gave A,max=322 nm, which did not vary in intensity or 
position over 60 min.
The reaction at pH 12 gave Xmax=396 and 328 nm at time zero, and the spectrum 
transformed steadily to A,max=368 nm without a well-defined isosbestic point. These results 
are shown as Figure 3.8.
In a separate experiment involving addition of either acid or base to change the pH 
as appropriate, it was shown that the spectral differences at time zero relate to prototropic 
equilibria (involving (113) and the related anion (114)). Further, that the time dependent 
spectral differences at pH 12 relate to base-catalysed hydrolysis. These transformations are 
outlined in Scheme 324.
O gN-^^^NH -to-CH zCH s
(113) W 22nm
NaOH
HCl
02N - ^ ^ - N ^ . ( o f c H 2CH3
(114) X=396 nm
0 2 N - ^ ~ y - N = C = 0  + CH3CH2O'
H2O
O2N NH2
(92)
Scheme 3.24 Equilibrium involving compound (113) in aqueouslDMSO (9:1, vfv)
and different pH
113
a)
322
Absorbance
0.5
250 500X (nm)
b)
Absorbance
0.5
iz;|-
500250
X (nm)
C)
Absorbance— ] -- :i r.T:
1  
O.Szii
X (nm)
O i# 2
Figure 3.8 Hydrolysis of (113) [4.8xl(r^M} in aqueousfDMSO (9:hvfv) at 37°C and
a) pH 2, b) pH 7, c) pH 12
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Chapter 4
Summary and Discussion
The project was aimed at the synthesis of aryl N-mustard compounds and evaluation of their 
suitability as prodrugs for ADEPT (antibody directed enzyme prodrug therapy) against 
human cancers. The choice of aryl-N-mustard prodrugs resulted from discussions with the 
Cancer Research Campain (especially via Professor K.D. Bagshawe and his colleagues at 
Charing Cross Hospital) and Cell-Tech PLC who had both an intellectual and financial 
interest in the project. Another consequence of these discussions was the selection of N-acetyl 
protected prodrugs for use with antibody-conjugated N-acylarylamidase enzymes. A suitable 
non-mammalian enzyme conjugated with an antibody specific for choriocarcinoma cells was 
available from parallel investigations by Charing Cross Hospital and the PHLS at Porton 
Down.
It was foreseen that suitable prod rugs would have to meet 4 important criteria:
1) Be excellent substrates for the N-acylarylamidese enzyme
2) Be highly stable under physiological conditions (ie. pH 6-8 and 37®C)
3) Be unreactive towards cellular substrates in their protected (prodrug) configuration
4) Be highly reactive towards cellular substrates in their deprotected (drug) 
configuration.
Criteria 3) and 4) are best referred to as a high differential reactivity between the 
prodrug and drug configurations. Assessment of this parameter was referred to colleagues at 
the Charing Cross Hospital using cultured cell-lines in vitro (see Appendix). The following 
mainly concerns chemical aspects of the project carried out at The Open University.
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4.1 N-Acylaminoaiyl and related N-mustards
4.1.1 Synthesis
Several compounds were successfully synthesised by adaptations of literature procedures and 
then fully characterised. In general, the 4-N-acylamino compounds were relatively stable 
and isolable; the parent 4-amino compounds, however, were very labile and difficult to 
obtain in a highly purified state.
4.1.2 Stability and decomposition
Although ary 1-N-mustards are relatively well-known compounds, surprisingly little 
quantitative information is available on their stability and reactivity. This partly relates 
to their low solubility in aqueous media and to priorities given to the study of 
N-2-chloroethyl compounds which have already found application as chemotherapeutic 
agents.
a) A series of unsubstituted aniline mustards were successfully synthesised to 
investigate the effect of the N-ethyl 2-substituent on stability and reactivity. These 
reactions were followed by pH titration and confirmed by HPLC. The effect of leaving group 
structure on reactivity towards water (hydrolysis) is summarised in Table 2.1. Although 
there is a parallel between the rates of hydrolysis and both the nucleofugacity [ie. leaving 
group constant L defined by equation 1.13] for Y* and the acidity (pKa) of HY ^38 on the 
N-ethy 1-2-substituent a good correlation is not evident. The N-2-mesylethyl compounds 
proved to be the most reactive followed by N-2-chloro compounds. The N-2-nitro, acetyl and 
thiocyanate compounds are unreactive and probably unsuitable for further study.
b) The 4-substituted aryl-JV-mustards [H (5), NH2 (10), NHCOCH3 (11), NHCOCF3 
(12 )] of the bis-N-2 -chloroethy 1 series were successively synthesised by adaptation of 
literature procedures. Their stability towards H2O (hydrolysis) was investigated at pH 
2-12/13 and 37“C by various methods (HPLC, ion-exchange chromatography and UV-visible 
spectrophotometry). HPLC proved the most useful allowing measurement of substrate loss as 
well as formation of intermediates and products and the evaluation of sequential 
decomposition steps.
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Table 4.1 summarises the pseudo first-order rate constants for the hydrolysis of 
mustards N,A/-bis(2-chloroethyl)aniline (5), N,N-bis(2-chloroethyl)-4-amino-aniline (10), 
N-[4-[N ',N '-bis(2-chloroethyl)amino]phenyl]acetamide (11) and N-[4-[N ',N ’-bis- 
(2-chloroethyl)aminolphenyl]trifluoroacetamide (12) in aqueous DMSO at 37°C under 
different conditions together with information on the assay method used. The rates at pH 2 
are slower than those at higher pH, probably related to protonation of the mustard N-atom.
The rate constants for mustard hydrolysis obtained by different assay methods agree 
reasonably well. Any differences probably reflect the effect of DMSO in lowering the 
dielectric constant of the medium. For some methods, the rate constants for both of the 
sequential decomposition steps (t] and k%) were evaluated [eg. HPLC assay at pH 2 (using 
enzfitter programe) and ion exchange chromatography assay (using time ratio method)]. The 
conclusion that kj s  k2 is not too unexpected because of the similarity of the two steps. This 
result agrees with literature data for the hydrolysis of 4-anilinoquinolinum aniline 
mustards.^^7
Values of k\ for the hydrolysis of mustards (5), (10), (11) and (12) in 3% DMSO 
phosphate buffer (lO ^M) pH 7.4 correlate with Hammett a  parameter (Figjtre 4.1). The fit 
of this plot (log k^/ k^ versus a ) is reasonable for only 3 data points and the low value of 
p= - 2.27 is consistent with an Sn2 (Sn,) displacement process where the N-lone pair electrons 
displace the leaving group to generate an aziridinium ion intermediate as outlined in 
Scheme 4.1. Comparison with the p= - 2.73 for the ionisation of ArNF^"*" in water at 25°C 
suggests that positive charge development of 80% is localised on the mustard N-atom in the 
transition state. Further, the present results agree reasonably well with p« -1.84 obtained by 
Ross et al. for the hydrolysis of other aniline mustards.
The low differential reactivity between CH3CONH or CF3CONH and NH% 
compounds (factors of 15 and 41, respectively) is too low for good prodrug/drug combination as 
shown by cell-line studies in the Appendix. This suggests that factors other than chemical 
deactivation of the 4-amino substituent of mustards (eg. differential transport) are necessary . 
to obtain useful prodrug / drug combinations.
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Table 4.1
Rate constants obtained by different assay methods for the hydrolysis of mustards (5 f (10), 
(11) and (12) ih aqueous DMSO at 37®C under different conditions
Compound
3% (v/v) DMSO phosphate buffer (KT^ M) pH 7.4
HPLC^ 1 Ion exchange chromatography
lO^Jti s-1 1 lO f^ci s-1 104jt2S-l
(5) 1.10
. . . . . . . . . . . .W . . . . . . . . . .  nil n irin g
1 1 2.56 1.79
(10) 17.35 15.8 1 26.6 16
(11) 1.13 1.03 1 2.9 1.6
(12) . 0.42 0.38 1 0.86 0.6
30% (v/ v) aqueous DMSO
HPLC
pH2 pH 12 pH 13
lO^tjs-: / 104 kiandk2S-^^) lO^Jti s'l lO f^ci s-1
(11 ) 0265 / 0.29; 0.86 0.453 0.80
(12) 0.098 / 0.044; 1.04 3.25 5.05
1% (v/ v) aqueous DMSO
UV/Visible
pH2 pH 12
10^*0 s-1 lO^Jkos-l
(10) 026 2.3
(11) 0.96 -
(12) 0.405 5.8
a) rate of disappearance of mustard starting material
b) rate of elimination of Cl"; time ratio method for calculating ki and ^
c) ki and ki calculated by enzfitter programe
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Figure 4.1 Hammet plot for the hydrolysis of (5), (10), (11) and (12) in phosphate 
buffer (IQ-^M) in 3% (vfv) DMSO at pH 7A and 3 7 ^
N
OH
^  “ L o h
OH
L ^ 'O H
Scheme 4.1 Two step decomposition pathway for mustard hydrolysis
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The product analyses show that at high pH, cyclisation occurs to form morpholine 
derivatives,, as first observed in 1973.^ ®® At physiological pH, however, this cyclisation is 
unimportant.
To further understand the mechanism of mustard hydrolyses, the behaviour of 
mustards (11) and (12) in aqueous DMSO (7:3,v/v) at 37®C and different pHs (pH 2, 7,12 and 
in some cases pH 13) was investigated. The reactions were monitored and the final products 
identified and quantified by HPLC. Identification of isolated products was confirmed by 
MS(FAB) and (El), GC and GC-MS. The HPLC studies revealed a steady decrease with time 
of the aryl-N-mustard substrate concomitant with the formation of an intermediate half- 
hydrolysW mustard, which then decreased with formation of the final products. In some 
cases, the final products proved unstable and reacted further. This information is entirely 
consistant with the mechanism outlined in Scheme 4.1.
The hydrolyses of mustards (10), (U) and (12) in aqueous DMSO (1%, v/v) at 37®C and 
at pH 2, 7.4 and 12, were also followed by UV/visible spectrophotometry. The similarity of 
the absorbances throughout the entire reaction for all the aryl N-mustards at pH 7 and for 
mustard (11) at pH 2 prohibited evaluation of rate constants.
4.2 Carbamate drug/prodrug combinations
The main aim here was to establish that after removal of protecting groups, 
4-aminobenzylcarbamate structures (72) spontaneously decompose to give 4-aminoaryl 
products (73) according to Scheme 4.2.
(72) Reactive carbamate (73) Drug
Scheme 4.2 Spontaneous decomposition of 4-aminobenzylcarbamate strutcure
into 4-aminoaryl products
The synthesis of the carbamate structures was accomplished by adaptation of 
literature procedures. The key problem was the protection of the 4'-amino group. Out of 
several protection groups tested (CBZ, trityl, Ac and f-BOC) the f-BOC derivative was found
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to be most suitable. Conditions were found for the removal of this group without damaging 
the central benzyloxycarbonyl bond in the molecule. Synthesis of both the f-BOC protected 
and unprotected compounds was achieved for model compounds without an N-mustard moiety.
The main problems involved with the use of the CBZ protection relate to its removal 
by hydrogenolysis, which preferentially removed the central carbamate moiety instead of 
the carbamate group in the CBZ protection. With the trityl protection the problems relate 
with the lability of this group which did not allow to obtain a pure compound.
Decomposition (hydrolysis) of the 4-N-acyl model substrate to a 4-amino aryl 
product was briefly examined at pH 2-13 at 25®C. It was possible to show that at pH 7 the 
4-N'-acetyl compound is stable whereas the 4-NH% compound is very unstable to give 
products of spontaneous decomposition which include a 4-aminoaryl product (73), a 
N-(4'-aminobenzyl)-aryl product (resulting from recombination of a pair of ions generated) 
and a polymeric structure. It was then shown that 4-aminobenzylcarbamate prodrugs should 
spontaneously decompose to an active drug on removal its protecting group. The 4 -N-acetyl 
compound proved to be à good substrate for an acylarylamidase enzyme which suggests that 
after introduction of the N-mustard moiety, these structures could be suitable prodrugs for 
ADEPT.
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Chapter 5
Experimental
5.1 General Instrumentation
Infra-red spectra were recorded as either thin films, nujol mulls or KBr discs, using a Perkin- 
Elmer 1410 spectrophotometer against a polystyrene standard.
Ultra-violet/visible spectra were run on either Cecil CE 5501, Kontrôn Uvikon 810P or 
LKB 4050 spectrophotometers, calibrated with a holmium filter.
Nuclear magnetic resonance spectra were provided by the Departmental service 
and recorded either on a Jeol FX90Q FT or a Jeol JNM-FX400. The internal standard for 
organic solvents was tetramethylsilane.
Mass spectra were provided by the Departmental service and obtained using a VG 20- 
250 instrument. Spectra provided were either electron impact, fast atom bombardment (with 
xenon as the ionising gas) or gc modulated (using a HP 4840 gc).
Microanalyses were supplied by Medac Ltd at Brunei University.
Melting points were measured on an Electrothermal digital melting point apparatus 
and are uncorrected.
pH measurements were made on a Radiometer PHM 82 pH meter, equipped with a 
titrator i l l  80 and autoburette ABU 80, using Radiometer G2040C glass and K4040 calomel 
electrodes, calibrated with BDH standard buffers.
HPLC analysis were run on a ternary gradient liquid chromatography, Varian model 
5060, equiped with a Varian 9060 diode array detector, coupled to a Physics chromojet 
computing integrator.
GC analysis were obtained with a Carlo Erba ,Vega Series I I6180 instrument.
Ion exchange chromatography was performed on a Milton Roy 3000 solvent delivery 
system equipped with a LDC/ Milton Roy conductivity monitor HI.
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A mathematical package, Enzeffiter-(EGA-version 1.03) by Elsevier-Biosoft,^^^ was 
used to analyse some kinetic data.
5.2 Reagents and Reactants
Reagents used for kinetic studies and buffer solutions, NaCl, NaClQ^, Na2B4 0 7  and l.OM 
NaOH (AVS) and HCl, tris(hydroxymethyl aminomethane), were Analar grade, from BDH 
and were used without further purification.
Solvents and buffers components for HPLC (ACN, DMSO, phosphoric acid, potassium 
dihydrogen orthophosphate, acetic acid, sodium acetate and phtalic acid) were either 
Analar or HPLC grade and were used as supplied.
The following reagents for syntheses were laboratory grade from commercial 
suppliers and were used as supplied: acetamide, 4-acetamidophenol, acetanilide (97%),
acetic anhydride, 4-aminoacetanilide, 4 aminoaniline, 4-am inobenzotrifluoride, 
4-aminobenzyl alcohol, 4-aminophenol, N-(4-aminophenyl)acetamide, benzhydrol, benzyl 
alcohol, butylithium (1.6M) in hexane, di-tert-butyl dicarbonate, 4-chlorobenzylalcohol 
(99%), 4-chloroacetanilide, 4-chloroaniline (98%), bis(2-chloroethyl)amine hydrochloride 
(98%), 1 -chloro-4-nitrobenzene, diethanolamine, ethanolamine, ethylene oxide, glacial 
acetic acid, methanesulfonyl chloride, 4-methoxybenzamide (97%), 2-methy 1-2-propanol, 
4-m ethylacetanilide, morpholine, 4-m orpholinoaniline (98%), 4-nitroaniline, 
4-nitroacetanilide, 4-nitrobenzamide (98%), 4-nitrobenzylalcohol, 4-nitrotoluidine, 10% 
palladium on charcoal, phenylisocyanate, 4-phénylmorpholine (98%), picric acid (1.0 wt. % 
in water), sodium acetate, sodium nitrite, sodium thiocyanate, sodium tetrafluoroborate 
(98%), toluene-4-sulphonyl chloride, p-toluidine, 4-trifluoromethylphenylisocyanate, 
triphenylmethanol (97%), triphenylmethylchloride, a,a,a-trifluoro-p-tolylisocyanate, 
trifluoroacetic anhydride, trifluoroacetic acid, a,a,a-trifluoroacetamide, and gaseous 
hydrogen chloride (Fisons).
Aniline, acetyl chloride, 4-nitrophenyl isocyanate, pyridine and triethylamine were 
purified by standard methods.
N,N-Bis(2-hydroxyethyl)-4-amino-aniline sulphate monohydrate was purified by 
the method described in Section 5.3.21, and 2-mercaptoethanesulfonic acid sodium salt (98%) 
was converted in the acid form according to procedure described in Section 5.3.32.
The solvents acetone, acetonitrile, benzene, dichlorom ethane, ethanol, 
2-ethoxyethanol, ethylacetate, methanol, tetrahydrofuran and toluene were also purified by 
standard procedures.^®^
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Isotopically labelled compounds (MSD Isotopes) were used as supplied.
Thin-layer chromatography was carried out using silica-gel UV254 (0.25mm) plates 
and the compounds visualized using UV light. Colunm chromatography was carried out using 
silica-gel, 60°A, obtained from usual suppliers.
Acylarylamidase enzyme (B.C. N° 3.5.1.13) was a gift from Dr. Roger Sherwood, 
Division of Biotechnology, PHLS. Centre for Applied Microbiology and Research, Porton 
Down, Salisbury, UK.
5.3 Synthesis of substrates
5.3.1 N,N-Bis(2-hydroxyethyl)aniline (37)
Following a literature procedure,^^'^® aniline (14 g, 150 mmol) and ethylene oxide (15 g,
340mmol) were heated at 150°C, for 20 h, in a Carius tube. Due to the volatility of ethylene 
oxide, the Carius tube containing the aniline was cooled in ice (0 to -5°C) before adding the 
ethylene oxide, and after sealing, was heated in suitably screened oven. The white solid 
product was recrystallised 5 times from benzene to give white plates of N,N-bis-  
(2-hydroxyethyl)aniline (37), yield 19.3 g (71%); m.p. 55.4-56°C (lit.^3 m.p. 55°C); 
Vmax (nujol) 3350 (OH), 1600 (ArH), 1500 (ArH), 1330, 750 cm'l; Ô^H ((CD3)zCO) 3.6 and 3.8 
(8H, dt, CH2), 4.7 (2H, br s, OH ), 6.7-7.1 centred at 7.0 ppm (5H, m, ArH).
5.3.2 N,N-Bis(2-methanesulphonyIoxyethyl)aniline (38) and
N,N-Bis(2'methane5ulphonyloxyethyl)aniline hydrochloride 
salt (43)
Methanesulphonyl chloride (2.4 cm^, 3 mmol) was added with vigorous stirring, to a solution 
of N,N-bis(2-hydroxyethyl)aniline (2.4 g, 13 irunol) in dry pyridine (15 cm^) at -5°C, and the 
mixture stirred at this temperature for 30 min. Water (1.3 cm^) was then added in three 
portions, with stirring, at ca. 5°C. The mixture was quickly diluted with ice-cold aqueous 
sulphuric acid (4.5 M; 36 cm®), immediately extracted into chloroform (20 cm®), and the 
extract vacuiim evaporated to give N,N-bis(2-methanesulphonyloxyethyl)aniline (38) as a 
syrupy product, yield 0.57 g (56%). A portion of this syrup was purified by silica column 
chromatography using DCM as eluent, vmax (thin film) 3005 (NH), 2910, 1600, 1500, 1350 
(OSO2CH3 ), 1175 (OSO2CH3), 750 and 700 (ArH) cm ;^ 6 %  (CDCI3) 2.9 (6H, s, OSO2CH3),
3.7 (4H, t, J=6 .8Hz, NCH2), 4.3 (4H, t, J=6 .8Hz, CH2OSO2), 6.7-7.4, centred at 7.05 ppm (5H,
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m, ArH); m /z (El) 337 (18%, M+), 228 (100, M+ - CH2OSO2 CH 3 ), 132 (43), 123 (72, 
+CH2CH2OSO2CH3), 105 (38), 104 (38), 91 (17, C7H7+), 79 (48, +SO2CH3).
The N,N-bis(2-methanesulphonyloxyethyl)aniline (38) (1.0 g) was converted into 
the hydrochloride salt by dissolving in chloroform (4 cm®) and passing dry, gaseous hydrogen 
chloride through the solution, until saturated. The solution was then refrigerated overnight. 
The precipitated crystals were filtered, washed with cold chloroform (without exposure to 
the air) until practically colourless, and pressed dry. The crystals were then suspended in 
cold acetone (precooled in dry ice-chloroform), refiltered and dried, giving colourless crystals. 
Yield 0.83 g (75%); m.p. 77-82°C (lit.^^O m.p. 98-105°C); vmax (nujol) 3400 (NH3+), 1350 
(OSO2CH3), 1175 (OSO2CH3), 1040, 720 cm-1; Ô^H ((CDgliSO) 3.2 (6H, s, CH3), 3.75 (4H, t , 
J=6Hz, NCH2), 4.35 (4H, t, J=6Hz, OGH2), 6.7-7.3 centred at 7.0 ppm (6H, m, ArH and NH) ; 
m/ z (FAB ) 372 (0,4%, M-H+), 95 (100, CH3SO2O ), 35 (14, Cl ").
5.3.3 Ar,N-Bis(2-acetoxyethyl)amline (39)
N,N-Bis(2-hydroxyethyl) aniline (37) (0.5 g, 2.8 mmol) was suspended in pyridine (5 cm®), at 
room temperature. Acetyl chloride (0.98 cm®, 14 mmol) was added slowly and the reaction 
allowed to proceed for 3h at room temperature. The disappearance of the starting material 
was followed by silica tic (DCM). The pyridine was removed under vacuum and low 
temperature, and the impure residue, yield 0.5 g (69%), column chromatographed on silica 
using ether/DCM (1:1, v/v) as eluent. The product was obtained after evaporation of the 
solvent as an yellow orange oil, 0.37 g (51%) (Found: C, 63.2; H, 7.3; N, 5.2. C14H 19NO4 
requires: C, 63.4; H, 7.2; N, 5.3%); vmax (nujol) 1670 (C=0), 1600, 1500, (CH2OCO), 1380 
(OCOCH3), 745 and 690 cm'l (ArH); Ô^H ((CP3>2CO) 2.0 (6H, s, OCOCH3), 3.7 (4H, t, 
J=7.5Hz, NCH2), 4.3 (4H, t, J=7.5Hz, OCH2 ), 6.7-7.3, centred at 7.05 ppm (5H, m, ArH); 
m/z (FAB+) 266 (18%, MH+), 206 (8, M+- OCOCH3), 192 (25, M+- CH2OCOCH3), 146 (4), 132 
(6), 120 (6), 104 (8), 91 (7, C7H7+), 87 (100, +C2H4OCOCH3), 43 (44, CH3CO+).
5.3.4 AT^iV-Bis(2-ethyltoluene'4-sulphonate)aniline (44)
Following a literature procedure,^^'^^ N,N-bis(2-hydroxyethyl)aniline (2.0 g, 11 mmol) 
was dissolved in pyridine (22 cm®), and toluene-4-sulphonylchloride (9.2 g, 48 mmol) was 
added in two aliquots, at Ih intervals, whilst the mixture was stirred at 0°C for 2h and for a 
further Ih at room temperature. The mixture was then cooled and treated dropwise with 
sufficient water to decompose the excess sulphonyl chloride. More water was added (60 cm®)
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and the resulting suspension was stirred overnight to give a pale yellow solid, which was
then filtered off, washed with water (60 cm®), and dried to give crude N,N-bis(2-
ethyltoluene-4-sulphonate)aniline, yield 4.4 g (82%). The solid was further recrystalised 
from ethanol to give white needles. Yield 4.1 g (75%); m.p. 88-89°C (lit.^^® m.p. 90-91 °C); 
Vmax (nujol) 1600 (ArH), 1500 (ArH), 1360,1100, 800, 750 cm‘l; Ô^H ((CDs)2CO) 2.4 (6H, s, 
CH3), 3.6 and 4.1 (8H, dt, CH2X 6.4-7.Z centred at 6.8 (5H, m, ArH), 7.3-7.8 centred at 7.5 ppm 
(8H, ABq, J=9.1Hz, ArH); m /z (El) 489 (10%, M+), 304 (89, M+- CHiOTs), 91 (100, C7H7+).
5.3.5 N,N-Bis(2-chloroethyl)aniline (5)
A solution of N,N-bis(2-ethyltoiuene-4-sulphonate)aniline (3.4 g, 7 mmol) and anhyd. CaCl2 
(2.0 g, 18 mmol) in dry 2-ethoxyethanol (25 cm®), was stirred at 120°C, for 1.5h and then 
allowed to cool. The solvent was removed under vacuum and the mustard was extracted into 
benzene (100 cm®). The benzene extract was washed with water (100 cm®) and dried with 
anhyd. MgSO^. On evaporation of the solvent, N,N-bis(2-chloroethyI)aniline was obtained 
as a syrup, yield 0.9 g (60%). It was recrystallised from toluene/n-hexane (1:1, v/v) giving a 
solid m.p. 43-45°C (lit.43 m.p. 45°C); vmax (nujol) 1600 (ArH), 1500 (ArH), 770, 650 cm‘l; 
ô^H ((CD3)2C0 ) 3.7 (8H, s, CH2), 6.7-73 centred at 7.0 ppm (5H, m, ArH); m /z (El) 217 
(11%, M+), 183 (25, M+- - Cl), 168 (100, M+- - CH2CI).
5.3.6 N^N-Bis(2-thiocyanoethyl)aniline (40)
A solution of N,N-bis(2-ethyltoluene-4-sulphonate)aniline (44) (1.24 g, 2.5 mmol) and sodium 
thiocyanate (0.75 g, 9.3 mmol), in dry 2-ethoxyethanol (13 cm®), was stirred at 120°C for 3h. 
The disappearance of the starting material was followed by silica tic using DCM as eluent. 
The solvent was removed under vacuum, the product was extracted into toluene (30cm®), and 
the toluene extract washed with water (30 cm®) and dried (anhyd. MgSO^). On evaporation 
of the solvent, a solid white residue was obtained. This residue was purified by silica column 
chromatography using DCM as eluent. The fractions containing the product were combined, 
the solvent removed under vacuum, and the white residue was further purified by 2 
recrystallisations from DCM/n-hexane (1:1, v/v), to give white crystals. Yield 0.23 g (49%); 
m.p. 68-70°C (lit.:47 m.p. 73-74°C); Xmax (DMSO) 280 nm; Vmax (KBr disc) 3076 (NH), 
2153 (CN), 1592 (N=), 722 (CS), 748 and 690 (ArH); Ô^H ((CD3)2CO) 3.3 (4H, t, J=8Hz, 
NCH2), 3.8 (4H, t, J=8Hz, OCH2), 6.7 7.3 centred at 7.0 ppm (5H, m, ArH); m /z (FAB^) 264 
(4%, MH+), 263 (6 ), 251 (2), 236 (3, M+- HCN), 223 (3), 205 (21, M+-SCN), 191 (26,
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M+ - CH2SCN), 178 (5), 164 (7), 146 (9), 132 (13), 115 (23), 104 (19), 86 (12), 75 (41), 57 (36), 
57 (36), 45 (46).
5.3.7 N,N-BiM2-nitratoethyl)aniline (41)
To N,N-bis(2-chloroethyl)aniline (5) (0.4 g, 1.85 mmol) in dry ACN (14 cm®), was added 
silver nitrate (1.2 g, 7.06 mmol) in dry ACN (2 cm®). The mixture was left to react under 
nitrogen, with vigorously stirring, at 40° C for 15h. The reaction was followed by silica tic 
using ether as eluent. On completion, the ACN was vacuum evaporated, the residue 
extracted with ether, and the ether layer washed with water (10 cm®), then dried over 
anhyd. MgSO^. The residue obtained after vacuum evaporation of the solvent [yield 0.34 g 
(66%)] was chromatographed on a silica column using ether /n-hexane (1:2, v/v) as eluent. 
The product recovered after vacuum evaporation of the solvent, was a yellow oil. Yield 0.21g 
(41%); 3^ax (DMSO) 260 nm; vmax (thin film) 2900, 1625, 1600, 1500, 1380,1280,1200, 980, 
840, 740, 700 cm'l; 8 %  ((CD3)2CO) 3.8 (4H, t, J=7Hz, NCH2), 4.75 (4H, t, J=7Hz, OCH2), 
6.7-7.S centred at 7.0 ppm (5H, m, Ph); m/z(EI) 271 (20%, M+-), 195 (27, M+- - • CH2ONO2), 
149 (46, C6H5N+(CH2)(C2H4 0 -)), 119 (97, 195 - CH2ONO2), 105 (33, C6H5CH2CH2+),
f
91 (100, C7H7+), 77 (45), 46 (39, NO2).
5.3.8 N,N-Bis(2'hydroxyethyl)-4-nitroso-aniline (50)
N,N-Bis(2-hydroxyethyl)aniline (0.2 g  1.1 nunol) was dissolved in warm conc. HCl (0.48cm®, 
1.58 mol) and water (0.45 cm®). The mixture was cooled to 5°C, and a solution of sodium 
nitrite (0.08 g, 1.2 mmol) in water (0.3 cm®), was added dropwise, under vigorously stirring, 
maintaining the the temperature at 5-7°C. After the addition, the mixture was stirred for a 
further 30min, after which a saturated aqueous solution of NaHCOg was added dropwise 
until pH 8 was obtained. The solution was then saturated with sodium perchlorate and 
extracted with ethyl acetate. The organic extracted was washed with water (2 x 25cm®) and 
dried (MgSO^), then purified by silica column chromatography with ethyl acetate as eluent. 
A tic showed a pure product. Yield 0.17 g (74%); m.p. 134-136°C (iit.^®  ^ m.p. 137-138°C); 
Vmax (KBr disc) 3350,1620, 1320, 1120,1040, 840 cm"!; Ô^H ((CD3)2CO) 3.0 (4H, s, NCH2),
3.8 (6H, d, CH2OH and OH), 6.9-7.7 ppm (4H, ABq, J=10.1Hz, ArH) ; m /z (El) 210 (21%, 
M+), 179 (47, M+- CH2OH ), 165 (12, M+- CH2CH2OH), 149 (100, M+- (CH2OH+NO)), 105 
(34, HN+- (C2H40H)2).
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5.3.9 N,N-Bis(2-methanesulphonyloxyethyl)>4-nitrosO'aniline (51)
N,N-Bis(2-methanesulphonyloxyethyl)aniline hydrochloride (43) (4.1 g, 11 mmol) was. 
suspended in ACN (20 cm®) and the solution cooled to -5 to 0 °C. Then, HCIO4 (60%; 6.6 cm®) 
and water (6 cm®) was added dropwise, keeping the solution at low tem perature. 
A solution of NaN02 (1 g  14 mmol) in water (2 cm®) was added dropwise over a period of 
30min, and the solution was stirred for further 30min. The solution was then neutralized 
with NaOH to pH 7 (temperature kept below 0°C), stirred for another Ih, and then extracted 
with DCM (3 X 50 cm®). On vacuum evaporation of the solvent, a dark green residue was 
obtained which was purified by silica column chromatography using ethyl acetate as eluent. 
Yield 2.5 g (62%); m.p. 116-118°C (lit.7 m.p. 117-118.5°C) (Found: C, 38.7; H, 4.9; N, 7.5. 
C12H 18N2O7S2 requires C, 39.3; H, 4.9; N, 7.6 %); vmax (KBr disc) 3030-2930, 1620, 1530, 
1380 (NO), 1350,1175 (OSQ2CH3), 1120, 980, 840 cm’l; Ô^H ((CD3)2CO) 3.1 (6H, s, CH3), 4.1 
(4H, t , J=6Hz, NCH2), 4.6 (4H, t , J=6Hz, OCH2), 7.1-7.8 ppm (4 H, ABq, J=10.3Hz, ArH); 
m /z (FAB+) 367 (2, MH+).
5.3.10 NpN>Bis(2'Chloroethyl)-4-nitroso'amlîne (52)
Following a literature procedure,^^ N,N-bis(2-chloroethyl)aniIine (2.0 g, 9.2 mmol) was 
dissolved in warm conc. HCl (3.9 cm®) and water (3.7 cm®). After cooling to 5°C, the mixture 
was vigorously stirred and a solution of sodium nitrite (0.67 g, 10 mmol) in water 
(1.85 cm®) was added dropwise while maintaining the temperature at ca. 5-7°C. The mixture 
was stirred for further 20min and then ether (40 cm®) and water (40 cm®) added. The aqueous 
layer was separated and extracted with ether (2 x 40 cm®). The ether extracts were combined 
and dried with anhyd. MgS0 4 . Vacuum evaporation of the solvent, followed by 
recrystallisation from ether, gave deep green plates of N,N-bis(2-chloroethyl)-4-nitroso- 
aniline. Yield 1.8 g (79%); m.p. 79-80°C (lit.^l m.p. 79-80°C); vmax (nujol) 3268 (NH), 1600 
(ArH), 1500 (ArH), 1380 (NO), 1100 cm 'l; Ô^H ((Cp3)2CO) 4.0 (8H, dt, CH2), 6.9,7.9 centred 
at 7.4 ppm (4H, ABq, J=9.0Hz, ArH ); m /z (El) 246 (18%, M+), 197 (72, M+- CH2CI), 167 (100, 
M+ - CH2CINO), 63 (50, +CH2CH2CI).
5.3.11 N,N-Bis(2>nitratoethyl)-4-nitToso-aiiiline (53)
N,N-Bis(2-nitratoethyl)aniline (41) (0.41 g, 1.5 mmol) was dissolved in water (0.5 cm®) and 
ACN (5 cm®). Then, aqueous HCIO4  (60%; 0.7 cm®) was added at room teihperature and, after
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cooling to 0-5°C, NaN02 (0.11 g  1.6 mmol) in water (0.5 cm®), was added dropwise, over 
20min. The reaction, followed by silica tic using DCM as eluent, was allowed to proceed for 
30min at 0-5°C, after which the ACN was vacuum evaporated and the aqueous residue 
extracted with ether (15 cm®), washed with water (10 cm®), and dried over anhyd. MgSO^. 
After vacuum evaporation of the solvent, a green solid was obtained. Yield 0.2 g (44%). This 
was further purified by silica column chromatography, using DCM as eluent. After 
evaporation of the solvent, the product was obtained as a green crystalline solid. Yield 
0.14 g (30%); m.p. 85-87°C (Found: C, 40.2; H, 4.0; N, 18.2. C10H 12N4O7 requires: C, 40.0; 
H, 4.0; N, 18.6%); vmax (KBr disc) 1640,1620,1525,1380 (NO), 1160,1130, 900, 860, 830 cm'l; 
Ô^H ((CD3)2C0) 4.14 (4H, t, J=6.7Hz, NCH2 ), 4.95 (4H, t , J=6.7Hz, OCH2), 7.0-7.8 centred 
at 7.45 ppm (4H, ABq, J=10.3Hz, ArH ); m /z (FAB+) 301 (5%, MH+), 224 (2, MH+-Me0N02); 
m /z  (El) 300 (45%, M+), 224 (10, M+- CH2 O N O 2 ), 178 (87, 224 - NO2 ), 148 (100, 
(ON)C6H4CH2CH2+), 120 (64, C6H5N+* (CH3)(CH3)), 91 (62, C7H7+), 90 (66), 77 (48, 
C6H5+), 56 (67), 46 (30, NQ2+), 30 (53, NO+).
5.3.12 N,N-Bis(2-chloroethyl)-4-amino-aniline (10) and 
N,N-bis(2-chloroethyi)-4-amino-aniline hydrochloride (54)
A solution of N,N-bis(2-chloroethyl)-4-nitroso-aniline (52) (0.8 g  3.2 mmol) in methanol (180 
cm®), containing 15% palladium on charcoal (0.15 g), was stirred under hydrogen, at 
atmospheric temperature and pressure, until the calculated volume of hydrogen was absorbed 
and the green colour had disappeared. The solution was filtered and the filtrate added to 
methanolic HCl (1:1, v/v; 21 cm®). On evaporation of the methanol, a brown residue was 
obtained which quickly darkened: it was therefore used immediately in the next stage of the 
synthesis. The crude yield was 0.7 g (81%). A small amount of the brown residue (0.2 g) was 
twice recrystallised from methanol/ether (1:1, v /v) to obtain a pure product as almost 
colourless plates, m.p. 245-258°C (lit.^®6 ^ .p . 250-260°C); vmax 2950 (NH3+), 2600, 1620, 
1520, 1410, 1370, 820, 740 cm"^; Ô^H ((CD3)2SO) 3.8 (8H, s, CH2), 6.8-7.3 centred at 7.0 (4H, 
ABq, J=9.4Hz, ArH), 10.3 ppm (3H, br s, NH); m /z (FAB+) 233 (10%, MH+ - HCl).
5.3.13 A/,.N-Bis(2-methanesulphonyloxyethyl)-4>amino-aiiiline (55) and 
N,N-bis(2'methanesulphonyloxyethyl)-4-amino'aniline methane- 
sulphonate salt (56)
A solution of N,N-bis(2-methanesulfonoxyethyl-4-nitroso-anilihe (51) (0.56 g  1.55 mmol) in 
methanol (190 cm®), containing 15% palladium-charcoal (0.08 g), was stirred under hydrogen 
until the calculated amount of gas had been taken up. The light yellow solution was filtered
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under nitrogen into methanesuKonic acid (0.25 cm®, 2.5 eq) in methanol (50 cm®). After the 
filtration, the solution was pale green, but on evaporation of the methanol, a brown oily 
residue (ca. 40% yield) which rapidly darkened, was obtained. Therefore, it was used 
immediately in the next stage of the synthesis.
5.3.14 N-[4-[N',N’-Bis(2-chloroethyl)amino]phenyl}acetamide (11)
N,N-Bis(2-chloroethyl)-4-amino-aniline hydrochloride (54) (0.44 g, 1.6 mmol) was 
suspended in DCM (15 cm®) and shaken with triethy lamine (0.56 cm®, 4.0 mmol). When all 
the solid had dissolved, the mixture was cooled in ice (0°C), and acetic anhydride (1.5 cm®, 
16 mmol) was added, with vigorous shaking. After 20min, the organic layer was washed 
with water (15 cm®) and dried over anhyd. MgSO^. After removing the solvent, the dark 
residue was crystallized from ether/n-hexane (1:1, v/v). The product was further purified by 
silica column chromatography using ether/DCM (3:1, v/v) as eluent. After removal of the 
solvent, the product was twice recrystallised from ether/n-hexane (1:1, v/v). Yield 0.11 g 
(25%); m.p. 120°C (lit.41 m.p. 124-126°C) (Found: C, 52.3; H,5.9; N, 9.9. C12H 16CI2N2O 
requires C, 52.4; H,5.9; N, 10.2%); X^ax (DMSO) 278nm (loge= 4.4); v^àx (KBr disc) 3300 
(NH), 1650 (C=0, amide), 1540 (ArH), 1520,1330,1180, 1140, 820 cm“l ; Ô^H ((CD3)2CO) 2.1 
(3H, s, CH3), 3.7 (8H, s, CH2), 6.7 - 7.5 centred at 7.1 (4H, ABq, J=10.0Hz, ArH), 10.1 ppm (IH, 
br s, NH) ; m /z (El) 274 (12%, M+), 225 (93, M+- -  CH2CI), 183 (14, M+ - CH2CI - CH2=C=0 ), 
120 (75), 106 (15, C6H5NHCH2+), 43 (100,CH3CO+).
5.3.15 N-[4-[N',N’-Bis(2-chloroethyl)amino]phenyl)trifluoroacetamide 
(12)
N,N-Bis(2-chloroethyl)-4-amino-aniline (1.25 g, 4.6 mmol) was suspended in DCM (25 cm®) 
and shaken with triethylamine (1.6 cm®, 11.5 mmol). Trifluoroacetic anhydride (3.2 cm®, 
23 mmol) was added with vigorous shaking. After 20min. the organic layer was washed 
with water (25 cm®) and dried over anhyd. MgSO^. After removing the solvent, the dark 
residue was recrystallised from ether/n-hexane (1:1, v/v). The product was further purified 
by silica column chromatography (ether/n-hexane (l:l,v/v)) and further recrystallised from 
ether/n-hexane (1:1, v/v) to give shining silver crystals. Yield 0.3 g (20%); m.p, 101-103°C 
(lit.40 m.p. 109-110°C) (Found: C, 44.1; H,4.1; N,8.4. C12H13CI2F3N2O requires: C, 43.8; H, 
4.0; N, 8.5%); X^ax (DMSO) 290nm (loge= 4.22); vmax (KBr disc) 3300 (NH), 1700 (C=0, 
amide), 1620 (ArH), 1600, 1520 (ArH), 1360, 1150, 820 cm'^; 0%  ((CD3)2CO) 3.8 (8H, s, CH2),
6.8 - 7.6 centred at 7.2 (4H, ABq, J=10.5Hz, ArH), 10.1 ppm (IH, br s, NH); m /z (El) 328 (5%,
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M+), 293 g , M+-C1X 279 (47, M+ - CH2CI), 119 (30), 91 (14, C7H 7+), 69 (27,CF3+), 65 (45), 63
(100).
5.3.16 N-[4-[N',JV’-Bis(2-iiiethanesulphonyloxyethyl)ainino]phenyl] 
acetamide (57)
N,N-Bis(2-methanesulphonyloxyethyl)-4-amino-aiviUne methanesulfonate sait (56) (0.7 g,
1.6 mmol) was suspended in dry pyridine (30 cm^) and shaken with triethylamine (0.6 cm^
4.6 mmol), at room temperature. When all the solid had dissolved, the mixture was cooled to 
0 to 5^C. Acetic anhydride (1.2 cm^ > 12.7 mmol) was added with vigorous shaking, and the 
mixture was stirred for 3h at 0 to -5®C. The pyridine was removed under vacuum and the 
residue washed with a saturared solution of NaHCOg (20 cm^) and extracted with DCM (30 
cm^). The organic extract was further washed with water (20 cm^) and dried over anhyd. 
MgSO^. After vacuum evaporation of the solvent, a yellow residue was obtained which was 
submitted to silica colunm chromatography using ethyl acetate as eluent. The product was 
obtained after vacuum evaporation of the solvent as a syrup. It was clearly impure and 
proved impossible to recristallise. Yield 0.3 g (54 %); m.p. 111°C (decomp.); vmax (thin 
film) 3300 (NH), 1670 (C=0, amide), 1600 (ArH), 1520 (ArH), 1350 (OSO2 CH3 ), 1175 
(OSO2 CH3 ), 800 (ArH) cm-l; Ô^H ((CD3 )2 CO) 2.0 (3H, s, NHC(0 )CH3 ), 3.0 (6H, s, 
SO2CH3), 3.8 (4H, t, J=6.3Hz, NCH2), 4.4 (4H, t, J=6.3Hz, OCH2), 6.S-7.5 centred at 7.15 
(4H, ABq, J=10.4Hz, ArH), 9.0 ppm (IH, br s, NH); m /z (El) 394 (1%, M+), 221 (65, 
M+ - (2XSQ2CH 3 ), 163 (28, 4-phenylmorpholine+ ), 96 (80, HOS+- O2 CH 3 ), 79 (100, 
+SO2CH3), 43 (28, CH3CO+).
5.3.17 A/-[4-[N',]V*>Bis(2>acetyloxy)ethyl]amino]phenyl]acetamide (58)
N,N-Bis(2-hydroxyethyl)-4-amino-aniline sulphate salt (0.5 g, 1.6 mmol) was suspended in 
pyridine (35 cm^), and shaken with triethylamine (0.6 cm^, 4.8 mmol), at room temperature, 
for lOmin. When most of the solid had dissolved, acetic anhydride (3 cm^, 32 mmol) was 
added and the mixture shaken vigorously at room temperature for 24h. The pyridine was 
removed under vacuum. To the residue, water (15 cm^) was added and the resultant solution 
was extracted with DCM (30 cm^). The organic layer was dried over anhyd. MgSO^, the 
solvent removed under vacuum and the residue submitted to silica column chromatography 
using ethyl acetate as eluent. The product was then twice recrystallised from DCM / n-hexane 
(l:l,v/v) to give shining white crystals. Yield 0.16 g (31%); m.p. 64-66®C (Found: C, 59.3; 
H, 6 .8; N, 8 .6 . C16H22N2O5 requires C, 59.6; H 6.9; N, 8.7%); vmax (thin film) 3300 (NH),
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2980 (ArH, COCH3), 1745 (C=0, ester), 1670 (C=0, amide), 1610, 1520, 1380 (CH3, ester), 
1230, 1050, 810 (ArH); Ô^H ((CD3)2CO) 1.9 (6H, s, CH2COCH3), 2.0 (3H, s, NHCOŒ 3),
3.6 (4H, t, J=6.7Hz, CHzh 4.2 (4H, t, J=6.7Hz, CH2I  6.8 - 7.5 (4H, ABq, J=10.2Hz, ArH),
8.9 ppm (IH, br s, NH); m /z (El) 322 (5%, M+), 249 (M+-CH3 C O CH 2 ), 109 (30, 
H2NC6H4NH3+), 87 (100, +CH2CH2COOCH3), 43 (50, CH3CO+).
5.3.18 N-[4-[N',N'-Bis(2-hydroxyethyl)amino]phenyl]acetamide (59)
N-[4-[N',N’-Bis(2-hydroxy)ethyl]amino]phenyllacetamide, was obtained by hydrolysis of 
ZV-[4-N',N’-(bis(2-acetyloxy)ethyl]amino]phenyl]acetamide (58) (0.3 g, 0.93 mmol) in 
aqueous O.OIM NaOH (100 cm^) at 40®C, and the reaction followed by HPLC. After 5h, when 
reaction was complete, the solution was neutralized with CO2 to pH 7 and extracted with 
DCM (150 cm^). After separation and drying (MgSO^), the solvent was removed under 
vacuum to give a grey residue. Yield 0.19 g (87%). This product resisted further purification. 
M.p. 142-150‘»C (decomp.) (lit.^^O ^.p. 141-142.5=0; v^ax (KBr disc) 3500 (br, OH), 2950 
(NH), 1560 (C=0), 1420,1060, 840,640 cm'^; Ô^H (CD3OD) 2.1 (3H, s, NHCOCH3), 3.5 and
3.6 (8H, dd, J-5Hz, CH2), 4.9 (3H, s, OH and NH), 6.7-7A centred at 7.05 ppm (4H, ABq, 
J=10Hz, ArH); m /z (El) 238 (30%, M+), 207 (100, M+ - CH2OH), 163 (31), 119 (20, 163), 
93 (13), 43 (30, CH3CO+).
5.3.19 N-[4-(4'inorpholino)phenyl]acetainide (60)
To 4-morpholinoaniline (0.8 g, 4.4 mmol) in freshly distilled THF (20 cm^), triethylamine 
(20 cm^, 143.5 mmol) was added. After cooling to 0 to -5°C, acetyl chloride (0.5 cm^, 6.16 
mmol) was added dropwise. After Ih stirring at room temperature, silica tic using DCM 
eluent, showed no presence of starting material. The solvent was lyophylised to give a wet 
residue, which was dissolved in water (20 cm^) then extracted with DCM (40 cm^). The 
organic extract after separation and drying over anhyd. MgSO^, was evaporated under 
reduced pressure to give a brown red residue which went brown metallic on standing. The 
residue was purified by silica column chromatography using DCM as eluent. Yield 0.76 g 
(78%); m.p. 198-200°C (Found: C, 64.1; H, 7.2; N, 11.6. C12H16N2O2 requires C, 65.4; H, 7.3; 
N, 12.7%); Vmax (KBr disc) 3300 (NH), 1660 (C=0, amide), 1520, 1380, 1220, 920, 820, cm“^ ; 
Ô^H (CDCI3) 2.14 (3H, s, CH3), 3.11 (4H, t, J=1.4Hz, CH2), 3.86 (4H, t, J=1.4Hz, CHzX 6 .88- 
7.38 (4H, ABq, J=3Hz, ArH), 7.41 ppm (IH, br s, NH); m /z  (FAB+) 221 (28, MH+); 
m /z (FAB ) 219 (27, M- H+); m /z (El) 220 (90, M+), 189 (2, M+-CH2OH), 177 (29, M+ - 
CH3CO), 162 (32), 120 (100, NH2C6H4NCH2 ), 43 (29, CH3CO+).
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5.3.20 iV-[4-CN',N’-Bis(2-hydroxyethyl)amino]phenylltrifluoroacetamide 
(65)
N-[4-[M',N'-Bis(2-hydroxyethyl)amino]phenyl]trifluoroacetamide was obtained by either 
acid or base hydrolysis of JV-[4-[A/',H’-bis(2-chloroethyl)amino]phenyl]trifluoro acetamide 
(12). Thus (12) (0.15 g, 0.46 mmol) was dissolved in aqueous DMSO (7:3, v /v) 
(0.6 cm^ DMSO + 13.8 cm^ H2O + 0.2 cm^ HCl (IM)] at pH 2. The mixture was stirred 
overnight at 37°C. When HPLC showed complete disappearance of the starting material, 
the mixture was neutralized with IM NaOH (500 1^) and freeze dried. The residue was 
extracted into ethyl acetate (35 cm^), washed with water (20 cm^), dried (MgS0 4 ) and the 
solvent evaporated under reduced pressure. HPLC of this residue gave a single peak 
(Rf=17.75min). Yield 0.12g (89%); vmax (KBr disc) 3500 (br, OH), 3300 (NH), 1700 (C=0, 
amide), 1630, 1600, 1520, 1350, 1170, 820 cm" ;^ Ô^H ((CD3>2CO) 2.55 (>2H, br s, OH), 
3.62 (4H, t, J=1.3Hz, CHzh 3.75 (4H, t, J=1.3Hz, CHzX 6.98 - 7.59 (4H, ABq, J-2Hz, ArH), 10.5 
ppm (IH, br s, NH; m /z (FAB+) 293 (100%, MH+), 275 (10, MH+- H2O), 261 (18, MH+- 
CH3OH), 243 (10), 231(14, MH+- CH2=CH2), 217 (30), 196 (3, MH+-CF3CO), 186 (14); m /z 
(FAB-) 291 (100%, M-H+), 273 (4, M-H+-H2O), 259 (2), 247 (7, 291-C02), 230 (5), 215 (7).
5.3.21 N,N>Bis(2-hydroxyethyl)-4-amino-aniline (66)
The N,N-Bis(2-hydroxyethyl)-4-amino-aniline sulphate salt (2.0 g, 6.4 mmol) after 
recrystallisation from ethyl alcohol, was dissolved in ethyl alcohol (5 cm^) and shaken with 
one equivalent of aqueous NaOH (IM, 6.4 cm^) for lOmin. The reaction was followed by 
HPLC. On completion, the solution was freeze dried and extracted with ethyl acetate 
(15 cm^). The organic solution was washed with water (10 cm^), dried over anhyd. MgS0 4  
and the solvent evaporated under vacuum. The residue was impure and proved impossible to 
purify. Yield 0.43 g (34%); m.p. 85-95=C (lit.^F m.p. 87-88=C); vmax (KBr disc) 3400 (OH), 
3000 (NH), 1620, 1500, 1100 (OH), 620.cm-^; 6%  ((C0 3 )2S0 ) 3.2 (8H, d, CH2), 4.9 (IH, br s, 
NH or OH), 6.8-7.S ppm (4H, ABq, J=2Hz, ArH); m/ z (FAB+) 197 (14%, MH+).
5.3.22 4-(N*Benzyloxycarbonylaiiiino)beiizyl alcohol (85)
4-Aminobenzyl alcohol (80) (1.3 g, 1.1 mmol) was dissolved in ether (100 cm^) at room 
temperature. To this solution, water (35 cm^) and magnesium oxide (3.2 g, 79 mmol) was 
added. The nuxture was cooled to 0®C, and benzyl chloroformate (1.6 cm^, 11.2 mmol) in ether
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(15 cm^) was added dropwise and the reaction allowed to proceed at 0=C for Ih, and for a 
further 3h at room temperature. The reaction was followed by silica tic using ether as eluent 
(Rf= 0.69). The organic layer was separated, washed with water (30 cm^), dried over anhyd. 
MgS0 4 , and the ether removed using a rotary evaporater. The residue (2.3 g; 85%) was 
purified by silica column chromatography using ether, and further recrystallised from 
ether/n-hexane (5:1, v/v) to give a white solid. Yield 1.7 g (64%); m.p. 94-95°C; Vmax (KBr 
disc) 3300 (OH and RCONHR ), 1710 (C=0, carbamate), 1600, 1540, 1420, 1310, 1240, 1080, 
1010, 840, 780, 740 and 690 cm"^;. Ô^H (CDCI3) 2.1 (IH, br s, OH), 4.5 (2H, s, ArCHzOH), 5.2 
(2H, s, ArCHzOCO), 6.9 (IH, br s, NH), 7.3 (8H, m, ArH); m /z (El) 257 (48 %, M+ ), 213 (42, 
M+- - CO2), 149 (43, M+- - PhCH2 0 H), 108 (56, PhCH2 0 H+ ), 107 (60, PhCH=OH+), 91 (100, 
C7H7+), 79 (66), 77 (53), 65 (13), 51 (26).
5.3.23 4'-(N*-Benzyloxycarbonylainino)beiizyl A/-(4-nitrophenyl) carba­
mate (75)
Compound (85) (0.63 g, 2.4 mmol) was dissolved in dry ACN (80 cm^) and diy DCM (20 cm^). 
Then, 4^nitrôphenyl isocyanate (0.49 g, 2.6 mmol) was added, and the reaction allowed to 
proceed for 12h at room temperature. Subsequently, the temperature was increased to 40=C 
and the reaction allowed to continue for a further 3h. The reaction was monitored by silica 
tic, using ether/n-hexane (4:1, v/v) as eluent (Rf=0.6). The solvents were vacuum evaporated, 
the residue was added to water (15 cm^) and then extracted with ether (45 cm^). The ether 
extract was dried over anhyd. MgSC4 and the solvent vacuum evaporated. The impure 
residue (0.71 g, 69%) was purified by silica column chromatography using ether as eluent, and 
further recrystallised from pet. ether (40-60°C). Yield 0.21 g (20%); m.p. 159-160=C (Found: 
C, 62.0; H, 4,6; N, 9.6. C22H19N3O6 requires: C, 62.7; H, 4.5; N, 9.9%); vmax (KBr disc) 2950, 
2260,1730 (C=0, carbamate), 1670,1600,1510,1350, 850, 745 and 680 cm'l; Ô^H (CDCI3) 5.25 
and 5.30 (4H, ds, ArCH2), 7.30 (9H, m, ArH), 7.85 (4H, ABq, J=10.3Hz, ArH); m /z (FAB ) 420 
(37%, M-H+).
5.3.24 4*-(N'-Benzyloxycarbonylamino)benzyl N-(4-trifluoromethyl- 
phenyl) carbamate (76)
The protected amino alcohol (85) (0.3 g, 1.17 mmol) was dissolved in dry ACN (50 cm^) and 
dry DCM (30 cm^). To this solution, 4-trifluoromethylphenylisocyanate (183 jtl, 0.28 mmol) 
was added, and the reaction allowed to proceed at room temperature for 2h, then was warmed 
to 40°C for 16h. The reaction was monitored by silica tic using ether/n-hexane (2 :l,v/v) as
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eluent (Rf=0.6). On completion, the solvent was evaporated under reduced pressure to give a 
residue which was purified by silica column chromatography using ether/n-hexane (2 :1, v/v) 
as eluent. The pure fraction after evaporation of the solvent gave a solid white residue (0.22 
g, 43%); m.p. 167-170.5=C; v^ax (KBr disc) 3350, 1720 (C=0, carbamate), 1610, 1540, 1420, 
1340,1420,1340,1240,1170,1120,1080, 840, 740 cm'h  (CDCI3 + (CD3)2CO)) 5.1 and 5.15 
(4H, ds, CH2), 7.2-7.7 (13H, m, ArH), 8.6 (IH, br s, NH), 8.9 (IH, br s, NH); m /z (El) 444 
(0.1%, M+), 400 (0.3, M+-CO2), 336 (0.1, M+- PhCH2 0 H), 257 (4, M+ for (85)), 187 (28, M+ for 
0 =C=NC6H4CF3 ), 132 (54), 91 (100, C7H7+).
5.3.25 4-(N‘-Triphenylmethylamino)benzyl alcohol (91)
Following a general procedure,^^^ 4-aminobenzyl alcohol (80) (0.8 g, 6.5 mmol), was dissolved 
in dry DCM (120 cm^), and triethylamine (0.9 cm^, 6.5 mmol) plus triphenylmethyl chloride 
(1.81 g, 6.5 mmol) was added. The mixture was stirred at 35=C, under N2, for 4h, and then 
washed with water (35 cm^), dried over anhyd. MgSO^, and evaporated at reduced pressure, 
to give an impure residue as a foam (2.36 g, 99.5%). The reaction was followed by silica tic 
using ether/n-hexane (2:1, v/v) as eluent (Rf=0.38). The residue was purified by silica 
column chromatography using ether/n-hexane (2 :1,v /v ) as eluent, followed by 
recrystallisation from DCM/n-hexane (3:1, v/v), to give a white solid. Yield 1.8 g (77%); 
m.p. 188-190=C (Found: C, 83.9; H, 6.3; N, 3.7. C26H23NO requires: C, 85.5; H, 6.3; N, 3.8%); 
Vmax (KBr disc) 3620 (OH), 3440 (NH), 1620,1500, 1450, 1330 (COH), 1010,1040 (COH), 840, 
760, 710 cm-h 5^H ((CD3)2SO) 3.4 (IH, s, NH), 4.2 (2H, d, CH2I  4.75 (IH, t, OH ), 6.55 (4H, 
ABq, J=8.7Hz, ArH), 7.25 (15H, m, Ph); m /z (El) 365 (2%, M+-), 347 (0.2, M+-H2O), 334 (0.3, 
M+-CH2OH), 288 (2, M+' - CeHg , Ph2 CN+HPhCH2 0 H ), 243 (100, Ph3 C+), 165 (48, 
PhCyHô).
5.3.26 4'-(N'-Triphenylmethylamino)benzyl N-(4-nitrophenyl) carbama­
te (77)
The protected alcohol (91) (0.46 g, 1.26 mmol) was dissolved in dry THF (60 cm^). The 
mixture was cooled to 0°C and n-butylithium (0.8 cm^, 1.3 mmol, 1.1 eq, 1.6M solution in 
hexane) was added dropwise and the reaction allowed to proceed for 15min under nitrogen. 
Then, 4-nitrophenylisocyanate was added at 0°C in four portions (0.23 g, 1.39 mmol, 1.1 eq) at 
intervals of 2h, after which the reaction was allowed to proceed at room temperature, under 
nitrogen, for a further Ih. The reaction was followed by silica tic, using ether/n-hexane (2:1, 
v /v) as eluent (Rf (77) =0.61, Rf (91) =0.37). On completion, the solvent was evaporated under
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reduced pressure, and the residue extracted into DCM (60 cm^). The DCM solution was 
washed with sat. aqueous ammonium chloride (pH 7; 30 cm^), water (30 cm^), dried over 
anhyd. MgSO^, and the solvent evaporated under reduced pressure. The residue was purified 
by a silica flash chromatography using ether as eluent, followed by a silica column 
chromatography using ether/n-hexane (2:1, v/v) as eluent. The fractions containing the 
product were combined and the solvent evaporated under reduced pressure to give a yellow 
residue. Yield 0.5 g (76%); m.p. 79-88°C (Found: C, 76.7; H, 5.7; N, 6.9. C33H2 7N3O4 
requires: C, 74.8; H, 5.1; N, 7.9%); vmax (KBr disc) 3400 (NH), 1730 (C=0, carbamate), 1600, 
1500, cm-1; Ô^H (CDCI3) 4.4 (2H, s, CH2 ), 5.1 (IH, s, NH), 6.35-6.9 (4H, ABq, J=2.0Hz, ArH), 
6.6-8.1 (4H, ABq, J=2.2Hz, ArH), 7.3 (17H, m, ArH); m /z (FAB+) 485 (0.1%, M+-CO2 ), 243 
(100, Ph3 C+); m /z  (El) 485 (0.1%, M +-CO2 ), 364 (10, Ph3 C+ NHPhCHOH), 347 
(52, Ph3CN+ PhCH2), 334 (8, PhaCNCaHs+l, 243 (100, Ph3 C+), 165 (65).
5.3.27 4-(N-t£f‘t-Butoxycarbonylamino)benzyl alcohol (93)
Following a literature p r o c e d u r e , ^ ^4 ^  mixture of 4-aminobenzyl alcohol (0.41 g, 3.3 mmol) 
and di-t-butyl dicarbonate (896 nl, 3.9 mmol), in diy THF (25 cm^), was stirred at 25®C, for 
17h. The reaction was monitorated by silica tic using ether as eluent (Rf(80)=0.44, 
Rf(93)=0.81). The solvent was evaporated under reduced pressure and the yellow-brown oily 
residue dissolved in ether (10 cm^), washed with 5% aqu. sodium bicarbonate (2 x 10 cm^) and 
dried over anhyd. MgSO^. The yellow-brown solid residue after vacuum removal of the 
solvent was chromatographed on a silica column with elution by ether. The fractions 
containing the product were combined, the solvent evaporated under reduced pressure and the 
residue vacuum dried. Yield 0.55 g (75%); m.p. 79-81 °C (Found: C, 64.59; H, 7.72; N, 6.22. 
C12H 17NO3 requires: C, 66.55; H, 7.67; N, 6.27%); vmax (KBr disc) 3480 (OH), 3380 (NH), 
1700 (C=0, carbamate), 1610, 1530, 1420, 1370, 1320, 1240, 1160, 1000, 830 and 770 cm'^; 
ôlH (CDCI3) 1.48 (9H, s, C(CH3)3), 3.77 (IH, s, OH or NH), 4.47 (2H, s, CH2), 7.12-7.27 
(4H, m, ABq, J=2.2 Hz, ArH), 7.29 (IH, s, NH or OH); m /z (El) 223 (18%, M+), 167 (75, M+ - 
C(CH3)3+), 138 (29), 132 (21), 123 (35, + NH2PhCH20H), 122 (33, H2N+ PhCHOH), 106 (16, 
H2N+PhCH2), 94 (18, CeHeO+O, 77 (16), 57 (100, C(CH3)3+), 41 (37).
5.3.28 4*-(A/*-tcrt-Butoxycarbonylamino)benzyl N-(4-nitro-phenyl) carba­
mate (78)
Compound (93) (0.7 g, 3.1 mmol) in dry THF (80 cm^) was cooled in an ice bath and 
n butyllithium (2.15 cm^, 3.4 mmol), was added dropwise. After 15 min, 4-nitrophenyl-
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isocyanate (0.56 g, 3.4 mmol), dissolved in THF (5 cm^), was added in 3 fractions, with the 
temperature mantained at 0°C After these additions, the mixture was stirred for 14h at 
room temperature. When silica tic using ether/n-hexane (2:1, v/v) as eluent (Rf(93)=0.34, 
Rf(78)=0.63) indicated complete disappearance of the starting material, the solvent was 
vacuum evaporated to give a yellow residue. This residue was taken up in ether (30 cm^), 
washed with satd. aqu. ammonium chloride (15 cm^), then water (15 cm^). After separation, 
the organic solvent was evaporated under vacuum to give a residue, which was dissolved in 
ether and purified by silica column chromatography using ether/n-hexane (2 :1, v/v) as 
eluent. The fractions containing the compound were combined, the solvent vacuum 
evaporated, and the resultant yellow solid residue recrystallised twice from ether/n-hexane 
(1:1, v/v). Yield 0.77 g (64%); m.p. 158-161 °C (Found: C, 58.5; H,5.4; N, 10.6. C19H21N3O6 
requires: C, 58.9; H, 3.5; N, 10.8 %); \  max (DMSO) 242, 319; Vmax (KBr disc) 1760 and 1715 
(C=0, carbamate), 1620, 1540,1360, 1230 cm'^- Ô^H (CDCI3) 1.52 (9H, s, C(CH3)3), 5.15 (2H, 
s, CH2), 6.55 (IH, s, NH), 7.17 (IH, s, NH), 7.32-7.38 and 7.32-8.19 ppm (8H, 2 ABq, f=2.0 Hz, 
ArH); m /z (El) 387 (0 .2%, M+ ), 343 (0.4, M+-CO2 ), 331 (0.4, M+-C(CH3 )3 ), 224 (2, 
(C H 3 )3 0 C 0 N H C 6 H 4 C H 2 0 H 2 + ), 182 (2, C (0)0H N H C 6H 4 N O 2 ), 167 (8 , 
COOHNHC6H4CH2OH), 150 (27), 138 (36, H2NC6H4NO2), 132 (20), 122 (6, C6H5NO2), 
106 (34), 92 (19), 65 (46), 57 (100, (CH3)3C+), 44 (50, CQz).
5.3.29 4-(N-Acetylamino)benzyl methyl ester (95)
4-AminobenzyI alcohol (0.52 g, 4,1 mmol) in dry pyridine (15 cm^) was reacted with acetic 
anhydride (3 cm^, 32 mmol) at room temperature, with vigorous stiring, for 12h, and for a 
further Ih, at 40=C. The reaction was followed by silica tic, using ether as eluent (Rf=0.2), 
and when all the starting material had disappeared, the pyridine was removed at reduced 
pressure and low temperature. The residue was dissolved in DCM (35 cm^) washed with 
water (15 cm^) and then dried over anhyd. MgS0 4 . After removing the solvent under reduced 
pressure, a white solid was obtained. Yield 0.79 g (93%); m.p. 101-103°C (lit.^^^ m.p. 102°C) 
(Found: C, 63.5; H, 6.3; N, 6.7. C11H 13NO3 requires: C, 63.7; H, 6.3; N, 6.7%); vmax (KBr 
disc) 3300, 1760 (C=0, ester), 1680 (C=0, amide), 1620, 1560, 1420, 1380, 1330, 1250, 1020, 980, 
840, 980 cm-1; Ô^H ((CD3)2CO) 2.02 (3H, s, OCOCH3), 2.07 (3H, s, NHCOCH3), 5.01 (2H, s, 
PhCH20C0), 7.51 (4H, ABq, J=11.0Hz, ArH), 9.21 (IH, br s, NH); m /z (El) 207 (18%, M+ ), 
165 (16, M+-CH2=C=0, H2N+ C6H4CH20C(0)CH3), 123 (42, + NH2PhCH20H), 106 (100, 
H2N+PhCH2), 94 (34, C5H4CHO+ H), 77 (31), 65 (10), 57 (9), 43 (35, CH3CO+).
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5.3.30 4-(N-Acetylamino)benzyl alcohol (96)
4-N~(Acetylamino)benzyJ methyl ester (95) (0.69 g, 3.3 mmol), was dissolved in ethanol 
(7 cm^), water (20 cm^), and NaOH (IM, 4.5 cm^). The mixture was stirred at 40°C, for 6h, to 
effect disappearance of the starting material (followed by HPLC). The solution was then 
neutralized to pH 7 with CO2 , concentrated to 5 cm^, and extracted into ethyl acetate 
(35 cm^). The organic extract was washed with satd. aqueous sodium bicarbonate (25 cm^), 
water (15 cm^), and dried over anhyd. MgSO^ . The solvent was then evaporated under 
reduced pressure to give a white solid. Yield 0.42 g (76%); m.p. 115-117.5=C (lit.^^^ 
m.p. 120-1=0; Vmax (KBr disc) 3450 (OH), 1680 (C=0, amide), 1620, 1560, 1520, 1420, 1380, 
1330,1280,1010, 840, 800, 580 cm ;^ Ô^H ((CD3)2CO) 2,1 (3H, s, COCH3), 4.2 (IH, t, J=7.0Hz, 
OH), 4.6 (2H, d, J=7Hz, ArCH2 0 H), 7.2-7.7 (4H, ABq, J=11.0Hz, ArH), 9.1 (IH, br s, NH); 
m /z (El) 165 (77%, M+ ), 123 (100, M+- CH2=C=0 ), 106 (99, +NH2PhCH2), 94 (76, CaHeO+O, 
77 (38, C6H5+), 43 (95, CH3CO+).
5.3.31 4 -(N -Acetylamino)benzyl N-(4-nitrophenyl) carbamate (26)
4-(N-Acety lamino)benzy 1 alcohol (96) (0.24 g, 1.5 mmol) was dissolved in ACN (15 cm^) and 
DCM (10 cm^), and 4-nitrophenylisocyanate (0.3 g, 1.8 mmol) was added. The reaction was 
allowed to proceed for 4h at room temperature, and another 5h, at 40=C. Loss of the starting 
material was followed by silica tic, using ethyl acetate as eluent (Rf (26) =0.81, Rf (96)=0.28). 
The solvents were removed under vacuum to give a yellow solid, which was purified by silica 
column chromatography using DCM as eluent. Yield 0.34 g (69%); m.p. 200-201=C (Found: 
C, 57.3; H, 4.4; N, 13.2. C16H 15N3O5 requires: C, 58.4; H, 4.6; N, 12.8%); vmax (KBr disc) 
3344 (NH), 1722 (C=0, carbamate), 1700 (C=0, amide), 1600,1534,1412,1222,1052, 850 cm'l; 
Ô^H (EtOD+ (CD3)2S0 ) 2.09 (3H, s, COCH3), 4.40 (2H, s, NH), 5.16 (2H, s, CH2OCO), 
7.32-8.24 (4H, ABq, J=9.0 Hz, ArH), 7.61-8.24 ppm (4H, ABq, J=9.0 Hz, ArH); m /z (FAB") 328 
(79%, M-H+), 259 (13), 213 (28), 137 (60, NHPhNC^“), 103 (28), 91 (18).
5.3.32 4 -Aminobenzyl N-(4-nitrophenyl) carbamate, picrate salt (94)
To compound (78) (0.3 g, 0.79 nunol) in THF (6 cm^) at room temperature, was added dropwise 
2-mercaptoethane sulphonic acid in glacial acetic acid (4 cm^, 20% w/v, 5.6 mmol) [Prepared 
by passing the sodium salt of 2-mercaptoethanesulphonic acid (0.64 g, 3.8 mol) dissolved in 
water (5 cm^) through a Dowex 50H''' ion exchange resin followed by lyophilisation of the
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solution to give the dry add (0.54 g, 3.8 mol), which was then dissolved in gladal acetic acid 
(2.7 cm^)]. After Ih with stirring at room temperature, silica tic using ether eluent showed 
complete disappearance of the starting material. An aqueous solution of picric acid (20 cm^, 
l%,w/w, 0.9 mmol) was then added and the solution cooled to 0-5=C. After a few min, an 
orange precipitate formed and the solution was left at 0-5°C overnight. The predpitate was 
filtered, washed with ice-water (0-5°C) and dried. Yield 0.34 g (84%); m.p. 120-122=C 
(Found: C, 46.5; H, 3.2; N, 15.8. C2 0 H 1 6 N 6 O 11 requires: C, 46.5; H, 3.1; N, 16.3%); 
Vmax (KBr disc) 1760 (C=0, carbamate), 1640, 1580, 1520, 1350, 1240, 1080 cm 'l; 
Ô^H (CD3)2S0 ) 5.26 (2H, s, ArCHzOCO), 6.62 - 7.45 (4H, ABq, J=2Hz, ArH), 7.43 (>2H, m, 
NH), 7.71 - 8.22 (4H, ABq, J=2Hz, ArH), 8.63 ppm (2H, s, ArH), 10.08 (IH, br s, NH); 
m /z (FAB+) 289 (1%, NO2C6H4NHCOOCH2C6H4NH3+), 123 (39, + NH2PhCH2 0 H), 105 
(100); m /z (FAB-) 243 (40), 228 (62, (NO2) 3C6H2O ), 212 (22), 199 (49), 121 (60), 77 (100), 59 
(10, CH3COO-).
5.3.33 4*-Aminobeiizyl N-(4-nitrophenyl) carbamate (74)
The picrate (94) (0.13 g, 0.25 mmol) in aqu. ethanolamine (15 cm^, 10%, w/w), was stirred for 
lOmin at room temperature, and then extracted into ether (45 cm^). Completion of the 
reaction was monitored by silica tic using ether/n-hexane (2:1, v/v) (Rf(74)=0.15). The ether 
extract was washed with water (30 cm^) and dried over anhyd. MgSO^. The solvent was 
vacuum evaporated and the residue purified by silica column chromatography using ether as 
eluent. The fractions containing the compound were combined, the solvent vacuum 
evaporated to give a solid yellow residue. Yield 0.04 g (55%); m.p. 110-140=C (decomp.); 
Vmax (KBr disc) 3400 (NH), 1760 (C=0, carbamate), 1630, 1610, 1520, 1340, 1230 cm“l; 
Ô^H (CDCI3 + (CT>3)2S0 ) 3.26 (>2H, s, NH), 4.47 (IH, s, NH), 5.04 (2H, s, CHzl 6.65 - 7.17 
(4H, ABq, 1=2.1 Hz, ArH), 7.70-8.11 (4H, ABq, 1=2.3 Hz, ArH), 10.10 (IH, br s, NH); 
m /z (FAB ) 286 (11%, M-H+), 259 (12), 225 (5, M+- (NH2+NO2», 213 (10, + NHPhCH2 0 H), 
197 (12, M+- (CO2+NO2)), 181 (15), 167 (18), 155 (19), 137 (38, NHPhNp2 ), 91 (8 ), 46 (3); 
(FAB+) 273 (7), 200 (6), 145 (10).
5.3.34 4-Nitrobenzyl N-phenyl carbamate (104)
Phenylisocyanate (0.78 cm^, 7.1 nunoi ) in ACN (5 cm^) added dropwise to 4-nitrobenzyI 
alcohol (105) (0.91 g, 5.9 mmol) in ACN (20 cm% was allowed to react at room temperature, 
for 48h. The reaction was followed by silica tic using ether/n-hexane (1:1, v/v) as eluent 
(Rf= 0.54). The solvent was vacuum evaporated and the residue after washing with water
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(15 cm^) was extracted into DCM (35 cm^). The product was purified by silica flash 
chromatography using ether/n-hexane (1:1,v/v) as eluent, followed by silica column 
chromatography using the same eluent. Yield 1.14 g (71%); m.p. 146-148°C; (Found: C, 62.1; 
H, 4.5; N, 10.2. C14H12N2O4 requires: C, 61.8; H, 4.5; N, 10.3%); vmax (KBr disc) 3300 
(NH), 1740 (C=0, carbamate), 1640, 1560, 1460, 1380, 1360, 1320, 1280, 1240, 740, 700 cm“^ ; 
Ô I h  (CDCI3) 5.2 (2H, s, CH2), 6.8 (IH, br s, NH), 7.3 (5H, m, ArH), 7.5-8.2 (4H, ABq, 
J=8 .8Hz, ArH); m /z (El) 272 (60%, M+), 255 (8, M+ - OH), 228 (15, M+ - CO2 ), 153 
(13, 4-nitrobenzyl alcohol^ ), 136 (100, ONC^H^CHO^ H - OH), 119 (90, phenylisocyanate^ ), 
106 (84, H2N+=C6H4=CH2), 89 (59), 78 (74), 64 (36), 51 (37), 30 (45, NO+ or CH2=0 + ).
5.3.35 Benzyl N-(4-methylphenyl) carbamate (112)
4-Toluidine (0.71 g, 6.6 mmol) in ether (100 cm^) and water (50 cm^) was mixed with MgO 
(2.5 g, 62.0 mmol). The solution was cooled to 0°C, and benzy Ichlorof orm a te (1.1 cm^,
7.9 mmol) added dropwise, with vigorous stirring. After 90min, silica tic using ether/ 
n-hexane (2:1, v/ v) show complete disappearance of the starting material. The organic layer 
was separated, washed with water (35 cm^), dried over anhyd. MgSO^, and the solvent 
vacuum evaporated. The residue was purified by silica column chromatography using DCM 
as eluent. Yield 1.4 g (89%); m.p. 78-79=C; vmax (KBr disc) 3316, 1725 (C=0, carbamate), 
1620,1560, 1250, 1080 cm‘l; Ô^H (CDCI3) 2.2 (3H, s, CH3), 5.1 (2H, s, CH2 ), 6.8-7.4 (4H, ABq, 
1=9.2 Hz, ArH), 7.3 ppm (5H, m, Ph); m /z (FAB+) 242 (2%, MH+), 108 (15); m /z (FAB") 240 
(5%, M-H+).
5.3.36 Ethyl N-(4-nitrophenyl) carbamate (113)
4-Nitrophenylisocyanate (0.5 g, 3 mmol) and ethanol (100 cm^) were stirred at 40°C for Ih. 
The reaction was followed by silica tic using DCM as eluent. The excess alcohol was 
evaporated under vacuum to give a solid residue. Yield 0.6 g, (98%). The residue was 
purified by flash chromatography using DCM. Yield 0.41 g, (67%); m.p. 134-135=C (Found: 
C, 51.6; H, 4.8; N, 13.2. C9HXON2O4 requires: C, 51.4; H, 4.8; N, 13.3%); vmax (KBr disc) 
3394, 1743 (C=0, carbamate), 1605, 1540,1500, 1330,1210,1060 cm" ;^ Ô^H (CDCI3) 1.3 (3H, t, 
CH3), 4.2 (2H, q, CH2), 7.3 (IH, br s, NH), 7.5-8.3 ppm (4 H, ABq, J=9.0Hz, ArH); m /z (El) 
210 (87%, M+), 165 (11, M+ - NO2 or C2H5OH), 151 (63), 138 (38), 108 (68), 105 (25), 92 (30), 29 
(100, C2H5+).
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5.4 Reaction methods
5.4.1 Kinetics of mustard (5) and (38) - (41) hydrolysis followed by 
autotitration
This method was used to follow the hydrolysis of simple mustards (5), (38), (39), (40), (41).
Usually, a solution of the substrate mustard in DMSO (100 pi, 8x10"  ^M) was injected 
into aqueous DMSO [either 99:1, 9:1, or 7:3 (v/v), depending on the substrate] (25 cm^) 
contained in a thermostatted reaction vessel of the auto-titrator at 37=C. Two electrodes 
(calomel and glass) were immersed in the solution. The initial pH of the solution was 
adjusted to pH 7.0 or 9.0 with standardised NaOH (5 mM) which was also used to titrate the 
acid released. The concentration of the substrate mustard in the reaction solution was ca. 
3.2x10"  ^M. With the solution vigorously stirred and under a continuous flow of nitrogen, the 
reaction was followed by autotitration of the acid released by hydrolysis of the mustard 
with the standardised 5 mM NaOH. The volume of NaOH added was monitored and plotted 
by the autotitrator as a function of time {Figure 5.1). Readings were continued until no further 
addition was apparent, when completion of the reaction was assumed ( t o o ) .
Values of kg {Rate = kg [substrate]} were calculated from plots of log ( v o o  - vt) versus 
time, where vt and voo = vol. of 5mM NaOH added at time = t and infinity, respectively.
5.4.2 Kinetics of mustard (10) - (12) hydrolysis by UV-visible spectro­
photometry
The hydrolysis of substrates (10), (11) and (12) in aqueous DMSO (99:1, v/v) at pH 2 and 12 
and in phosphate buffer/DMSO (1%, v/v) at pH 7.4, all at 37=C were also followed by 
UV-visible spectrophotometry.
Usually, a solution of the substrate mustard in DMSO (30 pi, 1.2xlO'^M) was injected 
into an aqueous solution at pH 2, or 12 (adjusted with either HCl (IM) or NaOH (IM)) to give 
a final aqueous DMSO solution (99:1, v/v), (3 cm^), contained in a cuvette thermostatted at 
37°C. This gave a substrate concentration of ca. 1x10"  ^M.
The UV-visible spectrum of the cell contents was monitored from 200-400 nm at 15 or 
30 min timed intervals, depending on the reaction rate.
A similar procedure was followed for reactions in phosphate buffer (0.05M)/DMSO 
(99:1, v/ v; pH 7.4) and in aqueous DMSO (9:1, v/v; pH 2) containing either NaCl (0.5M) or
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Figure 5.1 Hydrolj/sis of mustard (5) in aqueous .DMSO (7:3, v/v) at pH 9 and 37°C
followed by autotitration of HCl released; I5)init. ca. 3.2x7 0~^M
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NaC104 (0.5M). For these substrate in DMSO (10 pi, 1.5xl0"^M) was injected into the solution 
given a final concentration of 5xlO"^M.
Reactions were^  followed for 10 half-lives and kg (rate = kg [substrate]) was calculated 
from reaction half-lives (t%/2).
Table 5.1 shows the X^ iax and extinction coefficients of the substrate mustards and the 
hydrolysis products identified at different pH.
Table 5.1
kffiax of mustards and hydrolysis products in aqueous DMSO (l%,v/v) at different pH
Compoimd pH_ q 2
^ a x  / ® 
7 12 >12
N-14-lN>N’-Bis(2-chloroethyl)amino] 
phenyl]acetamide (11)
257 270 270/
4.11
[N-[4-[N',Ar-Bis(2-chloroethyl)amino] 246/ 
phenyl]trifluoroacetamide (12) 4.05
285/
4.08
286 279/
4.00
N,N-Bis(2-chloroethyl)-4-amino-aniline 258 
hydrochloride (54)
258/
4.18
258 254/
4.00
254
N-[4-|N',N’-Bis(2-hydroxy)ethyl]amino] 
phenyl]acetamide (59)
245/ 
. 3.74
271 271/
3.79
4-morphoiinophenylacetamide (60) 244/
4.14
258 258/
4.10
4-MorphoIinoaniline (61) 246 246 220
N-[4-[N',Ar-Bis(2-hydroxyethyl)amino] 
phenyI]trifluoroacetamide (65)
248,
290
N,N-Bis(2-hydroxyethyl)-4-amino-aniline (66) 260/
3.65
258 253/
4.08
253
Half-hydrolysed mustard (67) 278
Half-hydrolysed mustard (68) 297
Half-hydrolysed mustard (69) 260
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5.4.3 Kinetics of mustard (5), (10) - (12), (40), (41) and (58) hydrolysis and
analysis of products followed by HPLC
5.4.3.1 Analysis of hydrolysis products of mustard (10) and kinetics of mustard (11)
hydrolysis in aqueous DMSO
JV,N-Bis(2-thiocyanatoethyl)aniline (40) or JV,N-bis(2-nitratoethyl)aniline (41) in DMSO 
(100 pi, SxlO'^M) were injected into aqueous DMSO (7:3, v/v) (25 cm^) [3.2xlO“^ M]. The 
solution was adjusted to pH 9.0 with 5mM NaOH using the autotitrator (see Section 5.4.1). 
The solution was thermostatted at 37®C and kept under vigorous stirring and constant pH 9.0 
by the autotitrator.
For (40), an aliquot (10 pi) of the reaction mixture was taken after 72 h and for (41), 
aliquots (10 pi) of the reaction mixture were taken at regular intervals, over 97 h, and 
analysed by HPLC against authentic N,N-bis(2-hydroxyethyl)aniline (37), 4-phenyl- 
morpholine (45) and starting material either (40) or (41).
Two different HPLC conditions were used for the assays: Condition A for the 
hydrolysis products of (40) and Condition B for the hydrolysis products and monitoring of 
(41). The retention times for authentic (37), (40), (41) and (45) are summarised in Table 5.2, 
together with the HPLC conditions.
Table 5.2
HPLC conditions, retention times, and kmax authentic materials used in the product
analysis of mustards (40) and (41)
Condition A) Column: Cjb-APEX II OCTYL 5p; 25cm x 4.6mm i d. 
Temperature: 25=C
Eluent: Isocratic- aqueous O.OIM KH2PO4  / ACN (5:4.5, v/v) 
Flow rate: 1 cm^/min 
Detection: UV 263 nm 
Injection: 10 pi
Condition B) Column: C^-APEX II OCTYL 5p; 25cm x 4.6mm i.d. 
Temperature: 30°C
Eluent: Two component gradient using Solution Bl- aqueous. 
O.OIM KH2PO4 / ACN (6:4, v/v) and 
Solution B2- aqueous O.OIM KH2PO4 /ACN (3:7, v/v) 
Gradient program: 100% Bl to 100% B2 in lOmin 
Flow rate : 1 cm^/min
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Detection: UV 263 nm 
Injection : 10 pi
Compound
Retention time (min) 
/ HPLC condition
^ax**' 
HPLC eluent
A/,N“Bis(2“hydroxyethy!)aniline (37) 3.63(A); 3.78 (B) 258
N,N-Bis(2“thiocyanatoethyl)aniline (40) 1479(A) 249
N,N-Bis(2-nitratoethyl)aniline (41) 10.65(B) 260
4-Phenylmorpho!ine (45) 6.76(A); 7.21 (B) 260
DMSO 2.73(A); 2.45(B) cut off 250
S.4.3.2 HPLC conditions for analysis of hydrolysis products from mustards (5), (10) - (12) 
and (58)
The identity and quantity of hydrolysis products from the mustard substrate were usually 
determined by reverse-phase HPLC using the conditions and gradient program m es 
summarised in Table 5.3. This table also lists the retention times for several authentic 
mustards (5), (10), (11), (12) and (58), possible hydrolyse products (37), (45), (59), (60), (61), 
(62), (64), (65), (66), (86), (115) and (116), and some intermediate (half hydrolysed) mustards . 
(67), (68), (69) and (117).
Figure 5.2 shows typical HPLC chromatograms for the hydrolysis of mustards (10) 
(11) and (12) in aqueous phosphate buffer/DMSO (3%,v/v) at pH 7.4 and 37°C at t=0 min (a), 
after 30 min (b) and after 80 min (c) of reaction, run under the conditions described in Table 5.3.
Table 5.3
HPLC conditions and retention times for authentic materials used in product analysis of the
mustards (5), (10), (11), (12) and (58)
Column: Cg-APEX H OCTYL 5p; 25 cm x 4.6 mm i.d.
Temperature: 30®C 
Flow rate: 1 cm^/min 
Detection: UV 249 nm 
Injection : 20 pi
Eluent: Two component gradient system using Solution A: aqueous. 
KH2PO4 buffer (0.05M, pH 2.6) with 1%ACN* and
145
Solution B: aqueous KH2PO4  buffer (0.05M, pH 2.6) with 
. 60% ACN*
Gradient program: Programme 1 and 2 as shown:
Programme 1 (Pj) Programme 2 (P2)
Time (min) %A %B Time (min) % A %B
0 95 5 0 90 10
5 95 5 3.5 0 100
20 10 90
24 0 100
* Solution A prepared from KH2PO4  (IM, 50cm^) + ACN (lOcm^) + H3PO4 (lon^) 
diluted with H2O to 11
^Solution B prepared from KH2PO4 (IM, 50cm^) + ACN (600cm^) + H3PO4 (Icm^) 
diluted with H2O to 11
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Table 5.3 (continued)
Retention time (Rf) ^max fo
Gonyound (min)/ (Pi or ?%) HPLC eluent
N,N-Bis(2-chloroelhyl)aniline (5) 20.47(P^ 256
N,N-Bis(2-chloroethyl)-4-amino-aniline (10) 20.61(Pi) 258
N-l4-[N',N’-Bis(2-chloroethyl)aminophenyI]acetamide (11) 24.77(Pi) 10.63(P2) 276
N-[4-[N',N‘-Bis(2-chIoroethyl)aminolphenyll 
trifluoroacetamide (12)
29.80(Pi) 290
N-l4-[BisN',Ar-(2-acetyloxy)ethyl]aminol 
phenyl] acetamide (58)
19.91(Pi) 276
JV-l4-lN',iV’-Bis(2“hydroxyethyi)aminoJ 
phenyl] acetamide (59)
8.63(Pi) 249
N,N-Bis(2-hydroxyethyl)aniline (37) 4.92(P2) 258
A/,N-Bis(2-hydroxyethyl)-4-amino-aniline (66) 4.20(Pi) 258
4-Morpholinoaniline (61) 12.18(Pi) 246
4-AcetamidophenoI (62) 11.06(Pi) 246
4-Phenylmorpholine (45) 19.69(Pi) 242
4-Morpholinophenylacetamide (60) 15.16(Pj) 254
A/-l4-[H',AT-Bis(2-hydr6xyethyI)amino] 
phenyl] trifluoroacetamide (65) 17.75(Pi) 290, 248
4-Aminophenol (64) 12.49(Pi) 249,270
4-Phenylenediamine (86) 2.74(Pi ) 239
Acetanilide (115) 16.95(Pi) 244
Morpholine (116) 16.87(Pi)
DMSO 2.95(Pi) 2.98(P2) cut off 250
N-[4-[N-(2-Acetyloxyethyl)-N'-(2-hydroxy-ethyI) 
aminophenyl] acetamide (70) 15.16(Pi) 276
N-l4-|N'-(2-Chloroethyl)-A/'-(2-hydroxyethyl) aminophenyl] 
acetamide (67) 17.87(Pi) 278
N-[4-[N'-(2-Chloroethyl)-N'-(2-hydroxyethyl) 
aminophenyl [trifluoroacetamide (68) 23.61(Pi) 297
N-(2-Chloroethyl)-N-(2-hyroxyethyl)aniline (117) 1021(P2) 263 .
N-(2-Chloroethyl)-N-(2-hyroxyethyl)-4-amino-aniline (69) 14.64(Pi)
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Figtire 5.2 HPLC chromatograms of mustards (10), (11) and (12) hydrolyses in aqueous 
phosphate buffer/DMSO (3fo,v/v) at pH 7.4 and 37°C: 
a)t=Omin b) t=30min c) t=80min
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5.4.3.2.1 Calibration curves for standards
To quantify the reaction products from the hydrolysis of mustards (5), (10), (11) and (12), 
calibration curves were generated for the substrates (11) and (12) cuid .major final products 
((59), (60) and (65)).
Generally, standard solutions of the relevant compound in H2O/DMSO (7:3,v/v) 
obtained by dilution of a gravimetrically prepared stock solution, were assayed and 
quantitated by either peak area or peak height. The HPLC conditions used are those 
described in Table 5.3. All the calibration curves were linear and similar to the one shown in 
Figures 5.3 for compound (60). The linear coefficients are summarised in Table 5.4.
I
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Figure 5.3 HPLC calibration curve for authentic (60)
Table 5.4
Coefficients for HPLC calibration curves for authentic (11), (12), (59), (60) and (65); 
A=249 nm, eluent: aqueous KH2PO4 buffer (pH 2.6)
Gonyound 10  ^X Linear coefficient
N-[4-[A/',N'-Bis(2-chloroethyl)aminophenyll 
acetamide (11)
N-[4-( N^ AT-BisCZ-chl oroethyOaminoJpheny 1] 
trifluoroacetamide (12)
N-[4-(N',N’-Bis(2-hydroxyethyl)amino]phenyl] 
acetamide (59)
4-Morpholinophenylacetamide (60)
N-[4-lN',N’-Bis(2-hydroxyethyl)amino]phenyl] 
trifluoroacetamide (65)
2.81
1.21
3.78
9.25
3.91
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5.4.3.3 Hydrolysis of mustards (5), (10) - (12) and (58) in aqueous phosphate buffer/ 
/DMSO (3%, v/v) at pH 7.4 and 37°C
Generally, 150 pi of mustard {ca. SxlO'^M) in DMSO was injected into a reaction vessel 
containing aqueous phosphate buffer (IxlO'^M) at pH 7.4 and DMSO to give a final 
concentration of 3% (v/v) and a total volume of 30 cm^. The concentration of each mustard 
was ca. 1.5x10"  ^M. The reaction vessel was in a thermostatted bath at 37®C and the solution 
was stirred continuously. Aliquots (20pl) of the reaction solution were analysed by HPLC 
under the conditions summarized in Table 5.3. The elution gradient for the assay of mustard 
(5) (programme 2), was different from that for (10), (11), (12) and (58) (programme 1) so, 
mustard (5) was hydrolysed in a separate experiment simultaneously with mustard (11), 
which acted as a control. The disappearance of the substrate mustard was followed because 
several labile intermediates which reacted further, were evident. For all the mustards both 
the starting materials and reaction products were assayed.
5.4.3 4 Hydrolysis of mustards (10) - (12 ) and (58) in aqueous DMSO (7:3, v/v) at pH 2,1 2
or 13 and 37°C or 50°C
Similar to the procedure described above, 50 pi of the mustard {ca. 9x10"  ^M) in DMSO, was 
injected into a reaction vessel containing aqueous DMSO (7:3, v/v) at pH 2,12, or 13, adjusted 
by addition of either HCl (IM) or NaOH (IM) (30 cm^). The final concentration of the 
mustard was ca. 1.5x10"  ^M. The reaction vessel was in a thermostatted bath at 37®C (or 50°C 
for mustard (58))and the reaction solution was stirred continuously. Aliquots (20pi) of the 
reaction mixture were analysed by HPLC under the conditions outlined in Table 5.3. Both the 
disappearance of substrates and the formation of products was assayed and identified major 
products were quantified from calibration curves generated with authentic compounds.
5.4.4 Kinetics of mustard (5) and (10) - (12) hydrolysis in aqueous 
phosphate buffer followed by ion exchange chromatography
The same general procedure to that described in Section S.4.3.3 was followed. Thus, 150 pi of 
each mustard {ca. 3x10"  ^M) in DMSO was injected into a reaction vessel containing aqueous 
phosphate buffer (IxlO’^M) at pH 7.4 and DMSO (3%,v/v) thermostatted at 37®C. The total 
volume was 30 cm^ and the concentration of the substrate ca. l,5xlO"^M. Due to practical 
problems, it was not possible to stir the reaction mixture. Aliquots (20 pi) of the reaction 
mixture were analysed for Cl" by ion exchange chromatography under the conditions 
described in Table 5.5. The retention times of Cl" and HPO4"  (buffer) from injection of
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standard solutions pf KCl (IxlO'^M) and the phosphate buffer used for the hydrolysis 
reaction (lxlO"^M) are also listed.
Table 5.5
Conditions for analysis by ion exchange chromatography and retention times obtained 
for authentic phosphate buffer and Clr
Column: Ion chromatography 300 l.C. (VYDAC); 0.46 x 5 cm 
Temperature: 30°C
Eluent: 2% ACN in 0.25mM phthalic acid pH 7.0, 
adjusted with triethylamine 
Flow rate: 2cm^/min 
Detector: UV 249nm 
Injection: 20 pi
Ion Rf (min)
ci- 11.8
HP04= 8.2
5.4.5 Isolation and identification of hydrolysis products for mustards 
(11) and (12) by GC and GC-MS
Substrate (11) (20 mg, 0.072 mmol) or (12) (23 mg, 0.072 mmol) in aqueous DMSO (7:3,v/ v) 
(25 cm^) at pH 2, 7and 12 [pH adjusted with HCl (IM) or NaOH (IM)] was heated at 37°C, 
with stirring, for 24 h. Where necessary, the reaction mixture was neutralized to pH 7 with 
HCl (IM) or NaOH (IM) and immediately freeze-dried. The residue was extracted into 
ethyl acetate (20 cm^), washed with water (15 cm^) and dried over anhyd. MgSO^. It was 
then analysed by GC, GC-MS, MS (FAB) and MS (El). The solvents used to dissolve the 
samples were ACN for the GC and GC-MS and 2-thiodiethanoI for MS(FAB).
The GC analysis was done against authentic 4-morphoIinoaniline (61), 
4-acetamidophenol (62), 4-phenylmorpholine (45), diethaholamine (63), a n d  
4-morpholinophenylacetamide (60). Identification was confirmed by spiking the reaction 
mixture with the authentic compound.
In Table 5.6, both the GC and GC-MS conditions are summarised together with 
retention times for authentic compounds.
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Table 5.6
Conditions for GC and GC-MS analyses and retention times for authentic compounds involved 
in identification of hydrolysis products for mustards (11) and (12)
GC conditions; Capillary BPS column: 25ih x 0.53mm;
Detector: N/P, Temp: 276°C 
Injector temp 275°C
Oven programme: 90®C (2min) to 300°C (Ih) (10®C/ min)
Capillary BP20 column : 25m x 0.53mm 
Detector: FID, Temp: 276®C.
Injector temp: 275®C
Oven programme: 90®C (Imin) to 230°C (Ih) (16®C/ min)
GC-MS conditions: Capillary BP20 column : 12m x 0.53mm;
Oven program: 80°C (2nün) to 240°C at rate (30°C/min)
Coir^und
GCRf(min) 
Column: BP5 / BP20
N-[4r[N' ,N-Bi s(2-chloroethy 1 ) 
aminophenyllacetamide (11) 17.5/ -
N-[4-lN',N'-Bis(2-chloroethyl) 
amino]phenyl]trifluoroacetamide (12) 23.2/ -
4-R>enylmorpholine (45) 8.4 / -
4-Morpholinophenylacetamide (60) 18.82 / 22.9
4-Moipholinoaniline (61) 10.9 / -
4-Acetamidophenoi (62) 10.3 / -
Diethanolamine (63) 3.3 / 5.89
5.4.6 Decomposition of AT-acetyl carbamate (26)
5.4.6.1 By UV-visible spectrophotometry
In the usual procedure, an aliquot (10 pi) of the N-acetyl carbamate (26) in DMSO (1.2 x 
10"^M) was injected into a cuvette containing either aqueous DMSO (7:3, v/v) (3 cm^), at pH 2, 
7 or 12 (adjusted with NaOH IM or HCl IM), or the organic solvent. The final concentration 
of substrate was 4xlO"^M. The cuvette was kept at either 25®C for 24h, or Ih at 25®C then at 
70®C for 48h, by water circulated through the cuvette holder.
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The UV / visible spectra of the cell contents were recorded (240-500 nm) immediately 
after injection of the substrate into the cuvette, and at timed intervals (15 min during the first 
75 min; 60 min during the next 12h and after 24h and 48h),
S.4.6.2 By analytical HPLC
Usually, an aliquot (10 pi) of the N'-acetyl carbamate (26) in DMSO (1.2x10'^ M), was 
injected into a volumetric flask containing either aqueous DMSO (7:3, v/v, 3 cm^), at pH 2, 7 or 
12 (adjusted with either NaOH IM or HCl IM) or the organic solvent. The final 
concentration of substrate was ca. 4xlO“^ M. The reaction flask was kept at 37®C in a 
thermostatted water bath. At timed intervals, aliquots (20 pi) of the reaction solution were 
taken and analysed by reverse-phase HPLC. The HPLC parameters for these assays are 
summarised in Table 5.7.
The products were identified by their retention times (Rf) relative to those for 
authentic compounds, summarised in Table 5.7. The relative areas of the 4-(N'-acetyl)amino 
carbamate substrate (26) and products were obtained from the integrator output.
To quantify the reaction products, calibration curves were generated for the substrate 
and major final products. Generally, standard solutions of the relevant compound in 
H2O/DMSO (7:3,v/v) obtained by dilution of a gravimetrically prepared stock solution, were 
assayed and quantitated by peak area. The HPLC conditions used are those described in 
Table 5.7. All the calibration curves were linear and the linear coefficients are summarised 
in Table 5.8.
A  typical chromatogram for decomposition of N ’-acetyl carbamate (26) 
(Rf=24.01 min) in aqueous DMSO at pH 12 after 48 h, showing formation of 4-nitroaniline (92) 
(Rf=19.20 min), 4-aminobenzyl alcohol (80) (Rf=2.98 min) and 4-acetamidebenzylalcohol (96) 
(Rf=13.58 min), is shown in Figure 5.4.
Table 5.7
HPLC conditions and retention times for authentic compounds involved in 
decomposition of carbamate (26)
Column: Cjg-APEX II 5p; 25 cm x 4.6mm i.d.
Temperature: 30®C 
Flow rate: 1 cm^/min 
Detection : UV 249nm
Injection: 20 pi in auto injection or manually
Eluent: Two component gradient using: Solution A  - 1% (v/v)
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ACN in 0.05M aqueous KH2PO4  (pH 2.6)* and 
. Solution B- 60% ACN in 0.05M aqueous KH2PO4 (pH 2.6)^  
Gradient program:
Time (min) %A %B
0 90 10
3.5 0 100
30 90 10
* Solution A prepared from KH2PO4  (IM, 50cm^), ACN (lOcm^) and H3PO4 
(85%, p/v,lcm^) diluted to 11
*Solution B prepared from KH2PO4  (IM, 50cm^), ACN (600cm^) and H3PO4 
(85%, p/v, Icm^) diluted to 11.
(Compound
Rf (min)
A(nm) / loge 
at HPLC eluent
4-(N'>Acetylamino) carbamate (26) 24.01 325/ 1.23 
249/1.26
4-Aminobenzyl alcohol (80) 198 249 / 1.13
4-Nitroaniline (92) 19.20 381 /1.06 
249 / 0.49
4-(N-Acetylamino)benzyl alcohol (96) 13.58 246/ 1.15 
249/1.17
Table 5.8
Coefficients for HPLC calibration curves for authentic compounds involved in 
decomposition of (26): A=249 nm, eluent: aqueous KH2PO4 buffer (pH 2.6)
Compound 10  ^X Linear coefficient
4-(N'-Acetylamino) carbamate (26) 1.84
4-Aminobenzyl alcohol (80) 1.36
4-Nitroaniline (92) 0.31
4-(N-Acetylamino)benzyl alcohol (96) 1.49
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Figure 5.4 HPLC chromatogram for the hydrolysis of N'acetyl carbamate (26) in aqueous 
DMSO (7:3,v/v) at pH 12 and 37°C after 48h: l26Jinit. ca. 4xlO~^M; 7^249 nm
5.4.6.3 Hydrolysis by the enzyme acylarylamidase
5.4.6.3.1 UV-visible spectrophotometric studies of (26) and (103) hydrolyses
A solution of compound (103) or (26) in DMSO (15 |a1, IxlO'^M) was injected into a solution of 
tris/HCl buffer (O.IM, pH 8 .6, 1470 pi) contained in the cuvette of the spectrophotome ter 
thermostatted at 37®C. Subsequently, either acylarylamidase enzyme E.G. 3.5.1.13 (l.BxlO"^ 
unit/cm^) in tris/HCl (O.IM, pH 8.6,15 pi), or simply tris/HCl (O.IM, 15 pi) without enzyme, 
was added to the cell contents. The final concentration of (103) or (26) was lxlO"^M and the 
amount of enzyme was 2.7x10",^  units, i.e. 18x10"  ^units/cm^. The cell contents were monitored 
between 250 and 500 nm at timed intervals.
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S.4.6.3.2 HPLC studies of (26) hydrolysis
To a solution of compound (26) InDMSO (15 uL IxlO'^M) in tris/HCl (O.IM, pH 8.6, 1470 jil), 
at 37®C was added acylarylamidase enzyme B.C. 3.5.1.13 (l.SxlO'^unit/cm^) in tris/HCl 
(O.IM, pH 8.6, 15 fil). Aliquots of the reaction solution were taken just before addition of the 
enzyme, immediately after addition of the enzyme, and after 3 min and 15 min, were 
analysed by HPLC against authentic compounds. The HPLC conditions and retention times 
were the same as those described in Section 5.4.6.2.
5.4.7 Decomposition of carbamate (74)
5.4.7.1 General procedure
Carbamate (74) ( 4 r 8  mg) dissolved in a mixture of DMSO and chloroform in a ratio of (3:7, 
v/v) (2 cm^), was heated in a thermostatted bath at 65°C over 48h.
At timed intervals (2h, 5h, lOh, and 48h) the reaction mixture was examined by 
^H-NMR. After 5-6h, a precipitate was visible in the NMR tube.
Aliquots (5 1^) of the reaction mixture of compound (74) at timed intervals were also 
analysed by GC using either BP5 or BP20 columns and either FID or N,P detectors, against 
authentic 4-nitroaniline (92), 4-aminobenzyIalcohol (80) and p-toluidine (89).
Aliquots (5 ul) of the reaction mixture after 2h and 48h of reaction were also analysed 
by GC-MS on a BP5 column against authentic compounds. Conditions and retention times for 
the GC and GC-MS assays are given in Tablé 5.9.
Table 5.9
Conditions and retention times for GC and GC-MS assay of carbamate (74)
GC conditions: Condition A) Capillary BP5 column: 12.5m
Oven program: 90°C (2min) to 300®C(2h) 
rate 10°C/min 
Detector: Rb bead FID, Temp 250®C,
Injection: On column, 5^ il
Condition B) Capillary BP20 column: 12.5m
Oven program: 90^C (Imin) to 250®C (3h) 
rate 16®C/ min 
Detector: FID Temp 250®C
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GC-MS conditions:
Injection : Temp 200°C, 5jil
Capillary BPS column: 12.5m 
Oven program: 90°C (2min) to 300®C(20min) 
rate 10°C/ min 
Injection: On column, 2pl
Compound GC column /Rf (min)
AT-acylcarbamate (74) BP5 / not seen
BP20 / not seen
4-Aminobenzyl alcohol (80) BP5 / 8.26
BP20 / not seen
4-Toluidine (89) BP5 / 3.85
BP20 / 4.12
Nitroaniline (92) BP5 / 11.91
BP20 / 13.0
5.4.7 2 Decomposition in the presence of Lil
The carbamate (74) (5.4 mg, 0.019 mmol) was dissolved at room temperature in DMSO/CHCI3 
(3:7, v/v) (1.1 cm^). Lithium iodide (2.5 mg, 0.019 mmol) was added, and the solution was 
heated at 65°C for 3h. Silica tic using ether as eluent showed complete disappearance of the 
starting material after 2h. The reaction mixture was concentrated under vacuum, the residue 
dissolved in ethyl acetate, applied to a preparative silica tic plate which was eluted with 
DCM. Three major fractions were obtained showing Rf=0.6 (Fraction 1), Rf=0.4 (Fraction 2) 
and Rf=0.2 (Fraction 3). These were removed from the plate, extracted with DCM, the 
solvent vacuum evaporated and the three residues obtained were analysed by NMR and 
MS(FAB) / MS(EI). Fraction 1 and 2 were also analysed by GC (BP5 column under the same 
conditions described in Section 5.4.7.1).
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5.4.8 Hydrogenolysis of JV-CBZ carbamates (75) and (76) and carbamate
(104)
5.4.8.1 General procedure
Usually, the carbamate (1 mmol) was dissolved in either acid-washed, freshly distilled 
ethyl acetate or absolute ethanol (100 cm^) with (15%, w /w ) palladium on charcoal 
(0.1 mmol) and stirred under hydrogen at room temperature. The reaction was monitored by 
silica tic using ether/n-hexane (4:1, v/v) eluent for compound (75), and by GC for compounds 
(76) and (104). For (76) and (104) the reaction products were identified by GC-MS of the 
reaction mixture after a simple filtration. For compound (75) the final products were 
identified by ^H-NMR and MS of the residue obtained after filtration of the solution and 
vacuum evaporation of the solvent at low temperature.
5.4.8.1.1 Product identification for carbamate (76)
The products were identified by GC retention times against authentic compounds, including 
spiking of the reaction solution. Their identity was confirmed by GC-MS and interpretation 
of the MS fragmentation spectra.
The GC and GC-MS conditions and related retention times of the products of 
hydrogenolysis for carbamate (76) are summarised in Table 5.10.
Table 5.10
GC and GC-MS conditions and retention times for compounds involved in 
hydrogenolysis of carbamate (76)
GC conditions: Capillary BP20 column: 12.5m
Detector: FID, Temp 276°C 
Injector temp: 260®C
Oven program: 80°C (2min) to 200°C (15min) at rate
(10®C/min);200 to 220®C rate (10®C/min)
Injection : 2 jil
GC-MS conditions: Capillary BP20 column: 12.5m
Injector Temp: 260°C
Oven program: 80°C (2min) to 220®C (20min) at rate
(10®C/min), 220 to 240®C at rate (30®C/min)
Injection: 2^1
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Compound GC Rf (min)
N-(4-trifl uoromethy lphenyl)carbamate (76) 47.25
4-(JV-Benzyioxycarbonylamino)benzyl 18.11
alcohol (85)
4-Aminobenzotrifluoride (87) 13.91
Benzyl alcohol (90) 12.30
5.4.8.1.2 Product identification for carbamate (104)
Table 5.11 shows the GC and GC-MS conditions as well as the GC retention times for the 
products involved in hydrogenolysis of (104).
Table 5.11
GC and GC-MS conditions and retention times for the hydrogenolysis of (104)
GC conditions: Capillary BP20 column: 25m
Detector Temp: 276°C;
Injector temp: 260°C
Oven programme: 80°C (2min) to 200°C (15min) rate
(10°C/min) and to 220°C (6h) rate (10°C/min)
Injection : 10^1
GC-MS conditions: Capillary BP20 column: 12m
Oven program: 80®C(2min) to 240®C rate (30°C/min)
Injector temp: 250®C 
Injection : 2 \i\ sample in EtOH
Compound GCRf(min)
Aniline (106) 11.79
4-Aminobenzyl alcohol (80) not seen
4-Toluidine (89) 12.66
4-Nitroaniline (92) 62.53
4-Nitrobenzyl JV-phenyl carbamate (104) 66.12
4-N i trobenzy lalcoh ol (105) 45.38
4-Nitrotoluene (107) 13.45
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5.4.9 Hydrolysis of alcohol (91)
4-(N-Triphenylmethylamino)benzyl alcohol (91) (7.3 g, 20 mmol) in acetone (25 cm^) and 
HCl (IM, 0.5 cm^) was stirred at room temperature for 2h. The solution was neutralized with 
aqueous satd. solution of NaHCO) to pH 7.5 and extracted into DCM (45 cm^). The extract 
was washed with water (25 cm^), dried over anhyd. MgS0 4  and the solvent vacuum 
evaporated. The product was identihed by ^H NMR and MS(FAB* )^.
5.4.10 Hydrolysis of carbamate (113)
Ethyl N-(4-nitrophenyl) carbamate (113) in DMSO (10 pl,14.5mM) was injected in a UV
cuvette containing aqueous DMSO (9:l,v/ v) (3 cm^) at pH 2, 7 and 12 (adjusted with either 
HCl or NaOH) thermostatted at 37®C. The concentration of (113) in the cuvette was 
4.8x10"^M. The reaction was monitored by recording the spectrum between 200-500 nm at 
timed intervals.
5.4.11 Hydrolysis of ester (95)
A solution of 4-(N-acetylamino)benzyl methyl ester (95) (0.69 g, 3.3 mmol) in ethanol/H 2O 
(7:20, v/v) pH 12 (adjusted with NaOH IM, 4.5 cm^) was reacted at 40®C for 6h. At timed 
intervals, aliquots (100 pi), diluted with H2O (1 ml) and neutralized with O.IM HCl, were 
assayed by HPLC (10 pi).
Hydrolysis of compound (95) was monitored by following the disappearance of the 
peak at Rf= 4.18 min (95), and the appearance of a peak at Rf= 2.78 min [4-(N- 
acetylamino)benzyl alcohol (96)] using the HPLC conditions described in Table 5.12.
Table 5.12
HPLC conditions involved in hydrolysis of ester (95)
Column: (38-Apex II octyl; 25cm x 4.6mm i d.
Eluent Isocratic; aqueous phosphate (0.02M)/ CHgCN (3:2,v/v) 
Flow rate; 1 cm^/min 
Detector: UV 263 nm 
Injection: lOpl
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The cytotoxicity of several N-acetylated aryl nitrogen mustard 
prodrugs was assessed in LS174T human colorectal cells. HPLC 
analysis showed that the N-acetylated 4-aminparyl mustard prodrug 
was a substrate for a bacterial acylarylamidase enzyme (B.C. No. 
3.5.1.13.) with release of the aminoaryl ustard. The N- 
acetylated prodrugs were nearly as toxic as the parent drug in 
LS174T and also JAR choriocarcinoma cells. There was no evidence 
of conversion of prodrug to the parent drug by the cells. A 
series of model compounds, synthesised to optimise the rate of 
turnover, showed that relatively few N-acyl groups are substrates 
for the enzyme with the N-chloroacetyl analogue being most 
reactive.
Introduction
Monoclonal antibodies have been extensively studied to assess 
their potential use in cancer chemotherapy, carrying tumour- 
directed poisons such as radiolabel[8 ] or powerful toxins[6 ] or 
as agents to expose the tumour cells to attack from the body's 
immune system[12]. These therapies are limited to the once-only 
effect of the antibody or toxin at the tumour site and require a 
high level of homogeneity in tumour cell antigen expression for 
effective localisation and treatment. Repeated administration is 
limited by the immunogenicity of non-human antibodies.
An alternative means of treatment is antibody-directed enzyme 
prodrug therapy (ADEPT). A conjugate is prepared by covalently 
linking an enzyme to a tumour-directed monoclonal antibody, once 
localised, the conjugate can activate a relatively non-toxic 
prodrug to a cytotoxic drug at the tumour site[l], thus avoiding 
systemic toxicity. Multiple doses of the prodrug could be
administered during the time that conjugate remains active at 
the tumour site; active drug formed by the conjugate would be 
capable of reaching cells in tumour masses that are inaccessible 
to antibodies. An initial study, in this Department, using a 
carboxypeptidase enzyme-antibody conjugate and a glutamated 
benzoic acid mustard prodrug directed against choriocarcinoma 
permanently eliminated the xenograft in nude mice[2]. This system 
is currently undergoing clinical trials. Another group of 
workers[1 1 ], using etoposide phosphate as prodrug, has shown that 
animals treated with alkaline phosphatase conjugates have a much 
better anti-tumour response to tumour-directed than non-localised 
conjugate, indicating that this effect is not simply due to non­
specific slow release of cytotoxic species.
The present work describes attempts to design more reactive 
active species and to maximise the difference in toxicity 
between prodrug and active species. Acylarylamidase, an enzyme of 
bacterial origin, was selected to avoid activation of prodrug, 4- 
amidoaryl mustards, by endogenous enzymes in vivo. The enzyme 
cleaves the electron-withdrawing N-acyl substituent (Figure 1) 
and releases the more reactive parent drug, 4-aminoaryl mustard. 
Alkylating agents of the nitrogen mustard type were chosen 
because their mode of action is non-cell cycle dependent and they 
tend not to induce high levels of resistance in cells[13]. 
Materials and Methods
Acylarylamidase enzyme (E.C. No. 3.5.1.13.) was a gift from Dr 
Roger Sherwood, Division of Biotechnology, PHLS centre for 
Applied Microbiology and Research, Porton Down, Salisbury, UK.
All chemicals were Analar grade and supplied by BDH (Poole, 
Dorset, UK).
Cell culture materials were supplied by Flow Laboratories,
(Richmond, Hertfordshire, UK).
Cell Culture
Human LS174T colorectal or JAR choriocarcinoma cells were grown 
in a 5% CO 2  atmosphere at 373C. The growth medium was DMEH 
containing 10% foetal calf serum supplemented with 2mM glutamine 
and penicillin/streptomycin (100 units/ml and lOOug/ml 
respectively). Cells were plated out at a density of 5 x 10^ 
cells/ml in 2ml medium in 6  well plates.. After overnight 
incubation to allow their attachment to plastic, the cells were 
treated with the drug for 1  hour and then rinsed with fresh 
medium. Drug solutions were prepared immediately before addition 
to the cells. Appropriate solvent controls were included. After 7 
days (LS174T) or 5 days (JAR) ^ incubation the cells were 
trypsinised and counted by the trypan blue exclusion method. ICgQ 
and ICgg values were estimated by non-linear regression software, 
PCNONLIN (SCI Software, Lexington, Kentucky, USA).
HEL£
HPLC was performed on a Waters automated system containing a 
6000A pump, 490 UV detector set at 278nm and 712B WISP 
autossunpler, injection volume lOul. A 5u Apex Octyl column (25 x 
0.4cm) was used at a temperature of 40^. All solvents were 
filtered through 0.45um filters. The mobile phase contained 60% 
acetonitrile, 40% 0.05M ammonium acetate pH 4.0 at 1.2ml/min. 
HPLC samples from enzyme assays were prepared by adding an equal 
volume of acetonitrile to precipitate protein. The supernatant 
was injected onto the HPLC following centrifugation.
The resulting chromatograms are shown in Figure 2. The assay was 
linear (r>0.98) up to a concentration of ImM. Intra-assay 
precision was 2.1% for the N-trifluoroacetyl analogue (n=5).
z Samples containing 4-aminoaryl mustard (T(^ = 67 min for an 
aqueous sample prepared as above) were injected immediately. 
Synthesis.
N ,N-Bis-(2-chloroethyl)-4-nitrosoaniline (Compound 5): Aniline
was converted in 71% yield using ethylene oxide to its N,N-bis- 
(2 -hydroxyethyl) derivative[1 0 ], treatment of which with tosyl 
chloride gave the bis-tosylate in 81% yield. Heating the bis- 
tosylate with CaCl2  in 2-ethoxyethanol at 120^ furnished N,N- 
bis-(2-chloroethy1) aniline (60%) [4] and this was converted to 
N,N-bis-( 2 -chloroethyl)- 4 -nitrosoaniline in 78% yield using 
nitrous acid[5]. Recrystallisation from ether yielded green 
plates ; m.p. 79-8036 (literature m.p. [3] 79-803C); v^ g^ y (nujol) 
1600, 1500, 1380, 1100, 820, 710 cm“ ;^ Sjj ((CD3 )2 CO) 4.0 (8 H,
d.t.), 7.0 (2H,d,J=9.5Hz), 7.8 (2H,d,J=9.5Hz) ; m/z 247 (M***).
N-[4-(N ',N '-Bis-(2-chloroethyl)amino)phenyl]acetamide (Compound 
i): The 4-nitrosoaniline derivative (Compound 5) was reduced
using hydrogen with 15% Pd/C catalyst (0.2 equiv. w/w) to N,N- 
bis-(2-chloroethyl)-4-phenylene diamine, which was converted 
immediately to the hydrochloride salt in a crude yield of 81%. 
This crude salt was acetylated with acetic 
anhydride/triethylamine[10], and N-[4-(N',N'-bis-(2-
chloroethyl)amino)phenyl]acetamide was obtained in 25% yield 
after purification by column chromatography (silica) and 
recrystallisation from ether/n-hexane: m.p. 1203C" (literature
m.p. [5] 124-1263C); v^ g^^  ^ (KBr) 3300 (N-H), 1650 (C=0), 1540,
1520, 1330, 1140, 820 Sjj ( (CDg);^) 2.1 (3H,S), 3.72
(8 H,S), 6.71 (2H,d,J-9Hz), 7.49 (2H,d,J=9Hz), 8 . 8  (lH,br. ex.); 
m/z 274 (M+), 225 (M-CHjCl); (Found: C, 52.3; H, 5.9; N, 9.9%. 
Calc, for CigHj^gClgNgO: C, 52.4; H, 5.9; N, 10.2%).
N-[4-(N',N '-Bis-(2-chloroethyl)amino)phenyl]trifluoroacetamide 
(Compound 2): As for compound 1 using trifluoroacetic
anhydride/triethylamine. Purification by column chromatography 
(silica) and recrystal1isation from ether/n-hexane gave N-[4- 
(N',N '-Bis-(2-chloroethyl)amino)phenyl]trifluoroacetamide in 20% 
yield: m.p. 101-1033C (literature m.p. [5] 109-1103Ç); v^ ^^  ^ (KBr) 
3300 (NH), 1730, 1700 (C=0), 1620, 1600, 1550, 1520, 1360, 1150 
and 820 cm“ ;^ Sjj ((0 0 3 )3 0 0 ) 3.8 (8 H,s), 6.83 (2H,d,J=9Hz), 7.59 
(2H,d,J=9Hz), 10.1 (lH,br. ex.);m/z 328 (M+), 279 (M-CHgCl);
(Found C, 44.1; H, 4.1; N, 8.4%). Calc, for O 2 2 H 1 3 CI 2 F 3 N 2 O: C, 
43.8; H, 4.0; N, 8.5%).
N-[4-(N ',N'-Bis-(2-chloroethyl)amino)phenyl]chloroacetamide 
(Compound 3): This was prepared using a standard method[10]: Sy 
(CDCI3 ) 3.62 (4H,t), 3.77 (4H, t), 4.19 (2H,s), 6.67 (2H,d), 7.40 
(2H,d).
N-[4-(N',N'-Bis-(2-acetyloxyethy1)amino)phenyl]acetamide 
( Compound 4): N ,N-Bis-(2-hydroxyethyl)-4-phenylene diamine
obtained as for the bis-(2 -chloroethyl) analogue above was 
stirred with excess ( 2 0  equiv. w/w) acetic anhydride/ 
triethylamine in pyridine at room temperature for 24 hours. After 
removal of the pyridine, the residue was dissolved in H 2 O, 
extracted into CH 2 CI 2  and then purified by column chromatography 
(silica). Recrystallisation from CH 2 CI 3 /n-hexane gave the final 
product in 48% yield: m.p. 59-6355; v^ ^^  ^ (KBr) 3300 (NH), 1745 
(ester C=0), 1665 cm“  ^ (amide C=0); Sy ((0 0 3 )3 0 0 ) 1.99 (6 H,s), 
2.04 (3H,S), 3.61 (4H,t,J= 6 HZ), 4.20 (4H,t ,J= 6 HZ), 6.76
(2H,d,J=9Hz), 7.40 (2H,d,J=9Hz), 8.98 (lH,br. ex.); m/z 322 (M+). 
N,N-Bis-(2-chloroethyl)-4-nitroaniline (Compound 6 ): This was
prepared by reaction of the corresponding diol[9] with thionyl 
chloride. Recrystallisation from methanol gave yellow needles: Sg 
(CDCI3 ) 3.70 (4H,t), 3.86 (4H,t), 6.71 (2H,d), 8.12 (2H,d).
N ,N-Bis-(2-chloroethyl)-1,4-phenylenediamine (Compound 8  ) : This
was prepared by reduction of the corresponding nitro compound 
following the method[5] for the nitroso derivative. It was 
isolated as the hydrochloride salt: Sy (D2 O) 3.79 (4H,t), 3.85 
(4H,t), 6.97 (2H,d), 7.31 (2H,d).
Compounds 9-23 were prepared by reaction of the appropriate acyl 
chloride with 4-nitroaniline following standard procedures. All 
compounds were pure as determined by thin layer chromatography.
Enzvme Assay
Enzyme assays for compounds 9-23 were performed as follows[7]: 
SOOul of a ImM solution of the compound was mixed with 400ul of
O.IM Tris.HCl, pH 8 .6 . The reaction at 303C was initiated by 
adding lOOul 1 unit/ml enzyme. (1 unit hydrolyses lumole of 4- 
nitroacetani1ide/min at 3 0 ^ j. The initial rate of 4-nitroaniline 
release was assessed against a solvent blank at 382nm.
Results
Incubation of a ImM solution of compound 1 with 5 units of enzyme 
at 373C in phosphate-buffered saline resulted in virtually 
complete turnover of prodrug within 2 minutes, as shown by HPLC, 
with simultaneous release of active drug (compound 8 ). The 
reaction rate was similar over the pH range 7-8, only becoming 
markedly slower at pH 5 (Figure 3 ). Figure 4 indicates that
addition of enzyme (0.4 units/ml) has virtually no effect on the 
hydrolysis rate of a ImM solution of compound 2 at 373C, whereas 
compound 1 is virtually completely turned over within 15 minutes.
Table lÂ lists the toxicities of compounds 1-8 to LS174T cells. 1 
and 2  have similar toxicity, these contain potentially labile 
^ chlorine atoms, their hydrolysis rates are similar (Tx>2.5 and 
2.3 hr in DMEM at 37^, respectively) . Compound 4, which lacks 
labile chlorine atoms, has no detectable effect on growth. The
. deactivating effect of the N-acetyl group of compound 1, has
little effect on its cytotoxicity, compared to that for the
active drug, compound 8  (Tx=8 .1 min), either as a mixture or
chemically synthesised.
The high sensitivity of the cells to the 4-nitroso aryl mustard 
(compound 5) which is stable to hydrolysis, may be due to its 
reduction to the highly reactive amino mustard within the cell. 
It was shown, by HPLC, that this occurs in the presence of NADH 
in cell medium (results not shown). Compound 6  which contains the 
strongly deactivating 4 -nitro group has measurable toxicity. This 
result will be investigated in further experiments. A previous 
study[9] noted that this compound appeared to bind to plastic 
surfaces which reduced the efficiency of drug washout after the 1  
hour drug exposure.
The JAR cell line (Table IB) gives similar results to LS174T in 
that compound 3 is nearly as cytotoxic as the 4-aminoaryl mustard 
(compound 8 ).
Table 2 shows that the addition of enzyme alone up to 5 
units/well has little effect on cell survival. Viability is 
reduced to less than 5% of control cells in the presence of 25uM 
compound 1 and up to 5 units/well of enzyme. ---
The enzymatic turnover rates for the model compounds (Table 3) 
indicate that the best substrates contain a N-chloroacetyl or N- 
acetyl group with activity diminishing rapidly if the size or
polarity of this group is altered. The model compound 12 which 
contains the N-trifluoroacetyl group is a poor substrate for the 
enzyme, as already shown for the mustard prodrug (compound 2 ). 
This is presumably due to electronic and/or steric effects of the 
-CF3  group on the enzyme.
Discussion
J
This work was stimulated by the search for more potent drugs 
for use in antibody-directed enzyme prodrug therapy. An enzyme 
suitable for ADEPT therapy should not be present in the body. 
Acylarylamidase was selected due to its bacterial origin, 
although intestinal sterilisation might be required to eliminate 
it from the gut. In addition it seemed a suitable means of 
delivering prodrugs which could be converted to the extremely 
toxic 4-aminoaryl mustard.
The results in Table lA are somewhat disappointing, indicating 
that the inclusion of an N-acyl group, which considerably 
stabilises the molecule, in respect of lengthening the chemical 
half life has little effect on the toxicity to LS174T cells. This 
result was also shown in JAR cells (Table IB). The toxicity of 
compound 8  is, however, underestimated by a 1  hr exposure time 
due to its reactivity. The N-acetyl derivative is known to be 
biologically active against the Walker rat tumour[9], whereas the 
N-trifluoroacetyl and N-chloroacetyl derivatives are not active. 
An interesting feature of Table lA is the relative sensitivity of 
the LS174T cell line to compounds 1 and 2 when compared to the 
much higher IC^q value obtained with chlorambucil (compound 7) 
which would be expected to have a similar mechanism of action.
It is well established that the reactivity of aromatic nitrogen 
mustards towards hydrolysis and alkylation is affected by
substituent electronic properties [14]. However other factors 
such as drug transport and metabolism may affect this 
relationship. For instance, the N-trifluoroacetyl prodrug 
(compound 2 ) is more lipophilic than the active drug (compound 8 ) 
and may be more readily taken up by the cell than the latter 
compound. For arguments concerning relative toxicities of 
prodrugs and active drugs it was essential to eliminate the 
possibility that there is a similar enzyme to acylarylamidase 
present in the cells. This was checked by spectrophotometric 
assay. Incubation of 4-nitroacetani1ide with LS174T cell medium, 
either fresh or the cell supernatant, or a whole cell sonicate at 
a similar cell density to that of the cytotoxicity studies, 
showed that there was no formation of 4-nitroaniline. This 
indicated that prodrugs were not being activated by an 
intracellular enzyme, at least unless the putative enzyme was 
inactivated by cell disruption. The rate of turnover was found to 
be similar in the presence of fresh medium, cell supernatant or 
phosphate-buffered saline, rendering inactivation of the enzyme 
by medium unlikely.
The structure-activity relationship of model compounds in Table 3 
indicate that there is a very narrow range of acyl groups which 
are substrates for the arylamidase enzyme, with the N- 
chloroacetyl analogue having the highest turnover rate within 
this group.
Further work is now required to prepare more hydrophilic prodrugs 
that are substrates and also sufficiently non-toxic. 
Acknowledgements
We are grateful to Mr. P. Haycock for providing some of the nmr 
spectra (University of London Intercollegiate Research Service, 
Queen Mary and Westfield College).
10
Table lA. Cytotoxicity of prodrugs and 4-aminoaryl mustard in 
LS174T cells (1 hour exposure)
Compound
General structure:
4^R -C gH 4-N ( CHgCHgCl) g
R =
1^50 (UM) ICgQ (uM)
1. -NHCOCH.
-NHCOCH- + lU Enz
3.0
0.85
11.2
1.7
2 . -NHCOCF-
-NHCOCF- + lU Enz
1 . 2
0.90
10.2
3.0
3 . NHCOCHgCl N/A 14.4
4 . -NHCOCH.
-NHCOCH. + lU Enz
>100
>100
>100
>100
5 . -NO 0.09 0 . 2 0
6 . -NO. 45 320
7. -CH2 CH2 COOH, Chlorambucil
8 . ■r"'
38
0.29
380
6 . 0
Structure = 4 -CH3 C0 NH-CgH4 -N(CH2 CH2 0 C0 CHg ) 2  
- Added as the hydrochloride salt
Compounds were dissolved in DMSO and diluted in medium to <5% 
organic solvent just prior to addition to cells.
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1i . ^
Table IB. Cytotoxicity of prodrugs and 4-aminoaryl mustard in JAR 
cells ( 1  hour exposure)
Compound IÇ5 0  (UM) I£90 (UM)
General structure:
^-R-CgH^-NfCHgCHgClig
R =
3. -NHCOCHgCl 0.50 39.2
^  8 . -NHg £ 0 . 2 2 81.0
£ Added as the hydrochloride salt
Compounds were dissolved in DMSO and diluted in medium to <5% 
organic solvent just prior to addition to cells.
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Table 2. Effect of enzyme concentration on cell cytotoxicity 
of Compound 1.
Concentration Units enzyme/Well % Control
OuH 1 82.5
2 93.9
5 89.1
25uM 1 4.4
2 3.9
5 2.6
13
Table 3. Initial hydrolysis rates of 4-nitroacylanilides by the 
acylarylamidase enzyme.
compound Compound Initial hydrolysis rate 
Lambda-Max (4-nitroacetanilide = 100)
General structure:
NOg-A-CgH^-NHCO-R
R =
9. CHgCl 315 119.4, 105.1
1 0 . CHgBr 315 87.1, 76.7
1 1 . CHClg 310 45.2, 46.1
1 2 . CF 3 330 2 . 6
13. CH 2 CH 3 310 96.1
14. CH 2 CH 2 CH 3 320 32.3, 26.1
15. CH 2 CH 2 COOH 310 0, 3.7'
16. CH 2 N(CH3 ) 3  Br 310 0
17- CfiHs 320 0
18. CHzCgHg - 0
19. (CH2 )sCH3 320 2 . 8
2 0 . (CH=CH)CH3 310 9.5, 12.5
2 1 . (CH=CH)CgH5 310 5.6, 0
2 2 . (CHg)2C0NH-4-CgH4-N02 - 0
23. . (CH2)4C0NH-4-CgH4-N02 310 0
14
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Lsgend to Figgres 
Figure 1:
The N-acetylaryl mustard prodrug (compound 1) and its amino 
mustard product (compound 8) generated by acylarylamidase.
Figure 2 :
HPLC chromatograms of N-acetylaryl mustard prodrug (compound 1) 
A: in the absence & B: in the presence of 0.4U/ml acylarylamidase 
enzyme with release of 4-aminoaryl mustard (compound 8).
HPLC chromatograms of N-trifluoroacetylaryl mustard prodrug 
(compound 2) C: in the absence & D: in the presence of 0.4U/ml 
enzyme.
Compounds were incubated at 3 7 %  for 15 minutes.
Figure 3:
Initial turnover of ImN solution of compound 1 by acylarylamidase 
enzyme (0.25U/ml) at pH 5.0 - 8.0. Samples were analysed after 5 
minutes at 3 7 %  by HPLC.
Figure 4 :
Effect of acylarylamidase enzyme on ImH solutions of compound 1 
(S) and compound 2  ( O  ) in fresh DMEM at 3 % % .  Solid line - 
no enzyme, dotted line - 0.4 units/ml.
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